data_6agp_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6agp _Structure_validation_residue.Date_analyzed 2019-03-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.583 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.39 68.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--N 1.342 0.254 0 O-C-N 119.916 -1.74 . . . . 0.0 112.73 -179.759 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.4 t0 44.64 45.49 8.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.788 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.51 90.59 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.22 30.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.505 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.4 125.46 37.07 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.6 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.581 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.12 66.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.742 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 54.5 t0 48.67 36.31 7.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.234 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.51 90.51 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.581 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.58 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.87 64.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.133 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 48' ' ' GLY . 80.4 t . . . . . 0 C--O 1.222 -0.361 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 46' ' ' VAL . 53.6 p30 -30.52 73.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.679 0.612 . . . . 0.0 112.604 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.09 2.51 88.94 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.613 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.54 -36.09 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 110.982 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.034 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.58 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.561 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.18 -48.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.837 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.32 71.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.2 m . . . . . 0 C--N 1.341 0.208 0 O-C-N 120.492 -1.38 . . . . 0.0 111.203 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.19 0.519 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 t0 55.66 18.16 2.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.63 2.51 89.87 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.9 45.5 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 118.471 1.136 . . . . 0.0 112.423 -174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.491 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.54 77.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 m -60.76 -26.68 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 120.294 -1.504 . . . . 0.0 114.367 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.54 19.81 18.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.304 -0.873 . . . . 0.0 112.041 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.0 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 15.2 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.38 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.687 1.13 . . . . 0.0 112.502 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.09 -30.24 69.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.744 2.018 . . . . 0.0 111.574 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.85 -5.34 56.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.15 -1.37 48.61 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.25 1.42 . . . . 0.0 111.365 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.94 -1.725 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.61 -50.67 70.32 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.226 175.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.8 126.35 41.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.19 60.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 121.294 -0.879 . . . . 0.0 112.851 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 88.6 m -70.23 -45.1 67.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.38 -13.71 21.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 121.723 -0.611 . . . . 0.0 112.29 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.66 8.9 3.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.228 2.211 . . . . 0.0 113.489 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.82 115.9 5.26 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.256 -1.528 . . . . 0.0 113.076 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.98 -0.11 67.62 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.952 0.787 . . . . 0.0 114.274 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.7 tp -66.2 -46.09 78.51 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.24 -38.65 87.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 112.28 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.5 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.17 167.026 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -50.02 63.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 C--N 1.345 0.382 0 O-C-N 121.598 -0.689 . . . . 0.0 112.592 -177.641 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.3 t . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 59.87 37.28 21.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.759 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.6 2.51 90.55 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.45 70.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.7 -35.92 81.29 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.012 -1.055 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.29 19.85 11.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.034 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.76 37.46 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.572 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.27 30.37 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 175.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.31 125.46 36.98 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 84.4 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.98 69.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.467 0.402 0 O-C-N 120.65 -1.281 . . . . 0.0 112.751 -178.615 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 121.37 0.605 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 62.27 23.85 14.15 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.57 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.46 2.51 90.62 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.55 15.2 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.727 1.149 . . . . 0.0 112.502 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 97.8 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.9 70.2 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.533 0.296 0 O-C-N 120.569 -1.332 . . . . 0.0 113.88 -179.191 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 50.56 20.15 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.644 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.54 2.51 90.54 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 92.8 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.73 37.33 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.566 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.4 30.23 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 175.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.25 125.46 36.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.7 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.04 66.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.469 0.509 0 O-C-N 120.084 -1.635 . . . . 0.0 114.072 -178.789 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 121.236 0.541 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 60.31 28.73 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.991 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.51 90.0 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.579 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 80.3 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.72 64.56 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.256 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.676 ' CG2' ' O ' ' A' ' 49' ' ' LYS . 7.2 m . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -64.18 62.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.845 0.831 . . . . 0.0 111.489 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.62 2.51 89.84 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 115.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.676 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.54 15.19 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.736 1.153 . . . . 0.0 112.502 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.11 60.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 87.0 m -69.97 -45.44 67.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.46 -13.78 21.55 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.723 -0.611 . . . . 0.0 112.288 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.58 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.18 66.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.551 0 O-C-N 120.449 -1.407 . . . . 0.0 113.814 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.789 -0.078 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -81.3 67.61 7.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.668 0.747 . . . . 0.0 111.14 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.28 2.51 89.26 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.334 -1.303 . . . . 0.0 115.298 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.5 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.58 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 61.1 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.581 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.8 70.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.473 0.711 0 O-C-N 120.332 -1.48 . . . . 0.0 113.902 -179.246 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.58 68.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.618 0.723 . . . . 0.0 112.579 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.0 2.51 88.78 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.705 -1.134 . . . . 0.0 115.298 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.47 -36.1 81.4 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.858 -1.151 . . . . 0.0 111.225 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.25 19.85 11.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.034 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.581 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.15 30.49 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 175.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.42 125.46 37.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' CG ' ' SG ' ' A' ' 160' ' ' CYS . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.641 ' OG ' ' SG ' ' A' ' 160' ' ' CYS . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . 0.641 ' SG ' ' OG ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.6 71.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 CA--C 1.53 0.201 0 O-C-N 120.64 -1.288 . . . . 0.0 113.445 -179.513 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.466 0.651 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 54.3 t0 64.12 24.6 13.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.171 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.42 2.51 90.18 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.3 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.236 -0.915 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m 72.54 15.21 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.34 125.46 32.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.502 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 91.3 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.596 ' O ' ' OG1' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.535 ' O ' ' C ' ' A' ' 24' ' ' THR . 58.7 t80 -66.96 -49.09 66.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 30.8 p . . . . . 0 C--N 1.332 -0.152 0 O-C-N 121.336 -0.853 . . . . 0.0 110.736 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 48' ' ' GLY . 5.6 m . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -47.09 66.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 82.54 2.51 90.63 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.68 -1.146 . . . . 0.0 115.298 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.591 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 126.65 21.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 87.55 12.02 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.512 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -80.16 125.46 29.86 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.7 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.58 139.54 31.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 119.121 0.873 . . . . 0.0 111.498 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.21 128.0 53.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mt -126.42 126.18 68.68 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.63 124.83 45.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.713 -1.242 . . . . 0.0 111.752 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 t -119.48 131.36 55.58 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.096 -1.003 . . . . 0.0 111.472 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.5 t -116.98 132.66 66.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.39 124.37 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.342 1.057 . . . . 0.0 109.463 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.08 166.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.538 -1.976 . . . . 0.0 109.914 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.07 165.85 10.44 Favored Glycine 0 CA--C 1.494 -1.231 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.64 151.46 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.275 1.83 . . . . 0.0 113.93 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.11 146.71 35.78 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 118.816 -2.427 . . . . 0.0 111.833 165.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.71 0.62 3.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.44 -16.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 O-C-N 119.206 -2.184 . . . . 0.0 113.989 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.69 17.28 9.26 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 120.365 -1.46 . . . . 0.0 115.454 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.64 -49.6 75.93 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.116 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -61.54 -47.59 84.88 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.386 1.088 . . . . 0.0 113.004 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.1 m -63.12 -36.84 84.95 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.11 91.01 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.923 1.289 . . . . 0.0 112.31 172.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.79 -47.13 66.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.15 -48.4 88.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.127 0.876 . . . . 0.0 110.805 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -60.49 -41.36 94.1 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.94 -48.78 67.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.261 -0.899 . . . . 0.0 113.401 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.467 0.378 0 O-C-N 120.53 -1.356 . . . . 0.0 114.52 -178.445 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.14 28.09 14.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.885 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.49 90.49 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.98 123.88 45.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 118.494 1.147 . . . . 0.0 112.413 -174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.88 110.4 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 CA-C-N 121.77 1.668 . . . . 0.0 110.613 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -117.73 129.66 73.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.015 0.926 . . . . 0.0 109.413 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -103.01 106.11 16.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 tp -98.53 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.096 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.28 127.41 7.98 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 120.974 -1.078 . . . . 0.0 111.308 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.76 133.03 54.26 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.934 0.894 . . . . 0.0 110.63 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.33 123.15 31.06 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.979 0.912 . . . . 0.0 108.629 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.01 11.45 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 109.682 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.92 33.86 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 124.085 1.897 . . . . 0.0 113.439 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.58 108.26 11.85 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 120.288 -1.508 . . . . 0.0 109.906 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.95 -5.58 88.85 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 120.408 -1.432 . . . . 0.0 115.938 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -62.05 145.77 52.21 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.325 1.85 . . . . 0.0 112.159 -177.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.35 -30.59 70.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.861 2.064 . . . . 0.0 112.081 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.35 -36.21 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.874 -1.142 . . . . 0.0 111.235 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -96.15 19.83 11.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.028 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 49.8 m-20 -56.3 -27.18 54.63 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 113.63 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -29.53 25.68 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 175.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.9 tp -96.07 -36.97 10.81 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.978 1.311 . . . . 0.0 112.485 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -58.21 -39.68 77.42 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 119.869 -1.769 . . . . 0.0 115.181 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -65.2 -7.11 14.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 124.739 2.728 . . . . 0.0 115.587 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.29 -16.96 62.49 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.6 p -92.03 -8.15 46.79 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.607 -1.308 . . . . 0.0 112.445 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -68.47 -35.28 6.71 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 97.4 Cg_exo -52.39 130.92 38.09 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.505 2.804 . . . . 0.0 115.316 173.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.6 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 72.94 30.76 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.388 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.1 m -92.54 125.4 37.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 170.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.24 -30.87 22.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.151 0.98 . . . . 0.0 112.33 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.3 143.51 18.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.812 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.95 43.01 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.522 -1.361 . . . . 0.0 110.526 174.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.88 114.06 27.82 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.494 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.35 115.95 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.7 m -109.05 142.62 39.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.655 1.217 . . . . 0.0 112.418 -172.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -139.82 152.16 46.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 171.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.0 t -85.81 132.32 34.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.995 -1.066 . . . . 0.0 110.126 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.24 -12.79 61.58 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 125.239 1.416 . . . . 0.0 113.561 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.8 18.27 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.686 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 t -132.19 103.75 13.92 Favored Pre-proline 0 C--N 1.352 0.716 0 O-C-N 119.71 -1.869 . . . . 0.0 109.94 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -66.43 -27.12 47.22 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 123.17 2.58 . . . . 0.0 114.099 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.974 0.91 . . . . 0.0 112.597 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.35 -35.66 80.91 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.095 -1.003 . . . . 0.0 112.418 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.5 t80 -60.22 -49.26 78.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.747 1.219 . . . . 0.0 112.783 173.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.22 -23.07 60.32 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.451 -1.406 . . . . 0.0 113.175 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -66.45 -25.11 66.57 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.94 -1.725 . . . . 0.0 113.171 168.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.29 98.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 O-C-N 119.674 -1.891 . . . . 0.0 111.763 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.8 ttm-85 -64.81 -48.61 73.79 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.204 1.402 . . . . 0.0 114.161 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.98 25.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.84 -62.82 0.8 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.405 -1.435 . . . . 0.0 113.016 -172.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -67.78 -44.56 77.14 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -169.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.75 -48.37 79.79 Favored Pre-proline 0 C--N 1.353 0.751 0 CA-C-O 116.667 -1.635 . . . . 0.0 113.034 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -56.25 -42.91 61.18 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.117 2.545 . . . . 0.0 114.603 172.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.12 -51.38 66.74 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 119.074 0.852 . . . . 0.0 112.726 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.21 -42.27 92.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.028 -1.67 . . . . 0.0 111.529 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -66.64 -38.44 86.9 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.98 -44.44 97.36 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.429 1.013 . . . . 0.0 112.824 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -82.49 -31.31 29.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.72 -1.237 . . . . 0.0 113.228 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.64 90.06 14.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 120.17 -1.581 . . . . 0.0 110.256 -176.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.17 -30.84 19.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.954 1.769 . . . . 0.0 116.262 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.44 -6.59 16.1 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 124.052 0.941 . . . . 0.0 113.328 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.65 134.16 94.26 Favored Pre-proline 0 C--N 1.352 0.7 0 O-C-N 119.287 -2.133 . . . . 0.0 112.367 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.61 141.38 43.23 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 124.967 3.778 . . . . 0.0 117.685 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.494 HD11 HD12 ' A' ' 80' ' ' ILE . 81.7 mt -119.46 135.71 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.68 123.96 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 168.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.8 tp -89.02 124.02 33.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.87 120.68 65.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 121.977 0.894 . . . . 0.0 109.417 -174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.13 113.5 4.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.4 p -98.49 162.54 13.1 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.95 -1.324 . . . . 0.0 111.344 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.73 42.99 4.34 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.985 1.314 . . . . 0.0 112.865 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.4 -32.21 69.96 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.12 -30.23 69.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.764 2.025 . . . . 0.0 111.574 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.84 -5.37 56.93 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.77 -35.12 80.07 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.625 -1.297 . . . . 0.0 113.882 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.16 -1.36 48.6 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 111.386 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 118.03 12.08 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 119.877 -1.765 . . . . 0.0 111.326 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -44.99 93.32 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.6 -50.63 70.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.42 0.688 . . . . 0.0 111.244 175.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -55.54 -44.39 76.71 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.331 -1.481 . . . . 0.0 113.536 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.53 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.458 1.103 . . . . 0.0 112.715 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.4 -46.5 89.76 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.783 -1.198 . . . . 0.0 112.314 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.98 -37.27 79.14 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.71 -1.244 . . . . 0.0 114.111 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.05 -46.1 82.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.381 -1.45 . . . . 0.0 112.97 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.55 -34.76 73.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.76 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.737 1.215 . . . . 0.0 113.542 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.43 9.36 40.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.902 -1.124 . . . . 0.0 111.729 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.79 38.24 3.88 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 125.45 1.5 . . . . 0.0 114.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 161.33 24.6 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 125.933 1.693 . . . . 0.0 107.152 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.4 p -138.87 159.01 68.88 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.18 156.64 61.86 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.688 2.259 . . . . 0.0 114.213 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.99 117.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 122.729 1.252 . . . . 0.0 109.846 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 55.1 p -76.29 165.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.898 -1.126 . . . . 0.0 111.321 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -57.47 -46.2 99.81 Favored Pre-proline 0 C--N 1.354 0.769 0 O-C-N 120.531 -1.356 . . . . 0.0 112.671 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.37 -38.51 94.32 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 124.228 2.546 . . . . 0.0 116.051 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.47 -43.15 91.17 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.074 1.306 . . . . 0.0 112.744 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.33 -38.51 81.21 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 120.646 -1.284 . . . . 0.0 115.363 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.57 87.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.534 1.133 . . . . 0.0 113.518 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.1 90.66 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.334 1.054 . . . . 0.0 112.485 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.77 -41.17 97.35 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.46 85.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.059 0.943 . . . . 0.0 112.832 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.08 -43.46 95.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -62.22 -33.65 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.668 . . . . 0.0 113.928 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.66 2.9 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.634 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.81 41.17 50.75 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.265 -1.522 . . . . 0.0 116.32 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.28 148.05 52.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.224 1.012 . . . . 0.0 112.522 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.32 -34.28 65.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 O-C-N 121.006 -1.059 . . . . 0.0 110.582 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.4 150.72 30.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.815 -1.178 . . . . 0.0 109.679 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -115.63 128.74 56.15 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 169.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.9 mt -138.76 146.25 41.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.705 0.802 . . . . 0.0 109.552 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.53 137.94 54.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.77 30.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 123.532 1.634 . . . . 0.0 112.511 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.2 t -127.77 126.32 41.55 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.315 -0.866 . . . . 0.0 112.828 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 73.8 m -83.84 -41.21 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.556 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 77.0 p -98.94 -13.74 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.302 93.7 mt-30 75.7 8.88 3.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.217 2.207 . . . . 0.0 113.481 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.81 115.91 5.27 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.3 -1.5 . . . . 0.0 113.08 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.01 -0.14 67.67 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.985 0.802 . . . . 0.0 114.274 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.16 -46.15 78.44 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -38.61 87.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.094 0.957 . . . . 0.0 112.316 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.76 -37.27 68.3 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.529 1.932 . . . . 0.0 112.216 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 94.0 t -57.64 -46.62 86.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.575 1.15 . . . . 0.0 112.535 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.15 -32.09 50.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 0.0 112.733 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.15 -44.22 97.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.405 1.082 . . . . 0.0 111.717 172.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.67 -34.06 76.17 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.013 -1.679 . . . . 0.0 114.415 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.26 88.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.617 -1.302 . . . . 0.0 112.118 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.99 -45.84 89.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 124.129 0.972 . . . . 0.0 113.449 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -61.48 -31.43 71.41 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.202 -1.562 . . . . 0.0 114.344 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.84 69.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.4 -39.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.351 0.657 0 C-N-CA 125.04 1.336 . . . . 0.0 112.04 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.54 -19.96 40.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.049 -1.657 . . . . 0.0 114.775 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.34 67.67 76.56 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.7 -176.41 2.47 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.688 1.592 . . . . 0.0 109.0 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -112.11 122.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.567 2.172 0 O-C-N 125.256 2.187 . . . . 0.0 116.132 157.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.048 3.166 . . . . 0.0 116.138 167.016 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.51 68.32 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.62 ' O ' ' CG2' ' A' ' 24' ' ' THR . 11.9 t . . . . . 0 C--N 1.33 -0.27 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.737 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.538 ' CG1' ' H ' ' A' ' 47' ' ' ASP . 2.0 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.538 ' H ' ' CG1' ' A' ' 46' ' ' VAL . 98.6 m-20 -75.76 68.09 2.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.103 0.954 . . . . 0.0 111.054 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.51 89.78 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.298 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.5 OUTLIER -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.638 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.27 72.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 21' ' ' ILE . 99.3 m . . . . . 0 N--CA 1.466 0.349 0 O-C-N 120.743 -1.223 . . . . 0.0 112.134 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 110.823 -0.066 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -82.82 67.94 9.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.145 0.974 . . . . 0.0 111.783 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 2.51 89.27 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 113.502 -1.681 . . . . 0.0 115.298 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.8 37.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.571 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 14.6 m 73.19 30.43 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 175.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 72.4 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.63 67.96 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 m . . . . . 0 C--N 1.343 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.664 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.31 24.99 5.48 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.322 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.39 2.51 84.31 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.9 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 99.1 m -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.68 67.78 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 20' ' ' LEU . 15.3 t . . . . . 0 CA--C 1.532 0.258 0 O-C-N 119.803 -1.811 . . . . 0.0 113.346 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 49' ' ' LYS . 26.3 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -80.32 67.64 6.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.359 0.599 . . . . 0.0 112.343 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.51 90.58 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.042 -0.981 . . . . 0.0 115.298 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.577 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.52 70.64 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.2 m -62.5 -36.17 81.69 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.037 -1.039 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.14 19.85 11.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.034 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.559 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 60.4 m 73.21 30.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.29 125.46 36.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.23 59.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.4 m -84.52 -40.45 17.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -171.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.4 -13.78 19.42 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.581 ' HD3' ' SG ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.0 69.87 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' ILE . 94.4 m . . . . . 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.21 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.514 HG21 ' N ' ' A' ' 47' ' ' ASP . 11.9 p . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.514 ' N ' HG21 ' A' ' 46' ' ' VAL . 97.0 m-20 56.23 17.19 2.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.021 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.88 2.51 82.04 Favored Glycine 0 C--N 1.318 -0.421 0 CA-C-N 115.137 -0.938 . . . . 0.0 115.298 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.74 70.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.88 -36.86 82.5 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.024 -1.048 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -95.67 19.85 10.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.034 -175.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.569 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 129.3 31.12 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 74' ' ' CYS . 0.5 OUTLIER 77.18 26.32 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.371 173.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -89.76 125.46 35.3 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.59 59.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.82 -41.02 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.665 -171.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -98.96 -13.78 19.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -51.29 56.95 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.233 0.195 0 O-C-N 124.635 1.209 . . . . 0.0 113.117 -177.154 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 46' ' ' VAL . 54.5 p-10 -60.53 63.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.467 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.53 2.51 89.7 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.579 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 5.0 m 73.19 30.41 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.571 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 76.1 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.583 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.623 HD13 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.39 68.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.1 p -81.24 -52.64 7.12 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 119.916 -1.74 . . . . 0.0 112.73 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 21' ' ' ILE . 87.7 m -132.35 132.44 42.91 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.317 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.666 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 66.2 t30 -93.89 146.69 23.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.666 ' CB ' ' O ' ' A' ' 26' ' ' ASN . . . 107.48 145.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.781 0.676 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.62 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 78.3 m-85 -57.3 -45.82 99.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.022 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 38.1 Cg_endo -66.59 -17.33 52.83 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.433 2.089 . . . . 0.0 113.24 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 31' ' ' CYS . . . -60.38 -35.11 87.73 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.642 ' O ' ' SG ' ' A' ' 31' ' ' CYS . 22.6 p -23.73 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 30' ' ' GLY . 7.6 m-85 -98.85 161.84 13.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.48 1.134 . . . . 0.0 113.052 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.633 ' CG2' ' HD2' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -122.64 162.49 38.16 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 112.733 -2.031 . . . . 0.0 108.614 175.21 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.633 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 36.4 Cg_endo -65.89 -15.95 50.92 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.009 1.806 . . . . 0.0 112.007 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.1 p -70.62 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 38' ' ' ASP . 58.0 t -64.26 130.03 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -75.68 -12.31 60.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.588 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 98.9 m-20 -61.28 -41.9 97.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.349 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' CG ' ' O ' ' A' ' 38' ' ' ASP . 21.0 m-20 152.88 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.202 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 55' ' ' LEU . 14.0 t80 -118.59 -37.68 3.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.788 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.4 p -72.89 163.82 27.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.06 141.33 48.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.734 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' C ' ' HE2' ' A' ' 45' ' ' MET . 88.0 m-20 -86.59 100.05 12.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.779 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.621 ' C ' ' SD ' ' A' ' 45' ' ' MET . 6.2 p -123.37 136.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.116 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.621 ' SD ' ' C ' ' A' ' 44' ' ' VAL . 4.6 mmt -129.66 121.03 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.3 t -127.94 128.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.199 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.4 t0 44.64 45.49 8.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.788 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.51 90.59 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.585 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.22 30.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.505 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.4 125.46 37.07 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.6 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.581 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 29' ' ' PRO . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.12 66.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -59.79 -45.05 93.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 26' ' ' ASN . 14.2 t -106.87 141.25 38.4 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.991 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.56 ' O ' ' O ' ' A' ' 25' ' ' THR . 62.0 t30 -52.43 -140.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.054 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' H ' ' CG ' ' A' ' 26' ' ' ASN . . . -63.18 142.01 58.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.1 t80 62.98 104.47 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.559 ' HA ' ' CG2' ' A' ' 25' ' ' THR . 39.0 Cg_exo -57.56 142.63 95.57 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.981 2.454 . . . . 0.0 113.176 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.583 ' O ' ' C ' ' A' ' 31' ' ' CYS . . . -106.51 115.05 4.6 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' C ' ' O ' ' A' ' 30' ' ' GLY . 55.8 m 23.01 -110.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.675 0.274 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CD2' HG12 ' A' ' 33' ' ' ILE . 3.3 t80 -148.12 -91.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.607 HG12 ' CD2' ' A' ' 32' ' ' TYR . 47.8 mm -84.7 120.9 74.51 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.21 157.72 56.53 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.4 p -64.81 -21.08 66.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.099 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.93 126.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 23.1 p90 -108.95 58.2 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.871 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.14 111.16 22.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.625 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' C ' ' H ' ' A' ' 41' ' ' SER . 64.8 t30 58.86 46.56 13.73 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -68.61 1.42 3.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.866 0.841 . . . . 0.0 109.166 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 53' ' ' LEU . 95.6 p -93.63 -3.02 53.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.802 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 50.55 116.36 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.092 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.586 ' OD1' ' CE ' ' A' ' 45' ' ' MET . 48.5 p-10 -87.7 45.44 1.28 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.443 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 9.7 p -36.33 137.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.442 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.586 ' CE ' ' OD1' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -116.65 115.41 25.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.808 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -138.12 137.57 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 54.5 t0 48.67 36.31 7.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.234 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.51 90.51 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 43' ' ' ASN . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.581 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.58 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.502 ' HE2' ' HB1' ' A' ' 42' ' ' ALA . 58.7 t80 -66.96 -49.87 64.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p -79.94 -21.3 44.0 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.563 ' CG2' HG23 ' A' ' 21' ' ' ILE . 13.7 t -148.11 162.4 39.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.735 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 26' ' ' ASN . 29.2 t-20 -121.94 39.26 3.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.31 149.28 42.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.339 . . . . 0.0 110.921 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.525 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -59.61 -58.28 20.64 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.41 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 28' ' ' PHE . 54.3 Cg_exo -49.18 -161.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.981 2.454 . . . . 0.0 112.798 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 40.36 53.97 3.35 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.64 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.89 50.18 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.714 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.537 ' HB3' ' O ' ' A' ' 31' ' ' CYS . 79.9 t80 71.63 -5.19 1.7 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 31' ' ' CYS . 1.8 mp -53.63 -48.09 94.33 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.334 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 24.5 Cg_exo -62.96 142.81 89.58 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.019 1.813 . . . . 0.0 110.022 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -134.62 150.07 50.64 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 40' ' ' TYR . 48.2 t -147.48 90.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.294 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -65.46 -37.73 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.654 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.84 -42.46 97.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.514 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -154.96 94.45 1.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.947 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 84.3 t80 -143.11 107.13 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.613 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 92.7 p -158.73 159.98 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.247 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.623 ' CB ' HD13 ' A' ' 55' ' ' LEU . . . -68.86 145.86 53.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 110.12 21.4 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.661 ' O ' ' SD ' ' A' ' 45' ' ' MET . 33.2 m -128.04 153.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.273 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 44' ' ' VAL . 11.5 mmt -141.89 144.46 33.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.485 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 48' ' ' GLY . 80.4 t -134.4 158.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.447 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' N ' HG12 ' A' ' 46' ' ' VAL . 53.6 p30 -30.52 73.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.679 0.612 . . . . 0.0 112.604 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.09 2.51 88.94 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.613 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.623 HD13 ' CB ' ' A' ' 42' ' ' ALA . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.54 -36.09 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 110.982 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.034 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.58 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.561 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.574 HD12 ' CG2' ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.676 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 mt -60.18 -48.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.837 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' HE2' ' HB1' ' A' ' 42' ' ' ALA . 58.7 t80 -66.96 -47.32 71.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.614 ' O ' ' CB ' ' A' ' 25' ' ' THR . 43.2 m -53.97 131.34 40.18 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.492 -1.38 . . . . 0.0 111.203 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' THR . 2.3 m 95.28 -13.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.255 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' OD1' ' O ' ' A' ' 25' ' ' THR . 17.2 p30 32.07 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -153.77 140.24 18.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' O ' ' O ' ' A' ' 27' ' ' ALA . 2.6 p90 44.78 175.46 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 28' ' ' PHE . 15.4 Cg_endo -57.2 148.93 67.01 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.556 1.504 . . . . 0.0 112.682 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 21' ' ' ILE . . . -61.3 140.72 47.75 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.508 ' SG ' ' HZ ' ' A' ' 28' ' ' PHE . 1.8 m -76.79 -107.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.515 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.676 ' CE1' ' CD1' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 167.78 155.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.554 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 26.2 pt -138.59 57.48 11.88 Favored Pre-proline 0 C--O 1.232 0.179 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.014 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 33' ' ' ILE . 63.8 Cg_exo -54.81 -43.38 59.84 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.676 2.25 . . . . 0.0 112.479 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.9 p -131.88 -8.13 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG2' HG22 ' A' ' 33' ' ' ILE . 1.5 m -84.48 157.56 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 38' ' ' ASP . 97.0 m-85 -77.04 -75.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' HB3' HG22 ' A' ' 33' ' ' ILE . 53.1 t0 39.97 49.18 2.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.25 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.556 ' O ' ' O ' ' A' ' 40' ' ' TYR . 32.8 m120 -100.95 16.57 24.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.498 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.556 ' O ' ' O ' ' A' ' 39' ' ' ASN . 50.1 m-85 -54.3 -143.08 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.482 0.658 . . . . 0.0 110.874 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 99.1 p -137.31 160.88 37.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB1' ' HE2' ' A' ' 23' ' ' TYR . . . -61.8 143.6 56.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.06 0.457 . . . . 0.0 110.593 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.618 ' OD1' ' CE ' ' A' ' 45' ' ' MET . 43.6 t30 -88.11 88.64 7.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.621 ' C ' ' SD ' ' A' ' 45' ' ' MET . 33.3 m -116.37 142.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.278 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.621 ' SD ' ' C ' ' A' ' 44' ' ' VAL . 2.2 mpt? -157.36 85.76 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.647 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.63 161.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.873 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 t0 55.66 18.16 2.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.63 2.51 89.87 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.9 45.5 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 118.471 1.136 . . . . 0.0 112.423 -174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' HB ' HG21 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.491 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.54 77.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 m -60.76 -26.68 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 120.294 -1.504 . . . . 0.0 114.367 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.54 19.81 18.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.304 -0.873 . . . . 0.0 112.041 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.0 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 15.2 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.38 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.687 1.13 . . . . 0.0 112.502 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.09 -30.24 69.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.744 2.018 . . . . 0.0 111.574 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.85 -5.34 56.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.15 -1.37 48.61 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.25 1.42 . . . . 0.0 111.365 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.94 -1.725 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.61 -50.67 70.32 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.226 175.108 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.8 126.35 41.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.19 60.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 121.294 -0.879 . . . . 0.0 112.851 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.602 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 88.6 m -70.23 -45.1 67.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.38 -13.71 21.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 121.723 -0.611 . . . . 0.0 112.29 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.66 8.9 3.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.228 2.211 . . . . 0.0 113.489 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.82 115.9 5.26 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.256 -1.528 . . . . 0.0 113.076 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.98 -0.11 67.62 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.952 0.787 . . . . 0.0 114.274 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.7 tp -66.2 -46.09 78.51 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.24 -38.65 87.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 112.28 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.5 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.17 167.026 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.602 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.574 ' O ' ' CB ' ' A' ' 25' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -50.02 63.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.3 p -89.18 -2.43 58.5 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.598 -0.689 . . . . 0.0 112.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.623 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 94.2 m -109.16 130.44 55.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.935 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.534 ' O ' ' C ' ' A' ' 27' ' ' ALA . 33.6 m120 -47.37 135.07 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' C ' ' O ' ' A' ' 26' ' ' ASN . . . 27.97 -103.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.484 ' O ' HG23 ' A' ' 25' ' ' THR . 54.7 t80 -62.45 136.19 95.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.426 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 21' ' ' ILE . 32.2 Cg_exo -59.59 144.86 99.32 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.001 2.468 . . . . 0.0 112.554 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.623 ' N ' ' CG2' ' A' ' 25' ' ' THR . . . -166.97 -177.71 38.9 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 30' ' ' GLY . 41.5 t 49.19 98.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.207 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -57.33 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.971 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.599 ' CD1' ' C ' ' A' ' 33' ' ' ILE . 2.2 pp -129.58 155.04 80.89 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.659 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 55.7 Cg_endo -69.25 142.61 50.66 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.311 2.007 . . . . 0.0 112.239 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.1 p -122.13 10.6 10.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.735 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' OH ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -117.16 131.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.735 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.638 ' O ' ' O ' ' A' ' 38' ' ' ASP . 97.0 m-85 -63.53 -40.84 98.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.333 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.638 ' O ' ' O ' ' A' ' 37' ' ' PHE . 45.5 t0 -6.34 -118.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.664 0.603 . . . . 0.0 111.946 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 88.3 m-20 -149.44 133.52 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.548 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 34' ' ' PRO . 43.2 m-85 -122.84 77.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.969 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.631 ' O ' ' N ' ' A' ' 53' ' ' LEU . 48.7 m -121.37 -11.85 8.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.992 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 41' ' ' SER . . . 85.52 160.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.537 ' HA ' ' CE ' ' A' ' 45' ' ' MET . 50.6 p30 -100.08 35.65 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.654 ' O ' ' SD ' ' A' ' 45' ' ' MET . 2.0 p -68.68 113.81 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 111.6 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.654 ' SD ' ' O ' ' A' ' 44' ' ' VAL . 6.9 mmt -136.86 106.15 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.95 135.49 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 59.87 37.28 21.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.759 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.6 2.51 90.55 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.56 ' HB ' HG12 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.573 ' C ' ' HB3' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.45 70.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.7 -35.92 81.29 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.012 -1.055 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.29 19.85 11.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.034 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.76 37.46 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.572 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.27 30.37 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 175.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.31 125.46 36.98 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.976 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 84.4 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.509 HD12 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.976 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.48 ' CG2' ' HA3' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.98 69.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 25' ' ' THR . 71.2 p -51.86 169.21 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.65 -1.281 . . . . 0.0 112.751 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 24' ' ' THR . 27.9 p -19.53 140.59 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.607 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -90.32 76.3 6.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.372 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.592 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -159.96 151.89 20.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.467 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.719 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 52.7 t80 54.97 151.43 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.719 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 83.5 Cg_exo -43.77 -24.42 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.414 2.076 . . . . 0.0 113.22 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . 146.77 114.17 0.82 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.043 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.532 ' HB3' ' OH ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -66.45 152.91 44.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ILE . 34.5 t80 -123.1 -112.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.248 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER 51.6 115.19 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.38 -21.93 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.136 1.891 . . . . 0.0 111.83 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.63 ' OG1' ' CE1' ' A' ' 37' ' ' PHE . 78.3 p -82.4 168.79 17.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.667 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' A' ' 40' ' ' TYR . 1.1 t -116.59 122.14 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.38 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 87.3 m-85 -127.0 148.11 50.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.338 0.589 . . . . 0.0 111.242 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.4 t0 49.97 56.55 7.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.668 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' SER . 65.4 t30 57.98 50.39 10.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.704 -0.399 . . . . 0.0 112.001 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.591 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -69.27 68.84 0.21 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.898 0.856 . . . . 0.0 109.729 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 91.7 p -155.44 158.93 39.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.64 140.4 47.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.428 . . . . 0.0 111.207 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.592 ' O ' ' O ' ' A' ' 44' ' ' VAL . 98.6 m-20 -101.0 10.65 40.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.592 ' O ' ' O ' ' A' ' 43' ' ' ASN . 16.7 m -10.92 133.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.779 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.575 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -135.36 95.56 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.561 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -141.34 143.07 28.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.107 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 62.27 23.85 14.15 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.57 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.46 2.51 90.62 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.558 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.55 15.2 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.727 1.149 . . . . 0.0 112.502 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.581 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 97.8 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.437 HD13 HG23 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.581 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.636 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.9 70.2 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.531 ' C ' HG22 ' A' ' 25' ' ' THR . 73.3 p -94.64 -5.2 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.569 -1.332 . . . . 0.0 113.88 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.636 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 7.2 p -137.17 177.48 7.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.947 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 27' ' ' ALA . 53.7 p30 -92.48 -136.24 0.16 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -45.4 -176.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.503 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 32.7 m-85 -48.7 -46.65 72.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 28.0 Cg_exo -60.93 143.26 99.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.318 2.012 . . . . 0.0 112.695 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.82 -29.11 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.684 ' C ' ' CG ' ' A' ' 32' ' ' TYR . 1.1 m 60.65 24.8 14.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.684 ' CG ' ' C ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER 52.68 -91.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 3.2 mp -131.48 70.03 81.68 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.093 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.662 ' O ' ' CG2' ' A' ' 35' ' ' THR . 34.8 Cg_endo -65.36 -19.05 61.61 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.257 2.638 . . . . 0.0 112.486 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.662 ' CG2' ' O ' ' A' ' 34' ' ' PRO . 77.9 p 116.45 63.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.225 0.953 . . . . 0.0 110.041 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.7 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 98.7 t -64.84 -61.49 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.7 ' CD2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER 167.88 -95.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.94 177.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.717 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 96.3 m-20 -92.13 11.59 24.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.748 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -76.32 119.43 20.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.717 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -142.55 -46.37 0.33 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.429 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.594 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 89.7 p -162.7 162.08 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.138 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.78 157.45 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.758 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.665 ' O ' ' SD ' ' A' ' 45' ' ' MET . 98.6 m-20 -99.67 21.74 11.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.596 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' C ' ' O ' ' A' ' 43' ' ' ASN . 5.2 p -7.55 123.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.699 0.761 . . . . 0.0 110.926 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.665 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -120.26 85.5 2.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.127 -178.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.22 153.82 39.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 50.56 20.15 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.644 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.54 2.51 90.54 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.597 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.594 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 92.8 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.73 37.33 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.566 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.4 30.23 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 175.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.25 125.46 36.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.7 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.04 66.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p -84.81 -23.98 28.86 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.084 -1.635 . . . . 0.0 114.072 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 m -96.74 -38.02 10.06 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.979 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.605 ' HB3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER 81.33 173.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.593 ' N ' ' CG ' ' A' ' 26' ' ' ASN . . . 24.3 -124.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.75 120.93 72.73 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.472 ' HB2' HG22 ' A' ' 21' ' ' ILE . 44.4 Cg_endo -66.95 140.31 54.4 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.506 2.137 . . . . 0.0 114.367 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 178.34 59.45 0.07 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.422 -1.371 . . . . 0.0 112.174 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 1.1 t -177.82 48.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.435 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 1.8 t80 -41.24 -77.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.625 ' CG2' ' CE1' ' A' ' 32' ' ' TYR . 19.1 tt -151.51 46.84 0.39 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.67 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 91.3 Cg_endo -75.75 160.18 37.91 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.617 2.878 . . . . 0.0 112.286 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.6 m -61.4 129.51 41.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.599 ' CG1' ' H ' ' A' ' 37' ' ' PHE . 21.8 t -137.14 -172.23 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.6 ' O ' ' HB2' ' A' ' 38' ' ' ASP . 96.6 m-85 -59.5 -45.35 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.761 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 64.9 t0 163.46 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.129 0.268 . . . . 0.0 110.964 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.612 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 99.2 m-20 -145.98 -80.8 0.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.799 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 39' ' ' ASN . 37.9 m-85 87.83 -32.39 0.03 OUTLIER 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.11 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 88.0 p -159.03 158.86 33.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.69 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.74 152.2 31.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.915 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.543 ' HB3' ' CE ' ' A' ' 45' ' ' MET . 97.8 m-20 -87.36 119.04 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.581 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 6.3 p -122.51 134.79 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.43 0.633 . . . . 0.0 111.379 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.543 ' CE ' ' HB3' ' A' ' 43' ' ' ASN . 0.5 OUTLIER -138.38 95.15 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.537 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -125.82 132.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 60.31 28.73 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.991 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.51 90.0 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.425 ' HB2' ' HE2' ' A' ' 32' ' ' TYR . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.579 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.942 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 80.3 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.942 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.521 ' CG2' HG13 ' A' ' 33' ' ' ILE . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.616 ' CG2' ' HA3' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.72 64.56 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -66.17 -31.08 71.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 76.9 p -98.62 3.81 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.552 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' C ' HE22 ' A' ' 162' ' ' GLN . 98.0 m-20 55.37 33.13 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.728 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' A' ' 22' ' ' SER . . . -173.89 144.5 1.04 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.749 ' CD1' ' O ' ' A' ' 160' ' ' CYS . 0.0 OUTLIER -40.46 -54.29 5.0 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.627 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.628 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 92.2 Cg_endo -75.51 159.18 39.77 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.209 1.939 . . . . 0.0 110.945 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.616 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . -157.94 -135.14 1.85 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.534 ' CB ' HG23 ' A' ' 36' ' ' VAL . 1.7 m -103.84 -77.3 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.775 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.574 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -172.11 169.36 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.435 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.724 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 1.0 OUTLIER -70.1 -62.21 2.41 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.582 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.724 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 83.9 Cg_endo -77.74 156.52 31.46 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.446 2.097 . . . . 0.0 111.637 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.52 28.05 5.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG21 ' O ' ' A' ' 32' ' ' TYR . 21.0 t -123.42 -41.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CZ ' ' HB2' ' A' ' 40' ' ' TYR . 12.3 t80 -91.81 46.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.351 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.43 -45.97 90.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.283 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -148.28 62.96 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.441 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.63 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.6 m-85 -88.28 68.48 8.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.182 0.515 . . . . 0.0 109.956 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.59 ' OG ' ' ND2' ' A' ' 52' ' ' ASN . 39.3 t -62.25 -43.57 98.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.158 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 52' ' ' ASN . . . 69.55 126.33 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.626 ' O ' ' SD ' ' A' ' 45' ' ' MET . 50.5 p30 -118.21 36.73 4.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.944 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.616 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 11.8 p -26.75 154.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.127 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 2.5 mmt -118.69 134.22 55.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.321 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.676 ' CG2' ' O ' ' A' ' 49' ' ' LYS . 7.2 m -142.87 -165.17 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -64.18 62.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.845 0.831 . . . . 0.0 111.489 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.62 2.51 89.84 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 115.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.676 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.616 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.59 ' ND2' ' OG ' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.54 15.19 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.736 1.153 . . . . 0.0 112.502 178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.11 60.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.749 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 87.0 m -69.97 -45.44 67.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.46 -13.78 21.55 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.723 -0.611 . . . . 0.0 112.288 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.558 HE22 ' C ' ' A' ' 26' ' ' ASN 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.633 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.58 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 26' ' ' ASN . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.18 66.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.41 -37.83 65.8 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.449 -1.407 . . . . 0.0 113.814 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.573 ' CB ' ' O ' ' A' ' 28' ' ' PHE . 81.7 p -88.62 12.99 13.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.613 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.602 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 98.9 m-20 64.32 -128.48 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.57 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.32 -8.22 59.08 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.573 ' O ' ' CB ' ' A' ' 25' ' ' THR . 95.9 m-85 -121.27 142.87 36.08 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 159.59 45.62 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 123.423 2.749 . . . . 0.0 113.62 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -133.33 -36.76 0.26 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.594 ' O ' HG23 ' A' ' 33' ' ' ILE . 3.8 m 83.25 99.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.546 ' H ' HD12 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -59.06 104.95 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.632 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 1.7 pp -90.12 159.25 42.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.632 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 33.5 Cg_exo -58.49 137.79 82.26 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.986 1.791 . . . . 0.0 112.086 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.603 ' O ' ' O ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 46.53 127.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.409 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 38' ' ' ASP . 3.7 p -138.17 156.38 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -60.04 -44.3 94.76 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.709 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 98.6 m-20 -83.96 153.03 24.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.561 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 40' ' ' TYR . 53.5 p30 -102.16 26.68 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.286 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 91.7 m-85 71.1 46.5 0.45 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.564 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 82.2 p -61.08 -38.08 84.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.462 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' VAL . . . 43.42 74.66 0.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.144 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.545 ' OD1' ' O ' ' A' ' 43' ' ' ASN . 54.5 p30 -65.85 69.66 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.201 0.525 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 12.6 p -67.55 137.55 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.521 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.518 ' HE3' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -106.4 142.15 36.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.549 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -142.33 -144.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.789 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -81.3 67.61 7.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.668 0.747 . . . . 0.0 111.14 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.28 2.51 89.26 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.334 -1.303 . . . . 0.0 115.298 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.622 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.564 ' ND2' ' HB2' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.5 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.58 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 61.1 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.918 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 74.2 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.602 ' NE2' ' O ' ' A' ' 26' ' ' ASN 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.918 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.581 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.753 HG22 ' CB ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.8 70.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.5 p -89.83 -1.64 58.04 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.332 -1.48 . . . . 0.0 113.902 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.622 ' CG2' ' O ' ' A' ' 27' ' ' ALA . 30.4 m -113.78 128.35 56.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -78.13 -16.82 57.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.239 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.622 ' O ' ' CG2' ' A' ' 25' ' ' THR . . . -132.56 138.18 47.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.481 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 16.8 m-85 -49.95 -46.68 81.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 31' ' ' CYS . 71.1 Cg_exo -53.99 -38.81 86.78 Favored 'Trans proline' 0 N--CA 1.505 2.194 0 C-N-CA 122.906 2.404 . . . . 0.0 115.107 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -0.72 0.6 Allowed Glycine 0 N--CA 1.466 0.679 0 O-C-N 123.867 0.729 . . . . 0.0 112.026 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.753 ' CB ' HG22 ' A' ' 21' ' ' ILE . 28.0 p -68.12 81.81 0.22 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.651 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 16.5 t80 179.14 155.79 0.49 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' O ' ' CG2' ' A' ' 33' ' ' ILE . 0.1 OUTLIER 37.51 54.43 3.48 Favored Pre-proline 0 C--N 1.318 -0.776 1 CA-C-N 108.093 -4.14 . . . . 0.0 108.19 170.427 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.617 ' HD3' ' N ' ' A' ' 33' ' ' ILE . 32.0 Cg_exo -58.9 127.9 26.01 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.318 1.345 . . . . 0.0 111.366 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.585 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 77.6 p -130.19 2.03 4.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.093 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' HB ' ' O ' ' A' ' 35' ' ' THR . 2.9 t 71.86 71.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -62.07 -43.85 97.95 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -171.61 108.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 111.261 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 41' ' ' SER . 64.8 t30 53.55 56.6 7.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.98 10.09 0.24 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.085 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 42' ' ' ALA . 74.3 m -87.03 -5.54 59.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.942 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 48.73 128.61 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.092 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.628 ' O ' ' SD ' ' A' ' 45' ' ' MET . 53.3 p-10 -92.8 50.56 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.683 HG11 ' O ' ' A' ' 51' ' ' VAL . 2.1 p -29.39 144.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.72 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 5.0 mmt -106.8 139.17 41.64 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.72 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -143.52 -168.1 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.58 68.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.618 0.723 . . . . 0.0 112.579 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.0 2.51 88.78 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.705 -1.134 . . . . 0.0 115.298 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.683 ' O ' HG11 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.587 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.47 -36.1 81.4 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.858 -1.151 . . . . 0.0 111.225 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.25 19.85 11.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.034 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.581 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.15 30.49 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 175.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.42 125.46 37.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' CG ' ' SG ' ' A' ' 160' ' ' CYS . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.641 ' OG ' ' SG ' ' A' ' 160' ' ' CYS . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.892 ' SG ' ' N1 ' ' A' ' 201' ' ' GDP . 0.6 OUTLIER -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.522 HD13 HG13 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.892 ' N1 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.707 HD12 ' CB ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.6 71.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 p -84.04 -67.22 0.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.64 -1.288 . . . . 0.0 113.445 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 14.3 t -146.67 160.11 42.62 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.786 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 50.9 t30 -100.2 106.14 17.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.406 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 26' ' ' ASN . . . 166.61 115.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.62 ' O ' ' CB ' ' A' ' 31' ' ' CYS . 44.9 m-85 -54.4 -48.09 95.75 Favored Pre-proline 0 CA--C 1.519 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.952 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 36.3 Cg_endo -65.06 -24.72 59.37 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.795 1.664 . . . . 0.0 112.072 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' CYS . . . -93.5 -3.73 64.55 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.78 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -28.12 145.1 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.78 ' C ' ' O ' ' A' ' 31' ' ' CYS . 37.9 t80 -20.17 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' N ' ' O ' ' A' ' 31' ' ' CYS . 16.8 tt -142.55 126.25 9.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.085 176.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -20.5 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.756 2.304 . . . . 0.0 112.792 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.3 p -90.39 98.99 12.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 111.543 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.49 ' CG2' ' HE1' ' A' ' 40' ' ' TYR . 84.5 t -153.86 46.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.046 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 96.5 m-85 66.48 2.21 2.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.417 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -169.89 173.14 6.24 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.614 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.33 158.08 30.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 33' ' ' ILE . 1.5 m-85 -107.35 72.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.254 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.9 m -123.95 128.96 50.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 52' ' ' ASN . . . -68.89 135.35 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.35 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.564 ' O ' ' HG3' ' A' ' 45' ' ' MET . 65.6 t30 -98.5 16.91 20.32 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 44' ' ' VAL . 6.1 p -26.67 126.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.243 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.564 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 0.5 OUTLIER -120.98 88.09 2.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.091 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t -127.22 132.43 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.466 0.651 . . . . 0.0 112.301 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 54.3 t0 64.12 24.6 13.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.171 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.42 2.51 90.18 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.494 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.3 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.236 -0.915 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m 72.54 15.21 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.34 125.46 32.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.502 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.6 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 91.3 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.6 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.655 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.608 HD12 ' CD2' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.535 ' O ' ' C ' ' A' ' 24' ' ' THR . 58.7 t80 -66.96 -49.09 66.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 30.8 p -34.87 -39.16 0.09 Allowed 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.336 -0.853 . . . . 0.0 110.736 -178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.518 ' CB ' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -163.42 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.361 0.601 . . . . 0.0 111.062 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.664 ' O ' ' O ' ' A' ' 27' ' ' ALA . 4.9 p-10 -158.25 -179.19 7.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.448 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.69 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -28.18 -114.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 36.24 171.39 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.531 ' CD ' ' HB2' ' A' ' 28' ' ' PHE . 62.8 Cg_endo -96.69 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.576 2.851 . . . . 0.0 113.479 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.34 -91.65 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.566 ' HB3' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 178.49 -159.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.721 ' HB2' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -108.57 -60.96 1.67 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.67 -178.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.721 HD13 ' HB2' ' A' ' 32' ' ' TYR . 2.9 mp -135.41 49.34 3.48 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 73.6 Cg_endo -72.68 158.41 50.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.488 2.792 . . . . 0.0 111.803 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.4 m -77.98 106.17 9.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.017 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG13 ' H ' ' A' ' 38' ' ' ASP . 61.4 t -126.56 130.55 71.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.51 -22.55 21.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.858 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.585 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 80.1 m-20 -62.02 -42.15 98.85 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.353 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.585 ' CG ' ' O ' ' A' ' 38' ' ' ASP . 14.5 m-20 166.6 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 40' ' ' TYR . 1.4 t80 -136.08 -11.78 1.95 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.92 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.5 t -139.79 137.88 35.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.952 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.42 43.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.877 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.609 ' O ' ' O ' ' A' ' 44' ' ' VAL . 33.1 m120 -99.11 29.71 3.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.551 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.609 ' O ' ' O ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -6.87 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.585 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 6.1 mmt -99.17 120.6 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.766 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 48' ' ' GLY . 5.6 m -133.42 168.88 23.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.17 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -47.09 66.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 82.54 2.51 90.63 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.68 -1.146 . . . . 0.0 115.298 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.591 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.595 ' HB ' ' CG2' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 126.65 21.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 87.55 12.02 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.512 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -80.16 125.46 29.86 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.917 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.7 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.527 HD13 HG23 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.917 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.58 139.54 31.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 119.121 0.873 . . . . 0.0 111.498 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.21 128.0 53.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mt -126.42 126.18 68.68 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.63 124.83 45.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.713 -1.242 . . . . 0.0 111.752 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 t -119.48 131.36 55.58 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.096 -1.003 . . . . 0.0 111.472 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.5 t -116.98 132.66 66.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.39 124.37 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.342 1.057 . . . . 0.0 109.463 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.08 166.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.538 -1.976 . . . . 0.0 109.914 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.07 165.85 10.44 Favored Glycine 0 CA--C 1.494 -1.231 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.64 151.46 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.275 1.83 . . . . 0.0 113.93 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.11 146.71 35.78 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 118.816 -2.427 . . . . 0.0 111.833 165.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.71 0.62 3.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.44 -16.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 O-C-N 119.206 -2.184 . . . . 0.0 113.989 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.69 17.28 9.26 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 120.365 -1.46 . . . . 0.0 115.454 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.64 -49.6 75.93 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.116 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -61.54 -47.59 84.88 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.386 1.088 . . . . 0.0 113.004 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.1 m -63.12 -36.84 84.95 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.11 91.01 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.923 1.289 . . . . 0.0 112.31 172.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.79 -47.13 66.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.627 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 72.8 mt -60.15 -48.4 88.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.127 0.876 . . . . 0.0 110.805 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -60.49 -41.36 94.1 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.94 -48.78 67.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.261 -0.899 . . . . 0.0 113.401 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.2 p -93.11 -10.08 37.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.53 -1.356 . . . . 0.0 114.52 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.627 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 14.7 p -137.76 -173.38 3.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.21 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -70.08 159.05 34.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.746 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.19 86.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.614 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 98.2 m-85 -64.49 178.1 0.5 Allowed Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 28' ' ' PHE . 52.5 Cg_exo -51.4 118.98 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.867 1.044 . . . . 0.0 111.218 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.552 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . -90.85 -127.63 3.72 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.409 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.31 69.49 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.21 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.589 ' HB3' HD12 ' A' ' 21' ' ' ILE . 46.8 p90 -70.15 -16.64 63.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' THR . 19.1 tt -56.57 139.55 75.33 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' HD2' ' CG1' ' A' ' 33' ' ' ILE . 17.7 Cg_endo -58.69 71.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.744 1.629 . . . . 0.0 111.517 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 33' ' ' ILE . 81.5 p -129.88 150.43 51.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.509 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -131.14 130.45 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.114 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p90 -135.44 -7.36 2.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.977 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 37' ' ' PHE . 98.1 m-20 -136.22 -105.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.694 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.581 ' C ' ' H ' ' A' ' 41' ' ' SER . 61.3 t-20 -146.79 117.17 7.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.757 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -61.62 3.02 0.15 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.945 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.705 ' OG ' ' ND2' ' A' ' 52' ' ' ASN . 12.3 t -59.8 -43.53 94.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 124.254 0.971 . . . . 0.0 110.973 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 41' ' ' SER . . . 78.3 131.17 0.05 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.478 ' OD1' ' HE2' ' A' ' 45' ' ' MET . 65.0 t30 -79.98 79.09 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.892 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.633 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -126.36 110.49 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 44' ' ' VAL . 1.1 mpt? -147.21 131.66 17.64 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.651 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 45' ' ' MET . 1.5 m -161.59 154.63 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 111.882 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.14 28.09 14.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.885 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.49 90.49 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.98 123.88 45.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 118.494 1.147 . . . . 0.0 112.413 -174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.88 110.4 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 CA-C-N 121.77 1.668 . . . . 0.0 110.613 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' O ' HG11 ' A' ' 44' ' ' VAL . 70.7 t -117.73 129.66 73.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.015 0.926 . . . . 0.0 109.413 -172.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.705 ' ND2' ' OG ' ' A' ' 41' ' ' SER . 3.2 m120 -103.01 106.11 16.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 171.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 tp -98.53 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.096 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.28 127.41 7.98 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 120.974 -1.078 . . . . 0.0 111.308 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.76 133.03 54.26 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.934 0.894 . . . . 0.0 110.63 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.33 123.15 31.06 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.979 0.912 . . . . 0.0 108.629 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.01 11.45 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 109.682 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.92 33.86 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 124.085 1.897 . . . . 0.0 113.439 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.58 108.26 11.85 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 120.288 -1.508 . . . . 0.0 109.906 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.95 -5.58 88.85 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 120.408 -1.432 . . . . 0.0 115.938 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -62.05 145.77 52.21 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.325 1.85 . . . . 0.0 112.159 -177.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.35 -30.59 70.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.861 2.064 . . . . 0.0 112.081 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.35 -36.21 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.874 -1.142 . . . . 0.0 111.235 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -96.15 19.83 11.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.028 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 49.8 m-20 -56.3 -27.18 54.63 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 113.63 173.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -29.53 25.68 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 175.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.9 tp -96.07 -36.97 10.81 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.978 1.311 . . . . 0.0 112.485 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -58.21 -39.68 77.42 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 119.869 -1.769 . . . . 0.0 115.181 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -65.2 -7.11 14.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 124.739 2.728 . . . . 0.0 115.587 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.29 -16.96 62.49 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.6 p -92.03 -8.15 46.79 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.607 -1.308 . . . . 0.0 112.445 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -68.47 -35.28 6.71 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 97.4 Cg_exo -52.39 130.92 38.09 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.505 2.804 . . . . 0.0 115.316 173.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.6 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 72.94 30.76 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.388 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.1 m -92.54 125.4 37.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 170.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.24 -30.87 22.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.151 0.98 . . . . 0.0 112.33 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.3 143.51 18.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.812 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.95 43.01 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.522 -1.361 . . . . 0.0 110.526 174.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.88 114.06 27.82 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.494 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.35 115.95 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.7 m -109.05 142.62 39.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.655 1.217 . . . . 0.0 112.418 -172.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -139.82 152.16 46.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 171.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.0 t -85.81 132.32 34.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.995 -1.066 . . . . 0.0 110.126 175.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.24 -12.79 61.58 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 125.239 1.416 . . . . 0.0 113.561 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.8 18.27 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.686 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 t -132.19 103.75 13.92 Favored Pre-proline 0 C--N 1.352 0.716 0 O-C-N 119.71 -1.869 . . . . 0.0 109.94 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -66.43 -27.12 47.22 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 123.17 2.58 . . . . 0.0 114.099 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.974 0.91 . . . . 0.0 112.597 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.35 -35.66 80.91 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.095 -1.003 . . . . 0.0 112.418 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.5 t80 -60.22 -49.26 78.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.747 1.219 . . . . 0.0 112.783 173.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.22 -23.07 60.32 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.451 -1.406 . . . . 0.0 113.175 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -66.45 -25.11 66.57 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.94 -1.725 . . . . 0.0 113.171 168.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.29 98.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 O-C-N 119.674 -1.891 . . . . 0.0 111.763 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.8 ttm-85 -64.81 -48.61 73.79 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.204 1.402 . . . . 0.0 114.161 176.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.98 25.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.84 -62.82 0.8 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.405 -1.435 . . . . 0.0 113.016 -172.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -67.78 -44.56 77.14 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -169.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.75 -48.37 79.79 Favored Pre-proline 0 C--N 1.353 0.751 0 CA-C-O 116.667 -1.635 . . . . 0.0 113.034 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -56.25 -42.91 61.18 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.117 2.545 . . . . 0.0 114.603 172.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.12 -51.38 66.74 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 119.074 0.852 . . . . 0.0 112.726 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.21 -42.27 92.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.028 -1.67 . . . . 0.0 111.529 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -66.64 -38.44 86.9 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.98 -44.44 97.36 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.429 1.013 . . . . 0.0 112.824 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -82.49 -31.31 29.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.72 -1.237 . . . . 0.0 113.228 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.64 90.06 14.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 120.17 -1.581 . . . . 0.0 110.256 -176.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.17 -30.84 19.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.954 1.769 . . . . 0.0 116.262 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.44 -6.59 16.1 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 124.052 0.941 . . . . 0.0 113.328 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.65 134.16 94.26 Favored Pre-proline 0 C--N 1.352 0.7 0 O-C-N 119.287 -2.133 . . . . 0.0 112.367 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.61 141.38 43.23 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 124.967 3.778 . . . . 0.0 117.685 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.494 HD11 HD12 ' A' ' 80' ' ' ILE . 81.7 mt -119.46 135.71 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.68 123.96 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 168.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.8 tp -89.02 124.02 33.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.87 120.68 65.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 121.977 0.894 . . . . 0.0 109.417 -174.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.13 113.5 4.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.4 p -98.49 162.54 13.1 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.95 -1.324 . . . . 0.0 111.344 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.73 42.99 4.34 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.985 1.314 . . . . 0.0 112.865 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.4 -32.21 69.96 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.12 -30.23 69.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.764 2.025 . . . . 0.0 111.574 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.84 -5.37 56.93 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.77 -35.12 80.07 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.625 -1.297 . . . . 0.0 113.882 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.16 -1.36 48.6 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 111.386 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 118.03 12.08 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 119.877 -1.765 . . . . 0.0 111.326 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -44.99 93.32 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.6 -50.63 70.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.42 0.688 . . . . 0.0 111.244 175.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -55.54 -44.39 76.71 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.331 -1.481 . . . . 0.0 113.536 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.53 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.458 1.103 . . . . 0.0 112.715 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.4 -46.5 89.76 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.783 -1.198 . . . . 0.0 112.314 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.98 -37.27 79.14 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.71 -1.244 . . . . 0.0 114.111 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.05 -46.1 82.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.381 -1.45 . . . . 0.0 112.97 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.55 -34.76 73.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.76 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.737 1.215 . . . . 0.0 113.542 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.43 9.36 40.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.902 -1.124 . . . . 0.0 111.729 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.79 38.24 3.88 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 125.45 1.5 . . . . 0.0 114.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 161.33 24.6 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 125.933 1.693 . . . . 0.0 107.152 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.4 p -138.87 159.01 68.88 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.18 156.64 61.86 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.688 2.259 . . . . 0.0 114.213 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.99 117.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 122.729 1.252 . . . . 0.0 109.846 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 55.1 p -76.29 165.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.898 -1.126 . . . . 0.0 111.321 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -57.47 -46.2 99.81 Favored Pre-proline 0 C--N 1.354 0.769 0 O-C-N 120.531 -1.356 . . . . 0.0 112.671 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.37 -38.51 94.32 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 124.228 2.546 . . . . 0.0 116.051 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.47 -43.15 91.17 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.074 1.306 . . . . 0.0 112.744 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.33 -38.51 81.21 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 120.646 -1.284 . . . . 0.0 115.363 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.57 87.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.534 1.133 . . . . 0.0 113.518 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.1 90.66 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.334 1.054 . . . . 0.0 112.485 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.77 -41.17 97.35 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.46 85.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.059 0.943 . . . . 0.0 112.832 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.08 -43.46 95.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -62.22 -33.65 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.668 . . . . 0.0 113.928 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.66 2.9 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.634 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.81 41.17 50.75 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.265 -1.522 . . . . 0.0 116.32 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.28 148.05 52.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.224 1.012 . . . . 0.0 112.522 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.32 -34.28 65.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 O-C-N 121.006 -1.059 . . . . 0.0 110.582 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.4 150.72 30.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.815 -1.178 . . . . 0.0 109.679 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -115.63 128.74 56.15 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 169.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.9 mt -138.76 146.25 41.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.705 0.802 . . . . 0.0 109.552 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.53 137.94 54.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.77 30.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 123.532 1.634 . . . . 0.0 112.511 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.2 t -127.77 126.32 41.55 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.315 -0.866 . . . . 0.0 112.828 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.91 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 73.8 m -83.84 -41.21 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.556 -171.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 77.0 p -98.94 -13.74 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.302 93.7 mt-30 75.7 8.88 3.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.217 2.207 . . . . 0.0 113.481 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.81 115.91 5.27 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.3 -1.5 . . . . 0.0 113.08 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.01 -0.14 67.67 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.985 0.802 . . . . 0.0 114.274 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.16 -46.15 78.44 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -38.61 87.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.094 0.957 . . . . 0.0 112.316 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.76 -37.27 68.3 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.529 1.932 . . . . 0.0 112.216 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 94.0 t -57.64 -46.62 86.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.575 1.15 . . . . 0.0 112.535 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.15 -32.09 50.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 0.0 112.733 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.15 -44.22 97.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.405 1.082 . . . . 0.0 111.717 172.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.67 -34.06 76.17 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.013 -1.679 . . . . 0.0 114.415 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.26 88.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.617 -1.302 . . . . 0.0 112.118 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.536 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.99 -45.84 89.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 124.129 0.972 . . . . 0.0 113.449 172.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -61.48 -31.43 71.41 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.202 -1.562 . . . . 0.0 114.344 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.84 69.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.4 -39.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.351 0.657 0 C-N-CA 125.04 1.336 . . . . 0.0 112.04 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.54 -19.96 40.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.049 -1.657 . . . . 0.0 114.775 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.34 67.67 76.56 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.7 -176.41 2.47 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.688 1.592 . . . . 0.0 109.0 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -112.11 122.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.567 2.172 0 O-C-N 125.256 2.187 . . . . 0.0 116.132 157.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.048 3.166 . . . . 0.0 116.138 167.016 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.91 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.651 HG21 ' CA ' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.51 68.32 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.62 ' O ' ' CG2' ' A' ' 24' ' ' THR . 11.9 t -99.81 84.76 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.737 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.553 HG22 ' HA2' ' A' ' 30' ' ' GLY . 4.9 t 174.78 -179.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.9 p30 -146.22 172.87 12.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.512 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 26' ' ' ASN . . . 64.37 -114.98 0.38 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.643 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 29.4 t80 -52.28 147.45 13.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.643 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -52.51 13.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.385 2.057 . . . . 0.0 113.757 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.651 ' CA ' HG21 ' A' ' 21' ' ' ILE . . . 121.92 97.37 1.45 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.88 67.11 1.28 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' C ' ' HD2' ' A' ' 34' ' ' PRO . 74.1 m-85 -149.33 108.35 3.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.938 0.399 . . . . 0.0 110.872 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.769 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 29.1 mm -113.18 19.97 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.328 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.769 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 90.2 Cg_endo -79.27 177.27 8.78 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.468 2.112 . . . . 0.0 111.52 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.667 ' O ' ' C ' ' A' ' 36' ' ' VAL . 70.4 p -68.23 -16.68 64.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.667 ' C ' ' O ' ' A' ' 35' ' ' THR . 0.0 OUTLIER 0.96 88.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.692 ' O ' ' N ' ' A' ' 39' ' ' ASN . 94.8 m-85 -61.75 -51.9 66.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.95 11.68 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.727 0.299 . . . . 0.0 111.705 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' PHE . 87.2 m-20 54.44 18.86 2.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.183 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' ASN . 98.2 m-85 33.97 27.55 0.0 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.912 0.387 . . . . 0.0 109.968 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 39' ' ' ASN . 75.5 m -62.07 -41.9 98.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.775 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 53' ' ' LEU . . . 59.53 90.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.637 ' O ' ' CE ' ' A' ' 45' ' ' MET . 67.2 t30 -71.83 61.6 0.4 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.608 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 14.0 p -64.13 146.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.637 ' CE ' ' O ' ' A' ' 43' ' ' ASN . 1.0 OUTLIER -114.69 136.79 52.67 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.582 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.538 ' CG1' ' H ' ' A' ' 47' ' ' ASP . 2.0 t -140.69 -165.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.538 ' H ' ' CG1' ' A' ' 46' ' ' VAL . 98.6 m-20 -75.76 68.09 2.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.103 0.954 . . . . 0.0 111.054 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.51 89.78 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.298 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.608 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.57 ' ND2' ' HB3' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.5 OUTLIER -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.638 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.443 ' CD1' HG22 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.571 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.27 72.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.592 ' CG2' ' CE2' ' A' ' 40' ' ' TYR . 99.3 m -101.83 131.02 48.4 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.743 -1.223 . . . . 0.0 112.134 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 24' ' ' THR . 16.3 m 73.65 129.96 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 62.1 t30 -89.28 102.93 15.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.088 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASN . . . 158.46 133.18 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.031 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 29' ' ' PRO . 1.7 m-85 -51.23 -49.4 81.84 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.449 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 28' ' ' PHE . 51.2 Cg_exo -50.77 -149.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.467 2.778 . . . . 0.0 112.279 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 32' ' ' TYR . . . 59.57 48.8 84.24 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.689 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . 3.6 t -57.33 62.41 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.806 ' N ' HD12 ' A' ' 21' ' ' ILE . 76.0 t80 34.1 32.16 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.638 ' N ' ' O ' ' A' ' 31' ' ' CYS . 44.6 mm -64.32 136.75 96.88 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' HG22 ' A' ' 33' ' ' ILE . 72.0 Cg_endo -77.15 22.59 0.56 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.607 1.538 . . . . 0.0 111.88 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' HG23 ' A' ' 33' ' ' ILE . 98.6 m -61.49 -44.55 96.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.163 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.576 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 3.3 m -61.3 101.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.71 -42.08 99.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.605 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 39' ' ' ASN . 68.0 t0 -90.41 115.89 27.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 110.83 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.585 ' OD1' ' O ' ' A' ' 39' ' ' ASN . 51.1 p30 -36.0 142.55 0.08 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.279 0.561 . . . . 0.0 111.319 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.592 ' CE2' ' CG2' ' A' ' 24' ' ' THR . 68.5 t80 -95.18 121.09 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.871 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 m -141.18 91.96 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.673 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.39 142.7 58.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.635 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.696 ' O ' ' SD ' ' A' ' 45' ' ' MET . 56.3 p30 -81.82 62.09 5.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.567 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 12.9 p -36.91 147.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.968 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.696 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 1.7 mmt -105.15 122.96 47.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.694 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.77 -151.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.823 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -82.82 67.94 9.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.145 0.974 . . . . 0.0 111.783 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 2.51 89.27 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 113.502 -1.681 . . . . 0.0 115.298 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.567 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.494 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.8 37.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.571 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 14.6 m 73.19 30.43 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 175.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.898 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 72.4 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.898 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 29' ' ' PRO . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.63 67.96 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.548 ' OG1' ' OH ' ' A' ' 32' ' ' TYR . 76.0 m -38.43 -77.54 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.465 HG23 HG21 ' A' ' 24' ' ' THR . 53.2 p -133.72 157.06 46.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.573 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.634 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 27.4 t-20 -101.26 98.7 9.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.422 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.634 ' CB ' ' O ' ' A' ' 26' ' ' ASN . . . 143.31 144.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.496 0.497 . . . . 0.0 110.102 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 2.1 t80 56.97 147.25 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.653 ' O ' HG22 ' A' ' 21' ' ' ILE . 19.9 Cg_endo -60.14 -27.94 85.94 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.824 1.683 . . . . 0.0 112.343 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . 84.08 -100.98 2.37 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.619 ' O ' ' O ' ' A' ' 32' ' ' TYR . 7.0 t 72.22 81.79 0.14 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.619 ' O ' ' O ' ' A' ' 31' ' ' CYS . 51.9 m-85 -31.74 152.51 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 162.88 163.44 0.05 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD2' HG21 ' A' ' 33' ' ' ILE . 12.2 Cg_endo -55.7 14.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.923 2.415 . . . . 0.0 113.744 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.573 ' H ' ' C ' ' A' ' 33' ' ' ILE . 70.5 p -86.71 -18.49 31.08 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.051 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -99.46 -40.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.239 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 36' ' ' VAL . 1.4 m-30 53.03 142.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.663 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 97.0 m-20 56.31 43.37 26.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.025 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' OD1' ' C ' ' A' ' 39' ' ' ASN . 54.5 p30 -83.0 174.7 10.65 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.689 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -172.87 -101.64 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.916 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.642 ' OG ' ' O ' ' A' ' 53' ' ' LEU . 30.5 t -154.55 141.58 19.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.83 146.21 53.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.595 ' O ' ' CE ' ' A' ' 45' ' ' MET . 98.5 m-20 -79.56 64.6 4.48 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.396 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.586 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 7.4 p -41.14 129.42 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 45' ' ' MET . 0.5 OUTLIER -118.72 99.05 6.53 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.768 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.1 145.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.31 24.99 5.48 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.322 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.39 2.51 84.31 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.586 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.642 ' O ' ' OG ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.9 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.572 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 99.1 m -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.572 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.559 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.68 67.78 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 20' ' ' LEU . 15.3 t -87.87 -42.17 12.71 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 119.803 -1.811 . . . . 0.0 113.346 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.572 ' O ' ' O ' ' A' ' 21' ' ' ILE . 13.1 t -146.16 -158.48 0.91 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.553 ' CG ' ' HG2' ' A' ' 29' ' ' PRO . 44.4 t-20 -98.28 142.59 29.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.402 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . -42.63 -108.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 30.6 m-85 -39.8 -45.7 4.4 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.553 ' HG2' ' CG ' ' A' ' 26' ' ' ASN . 74.9 Cg_exo -52.87 -40.16 76.08 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.253 1.968 . . . . 0.0 113.223 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -100.02 -111.22 3.26 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.68 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 49.8 t 120.54 40.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.599 ' CD1' HD11 ' A' ' 33' ' ' ILE . 80.1 t80 61.52 133.03 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.628 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER 47.96 63.8 9.66 Favored Pre-proline 0 CA--C 1.522 -0.132 0 C-N-CA 116.655 -2.018 . . . . 0.0 109.182 -176.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.656 ' O ' ' CB ' ' A' ' 35' ' ' THR . 72.9 Cg_exo -51.74 -38.49 66.87 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.294 2.663 . . . . 0.0 112.172 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.656 ' CB ' ' O ' ' A' ' 34' ' ' PRO . 96.1 m 111.14 44.19 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 O-C-N 124.161 0.913 . . . . 0.0 110.326 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.652 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 58.6 t -93.12 19.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.652 ' CD1' ' O ' ' A' ' 36' ' ' VAL . 16.1 m-85 121.72 -58.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.399 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -159.76 173.36 16.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.115 0.484 . . . . 0.0 111.447 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.71 144.49 56.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.749 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -116.36 152.29 34.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 53' ' ' LEU . 96.4 p -89.56 11.42 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.889 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 60.93 137.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.637 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -90.28 120.83 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.542 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 9.7 p -126.22 135.74 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.343 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.73 132.61 55.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.339 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 49' ' ' LYS . 26.3 m -135.76 -153.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.211 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -80.32 67.64 6.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.359 0.599 . . . . 0.0 112.343 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.51 90.58 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.042 -0.981 . . . . 0.0 115.298 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.577 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.542 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' ND2' ' OG ' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.672 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.52 70.64 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.2 m -62.5 -36.17 81.69 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.037 -1.039 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.14 19.85 11.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.034 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.559 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 60.4 m 73.21 30.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.29 125.46 36.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.23 59.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.924 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.4 m -84.52 -40.45 17.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.4 -13.78 19.42 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.924 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.581 ' HD3' ' SG ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.609 HD12 ' CD1' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.0 69.87 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.583 ' O ' ' OG1' ' A' ' 25' ' ' THR . 94.4 m -103.36 129.28 50.39 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.21 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 24' ' ' THR . 67.9 p 62.15 102.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.245 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.485 ' CB ' ' HG2' ' A' ' 29' ' ' PRO . 99.1 m-20 37.81 -157.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.542 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 22' ' ' SER . . . -122.9 -71.62 0.72 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.671 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.593 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 49.5 m-85 -60.63 -42.22 86.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.433 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 34.5 Cg_exo -59.88 144.95 99.39 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 123.251 2.634 . . . . 0.0 113.438 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.626 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.35 174.91 16.14 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.831 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' O ' ' A' ' 30' ' ' GLY . 1.3 m 156.54 28.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.784 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.609 ' CD1' HD12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -85.03 70.06 10.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.328 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.18 113.32 63.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.04 -38.26 95.03 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.923 1.749 . . . . 0.0 111.541 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.5 p -138.7 146.56 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.748 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.681 ' CG1' ' HB2' ' A' ' 39' ' ' ASN . 86.3 t -133.36 133.8 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -48.3 82.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.966 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 68.2 t0 -144.94 73.89 1.39 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.49 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.681 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 22.4 m120 -166.04 -30.43 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.159 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.7 42.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 39' ' ' ASN . 63.1 m -118.68 151.53 37.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 52' ' ' ASN . . . -122.69 149.56 43.9 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.594 ' O ' ' HG3' ' A' ' 45' ' ' MET . 67.3 t30 -110.99 14.1 22.02 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.097 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.577 ' C ' ' O ' ' A' ' 43' ' ' ASN . 0.2 OUTLIER -23.06 129.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.131 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.661 ' SD ' ' N ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -127.72 110.32 12.52 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.583 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.514 HG21 ' N ' ' A' ' 47' ' ' ASP . 11.9 p -168.6 154.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.514 ' N ' HG21 ' A' ' 46' ' ' VAL . 97.0 m-20 56.23 17.19 2.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.021 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.88 2.51 82.04 Favored Glycine 0 C--N 1.318 -0.421 0 CA-C-N 115.137 -0.938 . . . . 0.0 115.298 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.74 70.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.88 -36.86 82.5 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.024 -1.048 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -95.67 19.85 10.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.034 -175.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.569 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 129.3 31.12 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 74' ' ' CYS . 0.5 OUTLIER 77.18 26.32 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.371 173.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -89.76 125.46 35.3 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.59 59.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.911 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.1 m -83.82 -41.02 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.665 -171.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -98.96 -13.78 19.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.911 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.666 HG23 ' HG1' ' A' ' 75' ' ' THR . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.72 HD13 ' HA ' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -51.29 56.95 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.467 HG23 ' CE2' ' A' ' 40' ' ' TYR . 99.3 m -63.52 -45.38 90.86 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 124.635 1.209 . . . . 0.0 113.117 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.47 ' CG2' ' HB3' ' A' ' 31' ' ' CYS . 60.8 p -95.13 156.04 16.48 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.799 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -133.11 61.7 1.67 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.216 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -158.75 -157.41 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.218 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CG ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -48.34 -165.58 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.298 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.645 ' CD ' ' CG ' ' A' ' 28' ' ' PHE . 89.8 Cg_endo -90.54 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.687 2.258 . . . . 0.0 113.169 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 32' ' ' TYR . . . -62.01 18.03 0.06 OUTLIER Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.223 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' PRO . 77.9 m -76.89 20.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.684 0.742 . . . . 0.0 110.65 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' HA ' HD13 ' A' ' 21' ' ' ILE . 76.9 m-85 -69.46 150.62 47.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.897 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.639 ' O ' ' O ' ' A' ' 32' ' ' TYR . 97.6 mt 52.95 119.84 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.92 138.06 76.97 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.901 1.734 . . . . 0.0 111.936 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -45.24 94.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.435 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.641 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -97.41 -60.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' CG ' ' O ' ' A' ' 36' ' ' VAL . 5.3 m-30 133.34 160.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.04 0.837 . . . . 0.0 109.814 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 25.6 m-20 155.05 171.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 40' ' ' TYR . 98.7 m-20 -98.86 11.99 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.861 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 87.9 m-85 75.88 74.86 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.215 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.635 ' O ' ' O ' ' A' ' 42' ' ' ALA . 75.1 m -60.11 -42.86 95.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.904 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 47.65 129.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.624 0.726 . . . . 0.0 111.643 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.596 ' O ' ' C ' ' A' ' 44' ' ' VAL . 98.6 m-20 -101.69 19.86 17.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.802 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.596 ' C ' ' O ' ' A' ' 43' ' ' ASN . 11.5 p -19.25 121.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.872 0.844 . . . . 0.0 110.662 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.645 ' SD ' ' N ' ' A' ' 45' ' ' MET . 0.5 OUTLIER -110.94 135.34 51.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.005 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -134.36 -157.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.463 -178.422 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 46' ' ' VAL . 54.5 p-10 -60.53 63.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.467 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.53 2.51 89.7 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.444 ' HB2' HG21 ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.492 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 96' ' ' LYS . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.579 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 5.0 m 73.19 30.41 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.571 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.666 ' HG1' HG23 ' A' ' 7' ' ' VAL . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 108' ' ' THR . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 111' ' ' ILE . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 HD12 HD11 ' A' ' 110' ' ' ILE . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HG ' ' HD2' ' A' ' 116' ' ' LYS . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.438 ' HB2' ' HE2' ' A' ' 145' ' ' MET . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 65' ' ' ASP . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.534 ' HB3' HG22 ' A' ' 108' ' ' THR . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 105' ' ' CYS . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 HD11 HD12 ' A' ' 80' ' ' ILE . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' HB ' HD21 ' A' ' 79' ' ' LEU . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD2' ' HG ' ' A' ' 83' ' ' SER . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' A' ' 161' ' ' THR . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.922 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 76.1 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.545 ' H ' ' HG ' ' A' ' 158' ' ' SER . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.517 ' CD1' HG23 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GDP . . . . . 0.922 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.595 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.39 68.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--N 1.342 0.254 0 O-C-N 119.916 -1.74 . . . . 0.0 112.73 -179.759 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.4 t0 44.64 45.49 8.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.788 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.51 90.59 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.595 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.22 30.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.505 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.4 125.46 37.07 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.6 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.12 66.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.742 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 54.5 t0 48.67 36.31 7.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.234 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.51 90.51 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.87 64.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.133 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 48' ' ' GLY . 80.4 t . . . . . 0 C--O 1.222 -0.361 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.6 p30 -30.52 73.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.679 0.612 . . . . 0.0 112.604 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.09 2.51 88.94 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.54 -36.09 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 110.982 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.034 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.61 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.18 -48.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.837 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.32 71.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.2 m . . . . . 0 C--N 1.341 0.208 0 O-C-N 120.492 -1.38 . . . . 0.0 111.203 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.19 0.519 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 t0 55.66 18.16 2.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.63 2.51 89.87 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.9 45.5 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 118.471 1.136 . . . . 0.0 112.423 -174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.54 77.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 m -60.76 -26.68 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 120.294 -1.504 . . . . 0.0 114.367 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.54 19.81 18.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.304 -0.873 . . . . 0.0 112.041 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.0 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 15.2 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.38 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.687 1.13 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.09 -30.24 69.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.744 2.018 . . . . 0.0 111.574 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.85 -5.34 56.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.15 -1.37 48.61 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.25 1.42 . . . . 0.0 111.365 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.94 -1.725 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.61 -50.67 70.32 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.226 175.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.8 126.35 41.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.19 60.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 121.294 -0.879 . . . . 0.0 112.851 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 88.6 m -70.23 -45.1 67.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.71 21.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 121.723 -0.611 . . . . 0.0 112.29 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.66 8.9 3.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.228 2.211 . . . . 0.0 113.489 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.82 115.9 5.26 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.256 -1.528 . . . . 0.0 113.076 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.98 -0.11 67.62 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.952 0.787 . . . . 0.0 114.274 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.7 tp -66.2 -46.09 78.51 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.24 -38.65 87.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 112.28 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.5 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.17 167.026 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.583 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -50.02 63.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 C--N 1.345 0.382 0 O-C-N 121.598 -0.689 . . . . 0.0 112.592 -177.641 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.3 t . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 59.87 37.28 21.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.759 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.6 2.51 90.55 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.45 70.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.7 -35.92 81.29 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.012 -1.055 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.29 19.85 11.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.034 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.76 37.46 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.27 30.37 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 175.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.31 125.46 36.98 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 84.4 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.837 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.98 69.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 20' ' ' LEU . 71.2 p . . . . . 0 N--CA 1.467 0.402 0 O-C-N 120.65 -1.281 . . . . 0.0 112.751 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 121.37 0.605 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 62.27 23.85 14.15 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.57 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.46 2.51 90.62 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.55 15.2 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.727 1.149 . . . . 0.0 112.502 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 97.8 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.9 70.2 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.533 0.296 0 O-C-N 120.569 -1.332 . . . . 0.0 113.88 -179.191 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 50.56 20.15 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.644 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.54 2.51 90.54 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 92.8 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.73 37.33 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.4 30.23 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 175.565 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.25 125.46 36.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.7 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.04 66.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.469 0.509 0 O-C-N 120.084 -1.635 . . . . 0.0 114.072 -178.789 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 121.236 0.541 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 60.31 28.73 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.991 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.51 90.0 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 80.3 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.72 64.56 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.256 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.676 ' CG2' ' O ' ' A' ' 49' ' ' LYS . 7.2 m . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -64.18 62.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.845 0.831 . . . . 0.0 111.489 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.62 2.51 89.84 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 115.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.676 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.54 15.19 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.421 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.736 1.153 . . . . 0.0 112.502 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.11 60.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 87.0 m -69.97 -45.44 67.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.46 -13.78 21.55 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.723 -0.611 . . . . 0.0 112.288 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.18 66.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.551 0 O-C-N 120.449 -1.407 . . . . 0.0 113.814 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 47' ' ' ASP . 1.4 t . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.789 -0.078 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 46' ' ' VAL . 66.3 t0 -81.3 67.61 7.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.668 0.747 . . . . 0.0 111.14 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.28 2.51 89.26 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.334 -1.303 . . . . 0.0 115.298 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.5 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 61.1 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.8 70.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.473 0.711 0 O-C-N 120.332 -1.48 . . . . 0.0 113.902 -179.246 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.58 68.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.618 0.723 . . . . 0.0 112.579 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.0 2.51 88.78 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.705 -1.134 . . . . 0.0 115.298 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.47 -36.1 81.4 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.858 -1.151 . . . . 0.0 111.225 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.25 19.85 11.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.034 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.15 30.49 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 175.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.42 125.46 37.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' CG ' ' SG ' ' A' ' 160' ' ' CYS . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.428 ' OG ' ' SG ' ' A' ' 160' ' ' CYS . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.539 ' SG ' ' CG ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.6 71.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 CA--C 1.53 0.201 0 O-C-N 120.64 -1.288 . . . . 0.0 113.445 -179.513 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.466 0.651 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 54.3 t0 64.12 24.6 13.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.171 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.42 2.51 90.18 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.3 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.236 -0.915 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m 72.54 15.21 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.34 125.46 32.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.502 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 91.3 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.596 ' O ' ' OG1' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.535 ' O ' ' C ' ' A' ' 24' ' ' THR . 58.7 t80 -66.96 -49.09 66.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 20' ' ' LEU . 30.8 p . . . . . 0 C--N 1.332 -0.152 0 O-C-N 121.336 -0.853 . . . . 0.0 110.736 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 48' ' ' GLY . 5.6 m . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -47.09 66.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 82.54 2.51 90.63 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.68 -1.146 . . . . 0.0 115.298 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.601 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 126.65 21.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 87.55 12.02 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.512 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -80.16 125.46 29.86 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.7 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.58 139.54 31.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 119.121 0.873 . . . . 0.0 111.498 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.21 128.0 53.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mt -126.42 126.18 68.68 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.63 124.83 45.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.713 -1.242 . . . . 0.0 111.752 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 t -119.48 131.36 55.58 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.096 -1.003 . . . . 0.0 111.472 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.98 132.66 66.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.39 124.37 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.342 1.057 . . . . 0.0 109.463 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.08 166.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.538 -1.976 . . . . 0.0 109.914 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.07 165.85 10.44 Favored Glycine 0 CA--C 1.494 -1.231 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.64 151.46 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.275 1.83 . . . . 0.0 113.93 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.11 146.71 35.78 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 118.816 -2.427 . . . . 0.0 111.833 165.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.71 0.62 3.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.44 -16.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 O-C-N 119.206 -2.184 . . . . 0.0 113.989 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.69 17.28 9.26 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 120.365 -1.46 . . . . 0.0 115.454 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.64 -49.6 75.93 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.116 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -61.54 -47.59 84.88 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.386 1.088 . . . . 0.0 113.004 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.1 m -63.12 -36.84 84.95 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.11 91.01 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.923 1.289 . . . . 0.0 112.31 172.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.79 -47.13 66.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.15 -48.4 88.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.127 0.876 . . . . 0.0 110.805 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -60.49 -41.36 94.1 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.94 -48.78 67.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.261 -0.899 . . . . 0.0 113.401 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.467 0.378 0 O-C-N 120.53 -1.356 . . . . 0.0 114.52 -178.445 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.14 28.09 14.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.885 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.49 90.49 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.98 123.88 45.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 118.494 1.147 . . . . 0.0 112.413 -174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.88 110.4 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 CA-C-N 121.77 1.668 . . . . 0.0 110.613 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -117.73 129.66 73.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.015 0.926 . . . . 0.0 109.413 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -103.01 106.11 16.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 tp -98.53 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.096 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.28 127.41 7.98 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 120.974 -1.078 . . . . 0.0 111.308 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.76 133.03 54.26 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.934 0.894 . . . . 0.0 110.63 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.33 123.15 31.06 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.979 0.912 . . . . 0.0 108.629 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.01 11.45 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 109.682 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.92 33.86 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 124.085 1.897 . . . . 0.0 113.439 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.58 108.26 11.85 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 120.288 -1.508 . . . . 0.0 109.906 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.95 -5.58 88.85 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 120.408 -1.432 . . . . 0.0 115.938 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -62.05 145.77 52.21 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.325 1.85 . . . . 0.0 112.159 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.35 -30.59 70.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.861 2.064 . . . . 0.0 112.081 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.35 -36.21 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.874 -1.142 . . . . 0.0 111.235 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -96.15 19.83 11.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.028 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -56.3 -27.18 54.63 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 113.63 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -29.53 25.68 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 175.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.9 tp -96.07 -36.97 10.81 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.978 1.311 . . . . 0.0 112.485 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -58.21 -39.68 77.42 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 119.869 -1.769 . . . . 0.0 115.181 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -65.2 -7.11 14.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 124.739 2.728 . . . . 0.0 115.587 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.29 -16.96 62.49 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.6 p -92.03 -8.15 46.79 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.607 -1.308 . . . . 0.0 112.445 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -68.47 -35.28 6.71 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 97.4 Cg_exo -52.39 130.92 38.09 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.505 2.804 . . . . 0.0 115.316 173.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.611 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 72.94 30.76 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.388 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.1 m -92.54 125.4 37.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.24 -30.87 22.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.151 0.98 . . . . 0.0 112.33 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.3 143.51 18.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.812 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.95 43.01 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.522 -1.361 . . . . 0.0 110.526 174.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.88 114.06 27.82 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.35 115.95 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.7 m -109.05 142.62 39.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.655 1.217 . . . . 0.0 112.418 -172.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -139.82 152.16 46.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 171.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -85.81 132.32 34.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.995 -1.066 . . . . 0.0 110.126 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.24 -12.79 61.58 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 125.239 1.416 . . . . 0.0 113.561 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.8 18.27 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.686 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 t -132.19 103.75 13.92 Favored Pre-proline 0 C--N 1.352 0.716 0 O-C-N 119.71 -1.869 . . . . 0.0 109.94 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -66.43 -27.12 47.22 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 123.17 2.58 . . . . 0.0 114.099 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.974 0.91 . . . . 0.0 112.597 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.35 -35.66 80.91 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.095 -1.003 . . . . 0.0 112.418 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.5 t80 -60.22 -49.26 78.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.747 1.219 . . . . 0.0 112.783 173.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.22 -23.07 60.32 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.451 -1.406 . . . . 0.0 113.175 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -66.45 -25.11 66.57 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.94 -1.725 . . . . 0.0 113.171 168.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.29 98.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 O-C-N 119.674 -1.891 . . . . 0.0 111.763 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -64.81 -48.61 73.79 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.204 1.402 . . . . 0.0 114.161 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.98 25.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.84 -62.82 0.8 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.405 -1.435 . . . . 0.0 113.016 -172.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -67.78 -44.56 77.14 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -169.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.417 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.75 -48.37 79.79 Favored Pre-proline 0 C--N 1.353 0.751 0 CA-C-O 116.667 -1.635 . . . . 0.0 113.034 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -56.25 -42.91 61.18 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.117 2.545 . . . . 0.0 114.603 172.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.12 -51.38 66.74 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 119.074 0.852 . . . . 0.0 112.726 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.21 -42.27 92.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.028 -1.67 . . . . 0.0 111.529 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -66.64 -38.44 86.9 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.98 -44.44 97.36 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.429 1.013 . . . . 0.0 112.824 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.49 -31.31 29.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.72 -1.237 . . . . 0.0 113.228 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.64 90.06 14.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 120.17 -1.581 . . . . 0.0 110.256 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.17 -30.84 19.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.954 1.769 . . . . 0.0 116.262 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.44 -6.59 16.1 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 124.052 0.941 . . . . 0.0 113.328 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.65 134.16 94.26 Favored Pre-proline 0 C--N 1.352 0.7 0 O-C-N 119.287 -2.133 . . . . 0.0 112.367 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.61 141.38 43.23 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 124.967 3.778 . . . . 0.0 117.685 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.7 mt -119.46 135.71 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.68 123.96 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 168.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.8 tp -89.02 124.02 33.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.87 120.68 65.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 121.977 0.894 . . . . 0.0 109.417 -174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.13 113.5 4.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.4 p -98.49 162.54 13.1 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.95 -1.324 . . . . 0.0 111.344 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.73 42.99 4.34 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.985 1.314 . . . . 0.0 112.865 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.4 -32.21 69.96 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.12 -30.23 69.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.764 2.025 . . . . 0.0 111.574 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.84 -5.37 56.93 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.77 -35.12 80.07 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.625 -1.297 . . . . 0.0 113.882 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.16 -1.36 48.6 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 111.386 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 118.03 12.08 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 119.877 -1.765 . . . . 0.0 111.326 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -44.99 93.32 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.6 -50.63 70.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.42 0.688 . . . . 0.0 111.244 175.102 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -55.54 -44.39 76.71 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.331 -1.481 . . . . 0.0 113.536 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.53 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.458 1.103 . . . . 0.0 112.715 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.4 -46.5 89.76 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.783 -1.198 . . . . 0.0 112.314 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.98 -37.27 79.14 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.71 -1.244 . . . . 0.0 114.111 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.05 -46.1 82.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.381 -1.45 . . . . 0.0 112.97 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.55 -34.76 73.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.76 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.737 1.215 . . . . 0.0 113.542 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.43 9.36 40.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.902 -1.124 . . . . 0.0 111.729 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.79 38.24 3.88 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 125.45 1.5 . . . . 0.0 114.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 161.33 24.6 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 125.933 1.693 . . . . 0.0 107.152 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.4 p -138.87 159.01 68.88 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.18 156.64 61.86 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.688 2.259 . . . . 0.0 114.213 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.99 117.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 122.729 1.252 . . . . 0.0 109.846 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 55.1 p -76.29 165.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.898 -1.126 . . . . 0.0 111.321 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -57.47 -46.2 99.81 Favored Pre-proline 0 C--N 1.354 0.769 0 O-C-N 120.531 -1.356 . . . . 0.0 112.671 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.37 -38.51 94.32 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 124.228 2.546 . . . . 0.0 116.051 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.47 -43.15 91.17 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.074 1.306 . . . . 0.0 112.744 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.33 -38.51 81.21 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 120.646 -1.284 . . . . 0.0 115.363 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.57 87.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.534 1.133 . . . . 0.0 113.518 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.1 90.66 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.334 1.054 . . . . 0.0 112.485 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.77 -41.17 97.35 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.46 85.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.059 0.943 . . . . 0.0 112.832 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.08 -43.46 95.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -62.22 -33.65 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.668 . . . . 0.0 113.928 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.417 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.66 2.9 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.634 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.81 41.17 50.75 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.265 -1.522 . . . . 0.0 116.32 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.28 148.05 52.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.224 1.012 . . . . 0.0 112.522 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.32 -34.28 65.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 O-C-N 121.006 -1.059 . . . . 0.0 110.582 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.4 150.72 30.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.815 -1.178 . . . . 0.0 109.679 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -115.63 128.74 56.15 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 169.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.9 mt -138.76 146.25 41.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.705 0.802 . . . . 0.0 109.552 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.53 137.94 54.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.77 30.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 123.532 1.634 . . . . 0.0 112.511 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.2 t -127.77 126.32 41.55 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.315 -0.866 . . . . 0.0 112.828 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 73.8 m -83.84 -41.21 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.556 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.0 p -98.94 -13.74 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.302 93.7 mt-30 75.7 8.88 3.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.217 2.207 . . . . 0.0 113.481 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.81 115.91 5.27 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.3 -1.5 . . . . 0.0 113.08 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.01 -0.14 67.67 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.985 0.802 . . . . 0.0 114.274 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.16 -46.15 78.44 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -38.61 87.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.094 0.957 . . . . 0.0 112.316 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.76 -37.27 68.3 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.529 1.932 . . . . 0.0 112.216 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.403 ' HA ' HD13 ' A' ' 155' ' ' LEU . 94.0 t -57.64 -46.62 86.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.575 1.15 . . . . 0.0 112.535 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.15 -32.09 50.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 0.0 112.733 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.15 -44.22 97.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.405 1.082 . . . . 0.0 111.717 172.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.67 -34.06 76.17 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.013 -1.679 . . . . 0.0 114.415 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.26 88.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.617 -1.302 . . . . 0.0 112.118 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.99 -45.84 89.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 124.129 0.972 . . . . 0.0 113.449 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -61.48 -31.43 71.41 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.202 -1.562 . . . . 0.0 114.344 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.84 69.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.4 -39.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.351 0.657 0 C-N-CA 125.04 1.336 . . . . 0.0 112.04 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.54 -19.96 40.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.049 -1.657 . . . . 0.0 114.775 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.34 67.67 76.56 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.7 -176.41 2.47 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.688 1.592 . . . . 0.0 109.0 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -112.11 122.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.567 2.172 0 O-C-N 125.256 2.187 . . . . 0.0 116.132 157.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.048 3.166 . . . . 0.0 116.138 167.016 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.711 ' O ' HG22 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.51 68.32 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.866 ' O ' HG23 ' A' ' 24' ' ' THR . 11.9 t . . . . . 0 C--N 1.33 -0.27 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.737 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.903 HG12 ' H ' ' A' ' 47' ' ' ASP . 2.0 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.903 ' H ' HG12 ' A' ' 46' ' ' VAL . 98.6 m-20 -75.76 68.09 2.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.103 0.954 . . . . 0.0 111.054 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.51 89.78 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.298 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' CYS . . . . . 0.684 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.5 OUTLIER -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.684 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.27 72.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 21' ' ' ILE . 99.3 m . . . . . 0 N--CA 1.466 0.349 0 O-C-N 120.743 -1.223 . . . . 0.0 112.134 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 110.823 -0.066 . . . . 0.0 110.823 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.413 ' H ' HG12 ' A' ' 46' ' ' VAL . 66.5 t0 -82.82 67.94 9.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.145 0.974 . . . . 0.0 111.783 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 2.51 89.27 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 113.502 -1.681 . . . . 0.0 115.298 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.8 37.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.582 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 14.6 m 73.19 30.43 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 175.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 72.4 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.63 67.96 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 m . . . . . 0 C--N 1.343 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.664 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.31 24.99 5.48 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.322 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.39 2.51 84.31 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.9 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 99.1 m -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.68 67.78 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 20' ' ' LEU . 15.3 t . . . . . 0 CA--C 1.532 0.258 0 O-C-N 119.803 -1.811 . . . . 0.0 113.346 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' A' ' 49' ' ' LYS . 26.3 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -80.32 67.64 6.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.359 0.599 . . . . 0.0 112.343 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.51 90.58 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.042 -0.981 . . . . 0.0 115.298 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.579 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.52 70.64 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.2 m -62.5 -36.17 81.69 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.037 -1.039 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.14 19.85 11.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.034 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 60.4 m 73.21 30.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.29 125.46 36.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.23 59.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.4 m -84.52 -40.45 17.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -171.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.4 -13.78 19.42 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.599 ' HD3' ' SG ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.0 69.87 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' ILE . 94.4 m . . . . . 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.21 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 47' ' ' ASP . 11.9 p . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 46' ' ' VAL . 97.0 m-20 56.23 17.19 2.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.021 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.88 2.51 82.04 Favored Glycine 0 C--N 1.318 -0.421 0 CA-C-N 115.137 -0.938 . . . . 0.0 115.298 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.74 70.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.88 -36.86 82.5 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.024 -1.048 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -95.67 19.85 10.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.034 -175.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.569 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 129.3 31.12 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 0.5 OUTLIER 77.18 26.32 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.371 173.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -89.76 125.46 35.3 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.59 59.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.82 -41.02 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.665 -171.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.96 -13.78 19.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -51.29 56.95 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.233 0.195 0 O-C-N 124.635 1.209 . . . . 0.0 113.117 -177.154 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' H ' ' HB ' ' A' ' 46' ' ' VAL . 54.5 p-10 -60.53 63.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.467 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.53 2.51 89.7 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HB2' HG23 ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 5.0 m 73.19 30.41 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.571 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 76.1 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.595 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.814 HD13 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.39 68.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.1 p -81.24 -52.64 7.12 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 119.916 -1.74 . . . . 0.0 112.73 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 21' ' ' ILE . 87.7 m -132.35 132.44 42.91 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.317 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.666 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 66.2 t30 -93.89 146.69 23.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.666 ' CB ' ' O ' ' A' ' 26' ' ' ASN . . . 107.48 145.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.781 0.676 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.646 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 78.3 m-85 -57.3 -45.82 99.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.022 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 38.1 Cg_endo -66.59 -17.33 52.83 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.433 2.089 . . . . 0.0 113.24 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 31' ' ' CYS . . . -60.38 -35.11 87.73 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.814 ' HA ' HD13 ' A' ' 21' ' ' ILE . 22.6 p -23.73 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 30' ' ' GLY . 7.6 m-85 -98.85 161.84 13.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.48 1.134 . . . . 0.0 113.052 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.039 HG22 ' HD2' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -122.64 162.49 38.16 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 112.733 -2.031 . . . . 0.0 108.614 175.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 1.039 ' HD2' HG22 ' A' ' 33' ' ' ILE . 36.4 Cg_endo -65.89 -15.95 50.92 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.009 1.806 . . . . 0.0 112.007 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.1 p -70.62 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.699 HG12 ' H ' ' A' ' 38' ' ' ASP . 58.0 t -64.26 130.03 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -75.68 -12.31 60.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.699 ' H ' HG12 ' A' ' 36' ' ' VAL . 98.9 m-20 -61.28 -41.9 97.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.349 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' CG ' ' O ' ' A' ' 38' ' ' ASP . 21.0 m-20 152.88 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.202 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 55' ' ' LEU . 14.0 t80 -118.59 -37.68 3.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.788 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.4 p -72.89 163.82 27.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.06 141.33 48.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.734 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -86.59 100.05 12.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.779 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.722 HG13 ' HB ' ' A' ' 51' ' ' VAL . 6.2 p -123.37 136.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.116 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.621 ' SD ' ' C ' ' A' ' 44' ' ' VAL . 4.6 mmt -129.66 121.03 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.3 t -127.94 128.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.199 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.4 t0 44.64 45.49 8.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.788 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.51 90.59 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.722 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.585 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.595 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.22 30.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.505 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.4 125.46 37.07 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.6 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.593 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 29' ' ' PRO . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.12 66.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -59.79 -45.05 93.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 29' ' ' PRO . 14.2 t -106.87 141.25 38.4 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.991 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.56 ' O ' ' O ' ' A' ' 25' ' ' THR . 62.0 t30 -52.43 -140.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.054 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' H ' ' CG ' ' A' ' 26' ' ' ASN . . . -63.18 142.01 58.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.1 t80 62.98 104.47 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.641 ' HA ' HG21 ' A' ' 25' ' ' THR . 39.0 Cg_exo -57.56 142.63 95.57 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.981 2.454 . . . . 0.0 113.176 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.612 ' H ' HG21 ' A' ' 25' ' ' THR . . . -106.51 115.05 4.6 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' C ' ' O ' ' A' ' 30' ' ' GLY . 55.8 m 23.01 -110.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.675 0.274 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CD2' HG12 ' A' ' 33' ' ' ILE . 3.3 t80 -148.12 -91.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.62 HG12 ' CD2' ' A' ' 32' ' ' TYR . 47.8 mm -84.7 120.9 74.51 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.21 157.72 56.53 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.4 p -64.81 -21.08 66.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.099 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 36' ' ' VAL . 8.3 p -120.93 126.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 23.1 p90 -108.95 58.2 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.871 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.14 111.16 22.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.625 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.44 ' C ' ' H ' ' A' ' 41' ' ' SER . 2.3 t-20 58.86 46.56 13.73 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -68.61 1.42 3.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.866 0.841 . . . . 0.0 109.166 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 53' ' ' LEU . 95.6 p -93.63 -3.02 53.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.802 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 50.55 116.36 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.092 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.76 ' O ' ' HE2' ' A' ' 45' ' ' MET . 48.5 p-10 -87.7 45.44 1.28 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 173' ' ' ILE . 9.7 p -36.33 137.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.442 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.76 ' HE2' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -116.65 115.41 25.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.808 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -138.12 137.57 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 54.5 t0 48.67 36.31 7.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.234 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.51 90.51 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.628 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 43' ' ' ASN . 2.1 m-80 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.641 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.782 HD13 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.741 ' HE2' ' HB1' ' A' ' 42' ' ' ALA . 58.7 t80 -66.96 -49.87 64.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p -79.94 -21.3 44.0 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.719 HG22 ' O ' ' A' ' 21' ' ' ILE . 13.7 t -148.11 162.4 39.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.735 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 26' ' ' ASN . 29.2 t-20 -121.94 39.26 3.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.31 149.28 42.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.339 . . . . 0.0 110.921 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.53 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -59.61 -58.28 20.64 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.41 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD3' ' CB ' ' A' ' 28' ' ' PHE . 54.3 Cg_exo -49.18 -161.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.981 2.454 . . . . 0.0 112.798 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 40.36 53.97 3.35 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.782 ' HA ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.89 50.18 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.714 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.544 ' HB3' ' O ' ' A' ' 31' ' ' CYS . 79.9 t80 71.63 -5.19 1.7 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 31' ' ' CYS . 1.8 mp -53.63 -48.09 94.33 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.334 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 24.5 Cg_exo -62.96 142.81 89.58 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.019 1.813 . . . . 0.0 110.022 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -134.62 150.07 50.64 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 39' ' ' ASN . 48.2 t -147.48 90.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.294 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -65.46 -37.73 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.654 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.84 -42.46 97.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.514 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.683 ' H ' HG12 ' A' ' 36' ' ' VAL . 25.4 t-20 -154.96 94.45 1.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.947 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 84.3 t80 -143.11 107.13 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 92.7 p -158.73 159.98 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.247 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.066 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . . . -68.86 145.86 53.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 110.12 21.4 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.861 HG21 ' CD1' ' A' ' 173' ' ' ILE . 33.2 m -128.04 153.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.273 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 44' ' ' VAL . 11.5 mmt -141.89 144.46 33.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.485 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 48' ' ' GLY . 80.4 t -134.4 158.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.447 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 53.6 p30 -30.52 73.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.679 0.612 . . . . 0.0 112.604 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.09 2.51 88.94 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.611 ' HB ' HG23 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.066 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.54 -36.09 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 110.982 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.034 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.61 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.861 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.676 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 mt -60.18 -48.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.837 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.455 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.32 71.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.614 ' O ' ' CB ' ' A' ' 25' ' ' THR . 43.2 m -53.97 131.34 40.18 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.492 -1.38 . . . . 0.0 111.203 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' THR . 2.3 m 95.28 -13.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.255 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' OD1' ' O ' ' A' ' 25' ' ' THR . 17.2 p30 32.07 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -153.77 140.24 18.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' O ' ' O ' ' A' ' 27' ' ' ALA . 2.6 p90 44.78 175.46 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 28' ' ' PHE . 15.4 Cg_endo -57.2 148.93 67.01 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.556 1.504 . . . . 0.0 112.682 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 21' ' ' ILE . . . -61.3 140.72 47.75 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HG ' ' HZ ' ' A' ' 28' ' ' PHE . 1.8 m -76.79 -107.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.515 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.676 ' CE1' ' CD1' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 167.78 155.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.668 HG22 HG22 ' A' ' 36' ' ' VAL . 26.2 pt -138.59 57.48 11.88 Favored Pre-proline 0 C--O 1.232 0.179 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.014 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 33' ' ' ILE . 63.8 Cg_exo -54.81 -43.38 59.84 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.676 2.25 . . . . 0.0 112.479 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.9 p -131.88 -8.13 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 33' ' ' ILE . 1.5 m -84.48 157.56 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 38' ' ' ASP . 97.0 m-85 -77.04 -75.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.626 ' HB3' HG21 ' A' ' 33' ' ' ILE . 53.1 t0 39.97 49.18 2.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.25 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.556 ' O ' ' O ' ' A' ' 40' ' ' TYR . 32.8 m120 -100.95 16.57 24.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.498 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.556 ' O ' ' O ' ' A' ' 39' ' ' ASN . 50.1 m-85 -54.3 -143.08 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.482 0.658 . . . . 0.0 110.874 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 99.1 p -137.31 160.88 37.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 143.6 56.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.06 0.457 . . . . 0.0 110.593 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.708 ' OD1' ' HE3' ' A' ' 45' ' ' MET . 43.6 t30 -88.11 88.64 7.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.621 ' C ' ' SD ' ' A' ' 45' ' ' MET . 33.3 m -116.37 142.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.278 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.708 ' HE3' ' OD1' ' A' ' 43' ' ' ASN . 2.2 mpt? -157.36 85.76 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.647 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.63 161.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.873 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 t0 55.66 18.16 2.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.63 2.51 89.87 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.9 45.5 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 118.471 1.136 . . . . 0.0 112.423 -174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.54 77.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 m -60.76 -26.68 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 120.294 -1.504 . . . . 0.0 114.367 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.54 19.81 18.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.304 -0.873 . . . . 0.0 112.041 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.0 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 15.2 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.38 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.687 1.13 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.09 -30.24 69.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.744 2.018 . . . . 0.0 111.574 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.85 -5.34 56.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.15 -1.37 48.61 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.25 1.42 . . . . 0.0 111.365 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.94 -1.725 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.61 -50.67 70.32 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.226 175.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.8 126.35 41.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.19 60.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 121.294 -0.879 . . . . 0.0 112.851 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.602 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 88.6 m -70.23 -45.1 67.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.71 21.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 121.723 -0.611 . . . . 0.0 112.29 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.66 8.9 3.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.228 2.211 . . . . 0.0 113.489 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.82 115.9 5.26 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.256 -1.528 . . . . 0.0 113.076 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.98 -0.11 67.62 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.952 0.787 . . . . 0.0 114.274 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.7 tp -66.2 -46.09 78.51 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.24 -38.65 87.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 112.28 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.5 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.17 167.026 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.602 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.583 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.574 ' O ' ' CB ' ' A' ' 25' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -50.02 63.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.3 p -89.18 -2.43 58.5 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.598 -0.689 . . . . 0.0 112.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 1.147 HG21 ' N ' ' A' ' 30' ' ' GLY . 94.2 m -109.16 130.44 55.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.935 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.534 ' O ' ' C ' ' A' ' 27' ' ' ALA . 33.6 m120 -47.37 135.07 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' C ' ' O ' ' A' ' 26' ' ' ASN . . . 27.97 -103.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 54.7 t80 -62.45 136.19 95.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.426 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.548 ' C ' HG21 ' A' ' 25' ' ' THR . 32.2 Cg_exo -59.59 144.86 99.32 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.001 2.468 . . . . 0.0 112.554 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 1.147 ' N ' HG21 ' A' ' 25' ' ' THR . . . -166.97 -177.71 38.9 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 30' ' ' GLY . 41.5 t 49.19 98.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.207 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -57.33 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.971 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.002 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.2 pp -129.58 155.04 80.89 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 55.7 Cg_endo -69.25 142.61 50.66 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.311 2.007 . . . . 0.0 112.239 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.1 p -122.13 10.6 10.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.735 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.543 HG13 ' OH ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -117.16 131.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.735 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.638 ' O ' ' O ' ' A' ' 38' ' ' ASP . 97.0 m-85 -63.53 -40.84 98.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.333 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.638 ' O ' ' O ' ' A' ' 37' ' ' PHE . 45.5 t0 -6.34 -118.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.664 0.603 . . . . 0.0 111.946 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 88.3 m-20 -149.44 133.52 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.548 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 34' ' ' PRO . 43.2 m-85 -122.84 77.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.969 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.725 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 48.7 m -121.37 -11.85 8.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.992 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . 85.52 160.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 45' ' ' MET . 50.6 p30 -100.08 35.65 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.784 HG11 ' CD1' ' A' ' 173' ' ' ILE . 2.0 p -68.68 113.81 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 111.6 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.654 ' SD ' ' O ' ' A' ' 44' ' ' VAL . 6.9 mmt -136.86 106.15 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.95 135.49 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 59.87 37.28 21.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.759 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.6 2.51 90.55 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.776 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.588 ' C ' ' HB3' ' A' ' 41' ' ' SER . 2.1 m-80 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.45 70.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.7 -35.92 81.29 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.012 -1.055 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.29 19.85 11.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.034 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.76 37.46 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.27 30.37 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 175.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.31 125.46 36.98 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.976 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 84.4 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.784 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.976 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.837 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.497 ' CG2' ' HA3' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.98 69.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 20' ' ' LEU . 71.2 p -51.86 169.21 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.65 -1.281 . . . . 0.0 112.751 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 24' ' ' THR . 27.9 p -19.53 140.59 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.607 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -90.32 76.3 6.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.372 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.592 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -159.96 151.89 20.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.467 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.745 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 52.7 t80 54.97 151.43 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.745 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 83.5 Cg_exo -43.77 -24.42 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.414 2.076 . . . . 0.0 113.22 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . 146.77 114.17 0.82 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.043 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.549 ' HB3' ' OH ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -66.45 152.91 44.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ILE . 34.5 t80 -123.1 -112.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.248 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER 51.6 115.19 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.38 -21.93 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.136 1.891 . . . . 0.0 111.83 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.618 ' OG1' ' CE1' ' A' ' 37' ' ' PHE . 78.3 p -82.4 168.79 17.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.667 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.121 HG22 ' HB3' ' A' ' 40' ' ' TYR . 1.1 t -116.59 122.14 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.38 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.618 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 87.3 m-85 -127.0 148.11 50.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.338 0.589 . . . . 0.0 111.242 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.4 t0 49.97 56.55 7.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.668 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' SER . 65.4 t30 57.98 50.39 10.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.704 -0.399 . . . . 0.0 112.001 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 1.121 ' HB3' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -69.27 68.84 0.21 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.898 0.856 . . . . 0.0 109.729 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 91.7 p -155.44 158.93 39.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.672 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -72.64 140.4 47.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.428 . . . . 0.0 111.207 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' A' ' 45' ' ' MET . 98.6 m-20 -101.0 10.65 40.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.841 HG23 ' HB ' ' A' ' 51' ' ' VAL . 16.7 m -10.92 133.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.779 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -135.36 95.56 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.561 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -141.34 143.07 28.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.107 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 62.27 23.85 14.15 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.57 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.46 2.51 90.62 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.841 ' HB ' HG23 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.55 15.2 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.727 1.149 . . . . 0.0 112.502 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.581 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 97.8 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.581 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.636 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.9 70.2 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -94.64 -5.2 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.569 -1.332 . . . . 0.0 113.88 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.636 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 7.2 p -137.17 177.48 7.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.947 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 27' ' ' ALA . 53.7 p30 -92.48 -136.24 0.16 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -45.4 -176.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 32.7 m-85 -48.7 -46.65 72.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 28.0 Cg_exo -60.93 143.26 99.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.318 2.012 . . . . 0.0 112.695 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.82 -29.11 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.684 ' C ' ' CG ' ' A' ' 32' ' ' TYR . 1.1 m 60.65 24.8 14.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.884 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 52.68 -91.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.884 HD12 ' C ' ' A' ' 32' ' ' TYR . 3.2 mp -131.48 70.03 81.68 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.093 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.83 ' O ' HG23 ' A' ' 35' ' ' THR . 34.8 Cg_endo -65.36 -19.05 61.61 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.257 2.638 . . . . 0.0 112.486 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 34' ' ' PRO . 77.9 p 116.45 63.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.225 0.953 . . . . 0.0 110.041 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.93 HG12 ' CE1' ' A' ' 37' ' ' PHE . 98.7 t -64.84 -61.49 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.93 ' CE1' HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER 167.88 -95.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.94 177.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.717 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 96.3 m-20 -92.13 11.59 24.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.748 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -76.32 119.43 20.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.717 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -142.55 -46.37 0.33 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.429 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.634 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 89.7 p -162.7 162.08 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.138 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.78 157.45 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.758 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.665 ' O ' ' SD ' ' A' ' 45' ' ' MET . 98.6 m-20 -99.67 21.74 11.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.596 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' C ' ' O ' ' A' ' 43' ' ' ASN . 5.2 p -7.55 123.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.699 0.761 . . . . 0.0 110.926 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.665 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -120.26 85.5 2.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.127 -178.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.22 153.82 39.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 50.56 20.15 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.644 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.54 2.51 90.54 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.634 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 92.8 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.73 37.33 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.4 30.23 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 175.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.25 125.46 36.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.7 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.04 66.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p -84.81 -23.98 28.86 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.084 -1.635 . . . . 0.0 114.072 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 m -96.74 -38.02 10.06 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.979 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.605 ' HB3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER 81.33 173.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.593 ' N ' ' CG ' ' A' ' 26' ' ' ASN . . . 24.3 -124.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.75 120.93 72.73 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HB2' HG21 ' A' ' 21' ' ' ILE . 44.4 Cg_endo -66.95 140.31 54.4 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.506 2.137 . . . . 0.0 114.367 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 178.34 59.45 0.07 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.422 -1.371 . . . . 0.0 112.174 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.594 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 1.1 t -177.82 48.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.435 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.954 ' CE1' HG22 ' A' ' 33' ' ' ILE . 1.8 t80 -41.24 -77.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.954 HG22 ' CE1' ' A' ' 32' ' ' TYR . 19.1 tt -151.51 46.84 0.39 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.67 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.594 ' HG3' ' HA ' ' A' ' 31' ' ' CYS . 91.3 Cg_endo -75.75 160.18 37.91 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.617 2.878 . . . . 0.0 112.286 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.6 m -61.4 129.51 41.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.937 HG12 ' H ' ' A' ' 37' ' ' PHE . 21.8 t -137.14 -172.23 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.937 ' H ' HG12 ' A' ' 36' ' ' VAL . 96.6 m-85 -59.5 -45.35 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.761 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 64.9 t0 163.46 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.129 0.268 . . . . 0.0 110.964 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.612 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 99.2 m-20 -145.98 -80.8 0.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.799 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 39' ' ' ASN . 37.9 m-85 87.83 -32.39 0.03 OUTLIER 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.11 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 88.0 p -159.03 158.86 33.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.69 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.74 152.2 31.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.915 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.569 ' HB3' ' CE ' ' A' ' 45' ' ' MET . 97.8 m-20 -87.36 119.04 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 51' ' ' VAL . 6.3 p -122.51 134.79 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.43 0.633 . . . . 0.0 111.379 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.569 ' CE ' ' HB3' ' A' ' 43' ' ' ASN . 0.5 OUTLIER -138.38 95.15 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.537 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -125.82 132.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 60.31 28.73 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.991 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.51 90.0 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.687 ' O ' HG12 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' HB2' ' HE2' ' A' ' 32' ' ' TYR . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.942 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 80.3 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.942 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.834 HG21 ' CG1' ' A' ' 33' ' ' ILE . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.622 ' CG2' ' HA3' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.72 64.56 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -66.17 -31.08 71.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.488 HG21 ' CA ' ' A' ' 30' ' ' GLY . 76.9 p -98.62 3.81 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.552 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 55.37 33.13 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.728 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 22' ' ' SER . . . -173.89 144.5 1.04 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.749 ' CD1' ' O ' ' A' ' 160' ' ' CYS . 0.0 OUTLIER -40.46 -54.29 5.0 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.627 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.663 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 92.2 Cg_endo -75.51 159.18 39.77 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.209 1.939 . . . . 0.0 110.945 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.622 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . -157.94 -135.14 1.85 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.84 -77.3 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.775 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.872 ' H ' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -172.11 169.36 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.435 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.913 ' H ' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -70.1 -62.21 2.41 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.582 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.768 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 83.9 Cg_endo -77.74 156.52 31.46 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.446 2.097 . . . . 0.0 111.637 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.52 28.05 5.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.872 HG21 ' H ' ' A' ' 32' ' ' TYR . 21.0 t -123.42 -41.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.669 ' CZ ' ' HB2' ' A' ' 40' ' ' TYR . 12.3 t80 -91.81 46.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.351 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.43 -45.97 90.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.283 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -148.28 62.96 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.441 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.669 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.6 m-85 -88.28 68.48 8.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.182 0.515 . . . . 0.0 109.956 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 39.3 t -62.25 -43.57 98.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.158 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 52' ' ' ASN . . . 69.55 126.33 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.626 ' O ' ' SD ' ' A' ' 45' ' ' MET . 50.5 p30 -118.21 36.73 4.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.944 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.926 HG12 ' O ' ' A' ' 51' ' ' VAL . 11.8 p -26.75 154.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.127 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 2.5 mmt -118.69 134.22 55.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.321 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.676 ' CG2' ' O ' ' A' ' 49' ' ' LYS . 7.2 m -142.87 -165.17 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -64.18 62.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.845 0.831 . . . . 0.0 111.489 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.62 2.51 89.84 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 115.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.676 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.926 ' O ' HG12 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 2.1 m-80 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.54 15.19 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.736 1.153 . . . . 0.0 112.502 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.11 60.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.749 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 87.0 m -69.97 -45.44 67.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.46 -13.78 21.55 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.723 -0.611 . . . . 0.0 112.288 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 31.4 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.633 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.738 HD13 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 26' ' ' ASN . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.18 66.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.41 -37.83 65.8 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.449 -1.407 . . . . 0.0 113.814 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 28' ' ' PHE . 81.7 p -88.62 12.99 13.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.613 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' O ' ' O ' ' A' ' 22' ' ' SER . 98.9 m-20 64.32 -128.48 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.57 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.32 -8.22 59.08 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.583 ' O ' ' HB ' ' A' ' 25' ' ' THR . 95.9 m-85 -121.27 142.87 36.08 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 159.59 45.62 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 123.423 2.749 . . . . 0.0 113.62 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -133.33 -36.76 0.26 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.738 ' HA ' HD13 ' A' ' 21' ' ' ILE . 3.8 m 83.25 99.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' H ' HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -59.06 104.95 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.872 ' C ' HD12 ' A' ' 33' ' ' ILE . 1.7 pp -90.12 159.25 42.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 35' ' ' THR . 33.5 Cg_exo -58.49 137.79 82.26 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.986 1.791 . . . . 0.0 112.086 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 46.53 127.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.409 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 38' ' ' ASP . 3.7 p -138.17 156.38 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -60.04 -44.3 94.76 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.709 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.62 ' O ' HG13 ' A' ' 36' ' ' VAL . 98.6 m-20 -83.96 153.03 24.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.561 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 40' ' ' TYR . 53.5 p30 -102.16 26.68 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.286 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 91.7 m-85 71.1 46.5 0.45 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.435 ' HB2' ' OD1' ' A' ' 52' ' ' ASN . 82.2 p -61.08 -38.08 84.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.462 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' VAL . . . 43.42 74.66 0.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.144 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.545 ' OD1' ' O ' ' A' ' 43' ' ' ASN . 54.5 p30 -65.85 69.66 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.201 0.525 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.783 HG11 ' CD1' ' A' ' 173' ' ' ILE . 12.6 p -67.55 137.55 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.521 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.484 ' CE ' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -106.4 142.15 36.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.549 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 47' ' ' ASP . 1.4 t -142.33 -144.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.789 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 46' ' ' VAL . 66.3 t0 -81.3 67.61 7.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.668 0.747 . . . . 0.0 111.14 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.28 2.51 89.26 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.334 -1.303 . . . . 0.0 115.298 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 41' ' ' SER . 2.1 m-80 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.5 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 61.1 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.918 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 74.2 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.453 ' OE1' ' O ' ' A' ' 26' ' ' ASN 0.301 31.4 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.783 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.918 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.763 HG21 ' CB ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.8 70.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.5 p -89.83 -1.64 58.04 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.332 -1.48 . . . . 0.0 113.902 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.622 ' CG2' ' O ' ' A' ' 27' ' ' ALA . 30.4 m -113.78 128.35 56.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -78.13 -16.82 57.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.239 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.622 ' O ' ' CG2' ' A' ' 25' ' ' THR . . . -132.56 138.18 47.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.481 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 16.8 m-85 -49.95 -46.68 81.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 31' ' ' CYS . 71.1 Cg_exo -53.99 -38.81 86.78 Favored 'Trans proline' 0 N--CA 1.505 2.194 0 C-N-CA 122.906 2.404 . . . . 0.0 115.107 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -0.72 0.6 Allowed Glycine 0 N--CA 1.466 0.679 0 O-C-N 123.867 0.729 . . . . 0.0 112.026 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.763 ' CB ' HG21 ' A' ' 21' ' ' ILE . 28.0 p -68.12 81.81 0.22 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.651 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 16.5 t80 179.14 155.79 0.49 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER 37.51 54.43 3.48 Favored Pre-proline 0 C--N 1.318 -0.776 1 CA-C-N 108.093 -4.14 . . . . 0.0 108.19 170.427 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 33' ' ' ILE . 32.0 Cg_exo -58.9 127.9 26.01 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.318 1.345 . . . . 0.0 111.366 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.607 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 77.6 p -130.19 2.03 4.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.093 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 36' ' ' VAL . 2.9 t 71.86 71.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -62.07 -43.85 97.95 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -171.61 108.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 111.261 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' SER . 64.8 t30 53.55 56.6 7.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.557 ' HB2' HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -67.98 10.09 0.24 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.085 178.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 42' ' ' ALA . 74.3 m -87.03 -5.54 59.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.942 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 48.73 128.61 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.092 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.628 ' O ' ' SD ' ' A' ' 45' ' ' MET . 53.3 p-10 -92.8 50.56 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.959 HG13 ' HB ' ' A' ' 51' ' ' VAL . 2.1 p -29.39 144.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.72 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 5.0 mmt -106.8 139.17 41.64 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.72 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -143.52 -168.1 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.58 68.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.618 0.723 . . . . 0.0 112.579 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.0 2.51 88.78 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.705 -1.134 . . . . 0.0 115.298 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.959 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.587 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.47 -36.1 81.4 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.858 -1.151 . . . . 0.0 111.225 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.25 19.85 11.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.034 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.15 30.49 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 175.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.42 125.46 37.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' CG ' ' SG ' ' A' ' 160' ' ' CYS . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.428 ' OG ' ' SG ' ' A' ' 160' ' ' CYS . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.892 ' SG ' ' N1 ' ' A' ' 201' ' ' GDP . 0.6 OUTLIER -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.892 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.892 ' N1 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.6 71.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 p -84.04 -67.22 0.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.64 -1.288 . . . . 0.0 113.445 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 14.3 t -146.67 160.11 42.62 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.786 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.61 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 50.9 t30 -100.2 106.14 17.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.406 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 26' ' ' ASN . . . 166.61 115.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.641 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 44.9 m-85 -54.4 -48.09 95.75 Favored Pre-proline 0 CA--C 1.519 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.952 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 36.3 Cg_endo -65.06 -24.72 59.37 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.795 1.664 . . . . 0.0 112.072 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' CYS . . . -93.5 -3.73 64.55 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.78 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -28.12 145.1 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.78 ' C ' ' O ' ' A' ' 31' ' ' CYS . 37.9 t80 -20.17 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' N ' ' O ' ' A' ' 31' ' ' CYS . 16.8 tt -142.55 126.25 9.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.085 176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -20.5 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.756 2.304 . . . . 0.0 112.792 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.445 ' C ' HG23 ' A' ' 36' ' ' VAL . 52.3 p -90.39 98.99 12.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 111.543 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 36' ' ' VAL . 84.5 t -153.86 46.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.046 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 96.5 m-85 66.48 2.21 2.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.417 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -169.89 173.14 6.24 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.614 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.33 158.08 30.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 33' ' ' ILE . 1.5 m-85 -107.35 72.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.254 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.9 m -123.95 128.96 50.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -68.89 135.35 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.35 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' O ' ' HG3' ' A' ' 45' ' ' MET . 65.6 t30 -98.5 16.91 20.32 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG11 HD13 ' A' ' 173' ' ' ILE . 6.1 p -26.67 126.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.243 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.572 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 0.5 OUTLIER -120.98 88.09 2.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.091 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG23 HG22 ' A' ' 44' ' ' VAL . 65.5 t -127.22 132.43 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.466 0.651 . . . . 0.0 112.301 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 54.3 t0 64.12 24.6 13.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.171 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.42 2.51 90.18 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.3 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.236 -0.915 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m 72.54 15.21 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.34 125.46 32.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.502 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.6 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 91.3 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.536 HD13 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.6 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.655 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.693 HD11 ' CD2' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.535 ' O ' ' C ' ' A' ' 24' ' ' THR . 58.7 t80 -66.96 -49.09 66.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 20' ' ' LEU . 30.8 p -34.87 -39.16 0.09 Allowed 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.336 -0.853 . . . . 0.0 110.736 -178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.522 ' CB ' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -163.42 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.361 0.601 . . . . 0.0 111.062 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.664 ' O ' ' O ' ' A' ' 27' ' ' ALA . 4.9 p-10 -158.25 -179.19 7.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.448 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.69 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -28.18 -114.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 36.24 171.39 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 28' ' ' PHE . 62.8 Cg_endo -96.69 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.576 2.851 . . . . 0.0 113.479 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.34 -91.65 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.558 ' HB3' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 178.49 -159.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 1.017 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -108.57 -60.96 1.67 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.67 -178.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.017 HD12 ' C ' ' A' ' 32' ' ' TYR . 2.9 mp -135.41 49.34 3.48 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 73.6 Cg_endo -72.68 158.41 50.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.488 2.792 . . . . 0.0 111.803 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.4 m -77.98 106.17 9.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.017 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 38' ' ' ASP . 61.4 t -126.56 130.55 71.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.51 -22.55 21.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.858 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.637 ' H ' HG12 ' A' ' 36' ' ' VAL . 80.1 m-20 -62.02 -42.15 98.85 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.353 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.585 ' CG ' ' O ' ' A' ' 38' ' ' ASP . 14.5 m-20 166.6 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 40' ' ' TYR . 1.4 t80 -136.08 -11.78 1.95 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.92 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.5 t -139.79 137.88 35.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.952 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.42 43.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.877 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.609 ' O ' ' O ' ' A' ' 44' ' ' VAL . 33.1 m120 -99.11 29.71 3.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.551 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.855 HG11 HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -6.87 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.585 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 6.1 mmt -99.17 120.6 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.766 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 48' ' ' GLY . 5.6 m -133.42 168.88 23.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.17 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -47.09 66.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 82.54 2.51 90.63 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.68 -1.146 . . . . 0.0 115.298 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.601 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.827 ' HB ' HG23 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 126.65 21.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 87.55 12.02 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.512 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -80.16 125.46 29.86 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.917 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.7 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.855 HD11 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.917 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.58 139.54 31.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 119.121 0.873 . . . . 0.0 111.498 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.21 128.0 53.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mt -126.42 126.18 68.68 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.63 124.83 45.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.713 -1.242 . . . . 0.0 111.752 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 t -119.48 131.36 55.58 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.096 -1.003 . . . . 0.0 111.472 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.98 132.66 66.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.39 124.37 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.342 1.057 . . . . 0.0 109.463 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.08 166.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.538 -1.976 . . . . 0.0 109.914 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.07 165.85 10.44 Favored Glycine 0 CA--C 1.494 -1.231 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.64 151.46 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.275 1.83 . . . . 0.0 113.93 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.11 146.71 35.78 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 118.816 -2.427 . . . . 0.0 111.833 165.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.71 0.62 3.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.44 -16.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 O-C-N 119.206 -2.184 . . . . 0.0 113.989 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.69 17.28 9.26 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 120.365 -1.46 . . . . 0.0 115.454 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.64 -49.6 75.93 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.116 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 32' ' ' TYR . 14.8 m -61.54 -47.59 84.88 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.386 1.088 . . . . 0.0 113.004 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.1 m -63.12 -36.84 84.95 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.11 91.01 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.923 1.289 . . . . 0.0 112.31 172.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.79 -47.13 66.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 32' ' ' TYR . 72.8 mt -60.15 -48.4 88.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.127 0.876 . . . . 0.0 110.805 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -60.49 -41.36 94.1 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.94 -48.78 67.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.261 -0.899 . . . . 0.0 113.401 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.2 p -93.11 -10.08 37.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.53 -1.356 . . . . 0.0 114.52 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.627 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 14.7 p -137.76 -173.38 3.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.21 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -70.08 159.05 34.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.746 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.19 86.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.665 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 98.2 m-85 -64.49 178.1 0.5 Allowed Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 28' ' ' PHE . 52.5 Cg_exo -51.4 118.98 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.867 1.044 . . . . 0.0 111.218 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . -90.85 -127.63 3.72 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.409 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.31 69.49 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.21 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.696 ' HB3' HD11 ' A' ' 21' ' ' ILE . 46.8 p90 -70.15 -16.64 63.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 35' ' ' THR . 19.1 tt -56.57 139.55 75.33 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.5 ' HD2' HG13 ' A' ' 33' ' ' ILE . 17.7 Cg_endo -58.69 71.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.744 1.629 . . . . 0.0 111.517 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.881 HG23 HG23 ' A' ' 33' ' ' ILE . 81.5 p -129.88 150.43 51.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.509 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -131.14 130.45 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.114 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p90 -135.44 -7.36 2.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.977 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 37' ' ' PHE . 98.1 m-20 -136.22 -105.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.694 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 41' ' ' SER . 61.3 t-20 -146.79 117.17 7.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.757 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -61.62 3.02 0.15 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.945 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.631 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 12.3 t -59.8 -43.53 94.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 124.254 0.971 . . . . 0.0 110.973 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . 78.3 131.17 0.05 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.582 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 65.0 t30 -79.98 79.09 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.892 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.633 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -126.36 110.49 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.715 ' O ' HG13 ' A' ' 46' ' ' VAL . 1.1 mpt? -147.21 131.66 17.64 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.651 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 45' ' ' MET . 1.5 m -161.59 154.63 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 111.882 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.14 28.09 14.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.885 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.49 90.49 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.98 123.88 45.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 118.494 1.147 . . . . 0.0 112.413 -174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.88 110.4 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 CA-C-N 121.77 1.668 . . . . 0.0 110.613 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.7 t -117.73 129.66 73.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.015 0.926 . . . . 0.0 109.413 -172.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.555 ' OD1' ' OG ' ' A' ' 41' ' ' SER . 2.1 m-80 -103.01 106.11 16.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 171.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 tp -98.53 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.096 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.28 127.41 7.98 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 120.974 -1.078 . . . . 0.0 111.308 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.76 133.03 54.26 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.934 0.894 . . . . 0.0 110.63 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.33 123.15 31.06 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.979 0.912 . . . . 0.0 108.629 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.01 11.45 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 109.682 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.92 33.86 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 124.085 1.897 . . . . 0.0 113.439 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.58 108.26 11.85 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 120.288 -1.508 . . . . 0.0 109.906 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.95 -5.58 88.85 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 120.408 -1.432 . . . . 0.0 115.938 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -62.05 145.77 52.21 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.325 1.85 . . . . 0.0 112.159 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.35 -30.59 70.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.861 2.064 . . . . 0.0 112.081 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.35 -36.21 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.874 -1.142 . . . . 0.0 111.235 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -96.15 19.83 11.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.028 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -56.3 -27.18 54.63 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 113.63 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -29.53 25.68 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 175.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.9 tp -96.07 -36.97 10.81 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.978 1.311 . . . . 0.0 112.485 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -58.21 -39.68 77.42 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 119.869 -1.769 . . . . 0.0 115.181 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -65.2 -7.11 14.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 124.739 2.728 . . . . 0.0 115.587 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.29 -16.96 62.49 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.6 p -92.03 -8.15 46.79 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.607 -1.308 . . . . 0.0 112.445 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -68.47 -35.28 6.71 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 97.4 Cg_exo -52.39 130.92 38.09 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.505 2.804 . . . . 0.0 115.316 173.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.611 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 72.94 30.76 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.388 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.1 m -92.54 125.4 37.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.24 -30.87 22.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.151 0.98 . . . . 0.0 112.33 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.3 143.51 18.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.812 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.95 43.01 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.522 -1.361 . . . . 0.0 110.526 174.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.88 114.06 27.82 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.35 115.95 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.7 m -109.05 142.62 39.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.655 1.217 . . . . 0.0 112.418 -172.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -139.82 152.16 46.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 171.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -85.81 132.32 34.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.995 -1.066 . . . . 0.0 110.126 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.24 -12.79 61.58 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 125.239 1.416 . . . . 0.0 113.561 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.8 18.27 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.686 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 t -132.19 103.75 13.92 Favored Pre-proline 0 C--N 1.352 0.716 0 O-C-N 119.71 -1.869 . . . . 0.0 109.94 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -66.43 -27.12 47.22 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 123.17 2.58 . . . . 0.0 114.099 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.974 0.91 . . . . 0.0 112.597 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.35 -35.66 80.91 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.095 -1.003 . . . . 0.0 112.418 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.5 t80 -60.22 -49.26 78.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.747 1.219 . . . . 0.0 112.783 173.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.22 -23.07 60.32 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.451 -1.406 . . . . 0.0 113.175 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -66.45 -25.11 66.57 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.94 -1.725 . . . . 0.0 113.171 168.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.29 98.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 O-C-N 119.674 -1.891 . . . . 0.0 111.763 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -64.81 -48.61 73.79 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.204 1.402 . . . . 0.0 114.161 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.98 25.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.84 -62.82 0.8 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.405 -1.435 . . . . 0.0 113.016 -172.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -67.78 -44.56 77.14 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -169.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.417 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.75 -48.37 79.79 Favored Pre-proline 0 C--N 1.353 0.751 0 CA-C-O 116.667 -1.635 . . . . 0.0 113.034 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -56.25 -42.91 61.18 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.117 2.545 . . . . 0.0 114.603 172.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.12 -51.38 66.74 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 119.074 0.852 . . . . 0.0 112.726 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.21 -42.27 92.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.028 -1.67 . . . . 0.0 111.529 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -66.64 -38.44 86.9 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.98 -44.44 97.36 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.429 1.013 . . . . 0.0 112.824 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.49 -31.31 29.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.72 -1.237 . . . . 0.0 113.228 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.64 90.06 14.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 120.17 -1.581 . . . . 0.0 110.256 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.17 -30.84 19.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.954 1.769 . . . . 0.0 116.262 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.44 -6.59 16.1 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 124.052 0.941 . . . . 0.0 113.328 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.65 134.16 94.26 Favored Pre-proline 0 C--N 1.352 0.7 0 O-C-N 119.287 -2.133 . . . . 0.0 112.367 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.61 141.38 43.23 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 124.967 3.778 . . . . 0.0 117.685 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.7 mt -119.46 135.71 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.68 123.96 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 168.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.8 tp -89.02 124.02 33.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.87 120.68 65.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 121.977 0.894 . . . . 0.0 109.417 -174.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.13 113.5 4.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.4 p -98.49 162.54 13.1 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.95 -1.324 . . . . 0.0 111.344 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.73 42.99 4.34 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.985 1.314 . . . . 0.0 112.865 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.4 -32.21 69.96 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.12 -30.23 69.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.764 2.025 . . . . 0.0 111.574 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.84 -5.37 56.93 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.77 -35.12 80.07 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.625 -1.297 . . . . 0.0 113.882 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.16 -1.36 48.6 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 111.386 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 118.03 12.08 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 119.877 -1.765 . . . . 0.0 111.326 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -44.99 93.32 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.6 -50.63 70.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.42 0.688 . . . . 0.0 111.244 175.102 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -55.54 -44.39 76.71 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.331 -1.481 . . . . 0.0 113.536 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.53 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.458 1.103 . . . . 0.0 112.715 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.4 -46.5 89.76 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.783 -1.198 . . . . 0.0 112.314 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.98 -37.27 79.14 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.71 -1.244 . . . . 0.0 114.111 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.05 -46.1 82.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.381 -1.45 . . . . 0.0 112.97 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.55 -34.76 73.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.76 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.737 1.215 . . . . 0.0 113.542 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.43 9.36 40.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.902 -1.124 . . . . 0.0 111.729 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.79 38.24 3.88 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 125.45 1.5 . . . . 0.0 114.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 161.33 24.6 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 125.933 1.693 . . . . 0.0 107.152 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.4 p -138.87 159.01 68.88 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.18 156.64 61.86 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.688 2.259 . . . . 0.0 114.213 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.99 117.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 122.729 1.252 . . . . 0.0 109.846 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 55.1 p -76.29 165.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.898 -1.126 . . . . 0.0 111.321 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -57.47 -46.2 99.81 Favored Pre-proline 0 C--N 1.354 0.769 0 O-C-N 120.531 -1.356 . . . . 0.0 112.671 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.37 -38.51 94.32 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 124.228 2.546 . . . . 0.0 116.051 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.47 -43.15 91.17 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.074 1.306 . . . . 0.0 112.744 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.33 -38.51 81.21 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 120.646 -1.284 . . . . 0.0 115.363 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.57 87.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.534 1.133 . . . . 0.0 113.518 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.1 90.66 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.334 1.054 . . . . 0.0 112.485 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.77 -41.17 97.35 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.46 85.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.059 0.943 . . . . 0.0 112.832 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.08 -43.46 95.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -62.22 -33.65 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.668 . . . . 0.0 113.928 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.417 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.66 2.9 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.634 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.81 41.17 50.75 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.265 -1.522 . . . . 0.0 116.32 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.28 148.05 52.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.224 1.012 . . . . 0.0 112.522 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.32 -34.28 65.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 O-C-N 121.006 -1.059 . . . . 0.0 110.582 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.4 150.72 30.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.815 -1.178 . . . . 0.0 109.679 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -115.63 128.74 56.15 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 169.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.9 mt -138.76 146.25 41.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.705 0.802 . . . . 0.0 109.552 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.53 137.94 54.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.77 30.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 123.532 1.634 . . . . 0.0 112.511 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.2 t -127.77 126.32 41.55 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.315 -0.866 . . . . 0.0 112.828 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.91 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 73.8 m -83.84 -41.21 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.556 -171.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.0 p -98.94 -13.74 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.302 93.7 mt-30 75.7 8.88 3.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.217 2.207 . . . . 0.0 113.481 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.81 115.91 5.27 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.3 -1.5 . . . . 0.0 113.08 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.01 -0.14 67.67 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.985 0.802 . . . . 0.0 114.274 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.16 -46.15 78.44 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -38.61 87.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.094 0.957 . . . . 0.0 112.316 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.76 -37.27 68.3 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.529 1.932 . . . . 0.0 112.216 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.403 ' HA ' HD13 ' A' ' 155' ' ' LEU . 94.0 t -57.64 -46.62 86.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.575 1.15 . . . . 0.0 112.535 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.15 -32.09 50.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 0.0 112.733 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.15 -44.22 97.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.405 1.082 . . . . 0.0 111.717 172.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.67 -34.06 76.17 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.013 -1.679 . . . . 0.0 114.415 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.26 88.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.617 -1.302 . . . . 0.0 112.118 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.99 -45.84 89.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 124.129 0.972 . . . . 0.0 113.449 172.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -61.48 -31.43 71.41 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.202 -1.562 . . . . 0.0 114.344 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.84 69.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.4 -39.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.351 0.657 0 C-N-CA 125.04 1.336 . . . . 0.0 112.04 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.54 -19.96 40.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.049 -1.657 . . . . 0.0 114.775 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.34 67.67 76.56 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.7 -176.41 2.47 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.688 1.592 . . . . 0.0 109.0 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -112.11 122.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.567 2.172 0 O-C-N 125.256 2.187 . . . . 0.0 116.132 157.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.048 3.166 . . . . 0.0 116.138 167.016 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.91 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.711 ' O ' HG22 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.659 HG22 ' CA ' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.51 68.32 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.866 ' O ' HG23 ' A' ' 24' ' ' THR . 11.9 t -99.81 84.76 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.737 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.887 HG21 ' HA2' ' A' ' 30' ' ' GLY . 4.9 t 174.78 -179.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 56.9 p30 -146.22 172.87 12.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.512 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 26' ' ' ASN . . . 64.37 -114.98 0.38 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.64 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 29.4 t80 -52.28 147.45 13.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.64 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -52.51 13.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.385 2.057 . . . . 0.0 113.757 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.887 ' HA2' HG21 ' A' ' 25' ' ' THR . . . 121.92 97.37 1.45 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.88 67.11 1.28 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' C ' ' HD2' ' A' ' 34' ' ' PRO . 74.1 m-85 -149.33 108.35 3.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.938 0.399 . . . . 0.0 110.872 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.836 ' O ' HG22 ' A' ' 33' ' ' ILE . 29.1 mm -113.18 19.97 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.328 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.769 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 90.2 Cg_endo -79.27 177.27 8.78 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.468 2.112 . . . . 0.0 111.52 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.667 ' O ' ' C ' ' A' ' 36' ' ' VAL . 70.4 p -68.23 -16.68 64.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.761 HG22 ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 0.96 88.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.692 ' O ' ' N ' ' A' ' 39' ' ' ASN . 94.8 m-85 -61.75 -51.9 66.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.95 11.68 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.727 0.299 . . . . 0.0 111.705 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' PHE . 87.2 m-20 54.44 18.86 2.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.183 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' ASN . 98.2 m-85 33.97 27.55 0.0 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.912 0.387 . . . . 0.0 109.968 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 39' ' ' ASN . 75.5 m -62.07 -41.9 98.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.775 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 59.53 90.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.637 ' O ' ' CE ' ' A' ' 45' ' ' MET . 67.2 t30 -71.83 61.6 0.4 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 51' ' ' VAL . 14.0 p -64.13 146.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.637 ' CE ' ' O ' ' A' ' 43' ' ' ASN . 1.0 OUTLIER -114.69 136.79 52.67 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.582 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.903 HG12 ' H ' ' A' ' 47' ' ' ASP . 2.0 t -140.69 -165.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.903 ' H ' HG12 ' A' ' 46' ' ' VAL . 98.6 m-20 -75.76 68.09 2.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.103 0.954 . . . . 0.0 111.054 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.51 89.78 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.298 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.827 ' O ' HG12 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 41' ' ' SER . 2.1 m-80 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.684 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.5 OUTLIER -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.684 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.744 ' CD1' ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.27 72.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.592 ' CG2' ' CE2' ' A' ' 40' ' ' TYR . 99.3 m -101.83 131.02 48.4 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.743 -1.223 . . . . 0.0 112.134 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 24' ' ' THR . 16.3 m 73.65 129.96 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 62.1 t30 -89.28 102.93 15.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.088 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 26' ' ' ASN . . . 158.46 133.18 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.031 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 29' ' ' PRO . 1.7 m-85 -51.23 -49.4 81.84 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.449 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 28' ' ' PHE . 51.2 Cg_exo -50.77 -149.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.467 2.778 . . . . 0.0 112.279 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 32' ' ' TYR . . . 59.57 48.8 84.24 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.744 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . 3.6 t -57.33 62.41 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.676 ' N ' HD11 ' A' ' 21' ' ' ILE . 76.0 t80 34.1 32.16 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.638 ' N ' ' O ' ' A' ' 31' ' ' CYS . 44.6 mm -64.32 136.75 96.88 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.15 22.59 0.56 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.607 1.538 . . . . 0.0 111.88 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 33' ' ' ILE . 98.6 m -61.49 -44.55 96.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.163 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG23 ' O ' ' A' ' 36' ' ' VAL . 3.3 m -61.3 101.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.71 -42.08 99.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.605 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 39' ' ' ASN . 68.0 t0 -90.41 115.89 27.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 110.83 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.585 ' OD1' ' O ' ' A' ' 39' ' ' ASN . 51.1 p30 -36.0 142.55 0.08 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.279 0.561 . . . . 0.0 111.319 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.592 ' CE2' ' CG2' ' A' ' 24' ' ' THR . 68.5 t80 -95.18 121.09 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.871 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 m -141.18 91.96 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.673 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.39 142.7 58.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.635 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.696 ' O ' ' SD ' ' A' ' 45' ' ' MET . 56.3 p30 -81.82 62.09 5.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.592 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 12.9 p -36.91 147.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.968 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.696 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 1.7 mmt -105.15 122.96 47.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.694 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER -129.77 -151.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.823 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.413 ' H ' HG12 ' A' ' 46' ' ' VAL . 66.5 t0 -82.82 67.94 9.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.145 0.974 . . . . 0.0 111.783 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 2.51 89.27 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 113.502 -1.681 . . . . 0.0 115.298 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.507 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.8 37.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.582 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 14.6 m 73.19 30.43 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 175.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.898 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 72.4 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.474 HD13 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.898 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 29' ' ' PRO . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.63 67.96 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 1.04 HG22 HG23 ' A' ' 25' ' ' THR . 76.0 m -38.43 -77.54 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 1.04 HG23 HG22 ' A' ' 24' ' ' THR . 53.2 p -133.72 157.06 46.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.573 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.714 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 27.4 t-20 -101.26 98.7 9.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.422 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 26' ' ' ASN . . . 143.31 144.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.496 0.497 . . . . 0.0 110.102 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 2.1 t80 56.97 147.25 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.66 ' O ' HG21 ' A' ' 21' ' ' ILE . 19.9 Cg_endo -60.14 -27.94 85.94 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.824 1.683 . . . . 0.0 112.343 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . 84.08 -100.98 2.37 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.619 ' O ' ' O ' ' A' ' 32' ' ' TYR . 7.0 t 72.22 81.79 0.14 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.619 ' O ' ' O ' ' A' ' 31' ' ' CYS . 51.9 m-85 -31.74 152.51 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.964 HG22 HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER 162.88 163.44 0.05 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.742 ' HD2' HG23 ' A' ' 33' ' ' ILE . 12.2 Cg_endo -55.7 14.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.923 2.415 . . . . 0.0 113.744 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.964 HG23 HG22 ' A' ' 33' ' ' ILE . 70.5 p -86.71 -18.49 31.08 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.051 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -99.46 -40.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.239 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 36' ' ' VAL . 1.4 m-30 53.03 142.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.663 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 97.0 m-20 56.31 43.37 26.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.025 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' OD1' ' C ' ' A' ' 39' ' ' ASN . 54.5 p30 -83.0 174.7 10.65 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.689 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -172.87 -101.64 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.916 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.642 ' OG ' ' O ' ' A' ' 53' ' ' LEU . 30.5 t -154.55 141.58 19.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.83 146.21 53.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.595 ' O ' ' CE ' ' A' ' 45' ' ' MET . 98.5 m-20 -79.56 64.6 4.48 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.396 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.616 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 7.4 p -41.14 129.42 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 45' ' ' MET . 0.5 OUTLIER -118.72 99.05 6.53 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.768 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.1 145.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.31 24.99 5.48 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.322 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.39 2.51 84.31 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.616 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.642 ' O ' ' OG ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.9 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.572 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 99.1 m -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.572 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.68 67.78 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 20' ' ' LEU . 15.3 t -87.87 -42.17 12.71 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 119.803 -1.811 . . . . 0.0 113.346 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.572 ' O ' ' O ' ' A' ' 21' ' ' ILE . 13.1 t -146.16 -158.48 0.91 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.552 ' CG ' ' HG2' ' A' ' 29' ' ' PRO . 44.4 t-20 -98.28 142.59 29.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.402 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . -42.63 -108.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 30.6 m-85 -39.8 -45.7 4.4 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.552 ' HG2' ' CG ' ' A' ' 26' ' ' ASN . 74.9 Cg_exo -52.87 -40.16 76.08 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.253 1.968 . . . . 0.0 113.223 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -100.02 -111.22 3.26 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.68 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 49.8 t 120.54 40.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.659 ' CD1' HD13 ' A' ' 33' ' ' ILE . 80.1 t80 61.52 133.03 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.837 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.8 OUTLIER 47.96 63.8 9.66 Favored Pre-proline 0 CA--C 1.522 -0.132 0 C-N-CA 116.655 -2.018 . . . . 0.0 109.182 -176.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.656 ' O ' ' CB ' ' A' ' 35' ' ' THR . 72.9 Cg_exo -51.74 -38.49 66.87 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.294 2.663 . . . . 0.0 112.172 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.762 ' O ' HG22 ' A' ' 35' ' ' THR . 96.1 m 111.14 44.19 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 O-C-N 124.161 0.913 . . . . 0.0 110.326 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 36' ' ' VAL . 58.6 t -93.12 19.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.652 ' CD1' ' O ' ' A' ' 36' ' ' VAL . 16.1 m-85 121.72 -58.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.399 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -159.76 173.36 16.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.115 0.484 . . . . 0.0 111.447 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.71 144.49 56.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.749 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -116.36 152.29 34.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 53' ' ' LEU . 96.4 p -89.56 11.42 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.889 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 60.93 137.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.637 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -90.28 120.83 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.574 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 9.7 p -126.22 135.74 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.343 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.73 132.61 55.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.339 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' A' ' 49' ' ' LYS . 26.3 m -135.76 -153.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.211 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -80.32 67.64 6.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.359 0.599 . . . . 0.0 112.343 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.51 90.58 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.042 -0.981 . . . . 0.0 115.298 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.579 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.672 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.52 70.64 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.2 m -62.5 -36.17 81.69 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.037 -1.039 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.14 19.85 11.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.034 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 60.4 m 73.21 30.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.29 125.46 36.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.23 59.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.924 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.4 m -84.52 -40.45 17.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.4 -13.78 19.42 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.407 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.924 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.599 ' HD3' ' SG ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.673 HD11 ' HB3' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.0 69.87 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.76 HG22 HG23 ' A' ' 25' ' ' THR . 94.4 m -103.36 129.28 50.39 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.21 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.76 HG23 HG22 ' A' ' 24' ' ' THR . 67.9 p 62.15 102.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.245 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.488 HD22 ' HG2' ' A' ' 29' ' ' PRO . 99.1 m-20 37.81 -157.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.542 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' SER . . . -122.9 -71.62 0.72 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.671 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.593 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 49.5 m-85 -60.63 -42.22 86.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.433 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 34.5 Cg_exo -59.88 144.95 99.39 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 123.251 2.634 . . . . 0.0 113.438 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.626 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.35 174.91 16.14 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.831 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' O ' ' A' ' 30' ' ' GLY . 1.3 m 156.54 28.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.784 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.673 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -85.03 70.06 10.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.328 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.682 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.18 113.32 63.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.31 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 14.9 Cg_endo -56.04 -38.26 95.03 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.923 1.749 . . . . 0.0 111.541 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.5 p -138.7 146.56 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.748 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.046 HG11 ' HB2' ' A' ' 39' ' ' ASN . 86.3 t -133.36 133.8 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -48.3 82.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.966 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 68.2 t0 -144.94 73.89 1.39 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.49 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 1.046 ' HB2' HG11 ' A' ' 36' ' ' VAL . 22.4 m120 -166.04 -30.43 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.159 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.7 42.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 39' ' ' ASN . 63.1 m -118.68 151.53 37.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.814 ' HB3' ' H ' ' A' ' 53' ' ' LEU . . . -122.69 149.56 43.9 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.691 ' O ' ' HE2' ' A' ' 45' ' ' MET . 67.3 t30 -110.99 14.1 22.02 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.097 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -23.06 129.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.131 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.691 ' HE2' ' O ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -127.72 110.32 12.52 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.583 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 47' ' ' ASP . 11.9 p -168.6 154.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 46' ' ' VAL . 97.0 m-20 56.23 17.19 2.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.021 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.88 2.51 82.04 Favored Glycine 0 C--N 1.318 -0.421 0 CA-C-N 115.137 -0.938 . . . . 0.0 115.298 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.814 ' H ' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.74 70.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.88 -36.86 82.5 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.024 -1.048 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -95.67 19.85 10.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.034 -175.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.569 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 129.3 31.12 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 74' ' ' CYS . 0.5 OUTLIER 77.18 26.32 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.371 173.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -89.76 125.46 35.3 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.59 59.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.911 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.1 m -83.82 -41.02 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.665 -171.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.96 -13.78 19.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.911 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -51.29 56.95 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.438 HG21 ' HE2' ' A' ' 40' ' ' TYR . 99.3 m -63.52 -45.38 90.86 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 124.635 1.209 . . . . 0.0 113.117 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.813 HG21 ' HB3' ' A' ' 31' ' ' CYS . 60.8 p -95.13 156.04 16.48 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.799 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -133.11 61.7 1.67 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.216 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -158.75 -157.41 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.218 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.665 ' CG ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -48.34 -165.58 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.298 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.665 ' HD3' ' CG ' ' A' ' 28' ' ' PHE . 89.8 Cg_endo -90.54 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.687 2.258 . . . . 0.0 113.169 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 32' ' ' TYR . . . -62.01 18.03 0.06 OUTLIER Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.223 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.813 ' HB3' HG21 ' A' ' 25' ' ' THR . 77.9 m -76.89 20.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.684 0.742 . . . . 0.0 110.65 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.84 ' HA ' HD13 ' A' ' 21' ' ' ILE . 76.9 m-85 -69.46 150.62 47.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.897 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.639 ' O ' ' O ' ' A' ' 32' ' ' TYR . 97.6 mt 52.95 119.84 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.92 138.06 76.97 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.901 1.734 . . . . 0.0 111.936 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -45.24 94.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.435 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.755 HG22 ' N ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -97.41 -60.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.755 ' N ' HG22 ' A' ' 36' ' ' VAL . 5.3 m-30 133.34 160.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.04 0.837 . . . . 0.0 109.814 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 25.6 m-20 155.05 171.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 40' ' ' TYR . 98.7 m-20 -98.86 11.99 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.861 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 87.9 m-85 75.88 74.86 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.215 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.635 ' O ' ' O ' ' A' ' 42' ' ' ALA . 75.1 m -60.11 -42.86 95.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.904 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 47.65 129.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.624 0.726 . . . . 0.0 111.643 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.596 ' O ' ' C ' ' A' ' 44' ' ' VAL . 98.6 m-20 -101.69 19.86 17.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.802 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.901 HG13 ' HB ' ' A' ' 51' ' ' VAL . 11.5 p -19.25 121.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.872 0.844 . . . . 0.0 110.662 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.645 ' SD ' ' N ' ' A' ' 45' ' ' MET . 0.5 OUTLIER -110.94 135.34 51.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.005 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -134.36 -157.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.463 -178.422 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' H ' ' HB ' ' A' ' 46' ' ' VAL . 54.5 p-10 -60.53 63.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.467 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.53 2.51 89.7 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HB2' HG23 ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.901 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 5.0 m 73.19 30.41 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.571 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.922 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 76.1 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.861 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GDP . . . . . 0.922 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.595 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.39 68.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 C--N 1.342 0.254 0 O-C-N 119.916 -1.74 . . . . 0.0 112.73 -179.759 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.4 t0 44.64 45.49 8.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.788 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.51 90.59 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.595 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.22 30.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.505 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.4 125.46 37.07 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.6 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.12 66.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 C--N 1.326 -0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.742 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 54.5 t0 48.67 36.31 7.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.234 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.51 90.51 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.87 64.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.133 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 48' ' ' GLY . 80.4 t . . . . . 0 C--O 1.222 -0.361 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 53.6 p30 -30.52 73.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.679 0.612 . . . . 0.0 112.604 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.09 2.51 88.94 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.54 -36.09 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 110.982 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.034 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.61 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.18 -48.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.837 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.32 71.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.2 m . . . . . 0 C--N 1.341 0.208 0 O-C-N 120.492 -1.38 . . . . 0.0 111.203 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.19 0.519 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 t0 55.66 18.16 2.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.63 2.51 89.87 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.9 45.5 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 118.471 1.136 . . . . 0.0 112.423 -174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.558 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.54 77.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 m -60.76 -26.68 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 120.294 -1.504 . . . . 0.0 114.367 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.54 19.81 18.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.304 -0.873 . . . . 0.0 112.041 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.0 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 15.2 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.38 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.687 1.13 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.09 -30.24 69.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.744 2.018 . . . . 0.0 111.574 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.85 -5.34 56.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.15 -1.37 48.61 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.25 1.42 . . . . 0.0 111.365 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.94 -1.725 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.61 -50.67 70.32 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.226 175.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.8 126.35 41.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.19 60.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 121.294 -0.879 . . . . 0.0 112.851 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 88.6 m -70.23 -45.1 67.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.71 21.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 121.723 -0.611 . . . . 0.0 112.29 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.66 8.9 3.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.228 2.211 . . . . 0.0 113.489 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.82 115.9 5.26 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.256 -1.528 . . . . 0.0 113.076 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.98 -0.11 67.62 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.952 0.787 . . . . 0.0 114.274 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.7 tp -66.2 -46.09 78.51 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.24 -38.65 87.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 112.28 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.5 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.17 167.026 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.583 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -50.02 63.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 C--N 1.345 0.382 0 O-C-N 121.598 -0.689 . . . . 0.0 112.592 -177.641 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.3 t . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 59.87 37.28 21.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.759 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.6 2.51 90.55 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.45 70.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.7 -35.92 81.29 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.012 -1.055 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.29 19.85 11.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.034 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.76 37.46 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.27 30.37 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 175.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.31 125.46 36.98 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 84.4 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.837 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.98 69.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 20' ' ' LEU . 71.2 p . . . . . 0 N--CA 1.467 0.402 0 O-C-N 120.65 -1.281 . . . . 0.0 112.751 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 121.37 0.605 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 62.27 23.85 14.15 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.57 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.46 2.51 90.62 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.55 15.2 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.727 1.149 . . . . 0.0 112.502 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 97.8 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.9 70.2 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 CA--C 1.533 0.296 0 O-C-N 120.569 -1.332 . . . . 0.0 113.88 -179.191 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 111.777 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 50.56 20.15 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.644 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.54 2.51 90.54 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 92.8 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.73 37.33 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.4 30.23 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 175.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.25 125.46 36.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.7 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.04 66.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.469 0.509 0 O-C-N 120.084 -1.635 . . . . 0.0 114.072 -178.789 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 121.236 0.541 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 60.31 28.73 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.991 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.51 90.0 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 80.3 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.72 64.56 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.256 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.676 ' CG2' ' O ' ' A' ' 49' ' ' LYS . 7.2 m . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -64.18 62.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.845 0.831 . . . . 0.0 111.489 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.62 2.51 89.84 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 115.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.676 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.54 15.19 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.736 1.153 . . . . 0.0 112.502 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.11 60.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 87.0 m -69.97 -45.44 67.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.46 -13.78 21.55 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.723 -0.611 . . . . 0.0 112.288 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.18 66.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.47 0.551 0 O-C-N 120.449 -1.407 . . . . 0.0 113.814 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 47' ' ' ASP . 1.4 t . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.789 -0.078 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 46' ' ' VAL . 66.3 t0 -81.3 67.61 7.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.668 0.747 . . . . 0.0 111.14 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.28 2.51 89.26 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.334 -1.303 . . . . 0.0 115.298 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.5 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 61.1 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.8 70.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.473 0.711 0 O-C-N 120.332 -1.48 . . . . 0.0 113.902 -179.246 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.58 68.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.618 0.723 . . . . 0.0 112.579 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.0 2.51 88.78 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.705 -1.134 . . . . 0.0 115.298 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.47 -36.1 81.4 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.858 -1.151 . . . . 0.0 111.225 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.25 19.85 11.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.034 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.15 30.49 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 175.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.42 125.46 37.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' CG ' ' SG ' ' A' ' 160' ' ' CYS . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.428 ' OG ' ' SG ' ' A' ' 160' ' ' CYS . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.539 ' SG ' ' CG ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.6 71.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 CA--C 1.53 0.201 0 O-C-N 120.64 -1.288 . . . . 0.0 113.445 -179.513 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.466 0.651 . . . . 0.0 112.301 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 54.3 t0 64.12 24.6 13.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.171 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.42 2.51 90.18 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.3 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.236 -0.915 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m 72.54 15.21 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.34 125.46 32.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.502 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 91.3 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.596 ' O ' ' OG1' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.535 ' O ' ' C ' ' A' ' 24' ' ' THR . 58.7 t80 -66.96 -49.09 66.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 20' ' ' LEU . 30.8 p . . . . . 0 C--N 1.332 -0.152 0 O-C-N 121.336 -0.853 . . . . 0.0 110.736 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 48' ' ' GLY . 5.6 m . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -47.09 66.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 82.54 2.51 90.63 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.68 -1.146 . . . . 0.0 115.298 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.601 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 126.65 21.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 87.55 12.02 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.512 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -80.16 125.46 29.86 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.7 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.58 139.54 31.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 119.121 0.873 . . . . 0.0 111.498 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.21 128.0 53.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mt -126.42 126.18 68.68 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.63 124.83 45.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.713 -1.242 . . . . 0.0 111.752 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 t -119.48 131.36 55.58 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.096 -1.003 . . . . 0.0 111.472 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.98 132.66 66.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.39 124.37 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.342 1.057 . . . . 0.0 109.463 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.08 166.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.538 -1.976 . . . . 0.0 109.914 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.07 165.85 10.44 Favored Glycine 0 CA--C 1.494 -1.231 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.64 151.46 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.275 1.83 . . . . 0.0 113.93 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.11 146.71 35.78 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 118.816 -2.427 . . . . 0.0 111.833 165.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.71 0.62 3.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.44 -16.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 O-C-N 119.206 -2.184 . . . . 0.0 113.989 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.69 17.28 9.26 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 120.365 -1.46 . . . . 0.0 115.454 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.64 -49.6 75.93 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.116 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m -61.54 -47.59 84.88 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.386 1.088 . . . . 0.0 113.004 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.1 m -63.12 -36.84 84.95 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.11 91.01 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.923 1.289 . . . . 0.0 112.31 172.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.79 -47.13 66.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.15 -48.4 88.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.127 0.876 . . . . 0.0 110.805 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -60.49 -41.36 94.1 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.94 -48.78 67.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.261 -0.899 . . . . 0.0 113.401 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.467 0.378 0 O-C-N 120.53 -1.356 . . . . 0.0 114.52 -178.445 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.534 0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.14 28.09 14.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.885 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.49 90.49 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.98 123.88 45.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 118.494 1.147 . . . . 0.0 112.413 -174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.88 110.4 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 CA-C-N 121.77 1.668 . . . . 0.0 110.613 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.7 t -117.73 129.66 73.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.015 0.926 . . . . 0.0 109.413 -172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -103.01 106.11 16.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 tp -98.53 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.096 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.28 127.41 7.98 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 120.974 -1.078 . . . . 0.0 111.308 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.76 133.03 54.26 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.934 0.894 . . . . 0.0 110.63 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.33 123.15 31.06 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.979 0.912 . . . . 0.0 108.629 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.01 11.45 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 109.682 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.92 33.86 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 124.085 1.897 . . . . 0.0 113.439 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.58 108.26 11.85 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 120.288 -1.508 . . . . 0.0 109.906 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.95 -5.58 88.85 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 120.408 -1.432 . . . . 0.0 115.938 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -62.05 145.77 52.21 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.325 1.85 . . . . 0.0 112.159 -177.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.35 -30.59 70.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.861 2.064 . . . . 0.0 112.081 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.35 -36.21 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.874 -1.142 . . . . 0.0 111.235 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -96.15 19.83 11.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.028 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -56.3 -27.18 54.63 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 113.63 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -29.53 25.68 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 175.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.9 tp -96.07 -36.97 10.81 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.978 1.311 . . . . 0.0 112.485 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -58.21 -39.68 77.42 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 119.869 -1.769 . . . . 0.0 115.181 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -65.2 -7.11 14.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 124.739 2.728 . . . . 0.0 115.587 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.29 -16.96 62.49 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.6 p -92.03 -8.15 46.79 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.607 -1.308 . . . . 0.0 112.445 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -68.47 -35.28 6.71 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 97.4 Cg_exo -52.39 130.92 38.09 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.505 2.804 . . . . 0.0 115.316 173.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.611 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 72.94 30.76 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.388 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.1 m -92.54 125.4 37.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.24 -30.87 22.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.151 0.98 . . . . 0.0 112.33 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.3 143.51 18.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.812 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.95 43.01 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.522 -1.361 . . . . 0.0 110.526 174.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.88 114.06 27.82 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.35 115.95 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.7 m -109.05 142.62 39.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.655 1.217 . . . . 0.0 112.418 -172.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -139.82 152.16 46.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 171.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -85.81 132.32 34.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.995 -1.066 . . . . 0.0 110.126 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.24 -12.79 61.58 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 125.239 1.416 . . . . 0.0 113.561 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.8 18.27 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.686 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 t -132.19 103.75 13.92 Favored Pre-proline 0 C--N 1.352 0.716 0 O-C-N 119.71 -1.869 . . . . 0.0 109.94 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -66.43 -27.12 47.22 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 123.17 2.58 . . . . 0.0 114.099 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.974 0.91 . . . . 0.0 112.597 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.35 -35.66 80.91 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.095 -1.003 . . . . 0.0 112.418 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.5 t80 -60.22 -49.26 78.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.747 1.219 . . . . 0.0 112.783 173.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.22 -23.07 60.32 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.451 -1.406 . . . . 0.0 113.175 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -66.45 -25.11 66.57 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.94 -1.725 . . . . 0.0 113.171 168.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.29 98.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 O-C-N 119.674 -1.891 . . . . 0.0 111.763 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -64.81 -48.61 73.79 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.204 1.402 . . . . 0.0 114.161 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.98 25.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.84 -62.82 0.8 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.405 -1.435 . . . . 0.0 113.016 -172.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -67.78 -44.56 77.14 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -169.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.417 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.75 -48.37 79.79 Favored Pre-proline 0 C--N 1.353 0.751 0 CA-C-O 116.667 -1.635 . . . . 0.0 113.034 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -56.25 -42.91 61.18 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.117 2.545 . . . . 0.0 114.603 172.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.12 -51.38 66.74 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 119.074 0.852 . . . . 0.0 112.726 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.21 -42.27 92.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.028 -1.67 . . . . 0.0 111.529 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -66.64 -38.44 86.9 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.98 -44.44 97.36 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.429 1.013 . . . . 0.0 112.824 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -82.49 -31.31 29.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.72 -1.237 . . . . 0.0 113.228 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.64 90.06 14.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 120.17 -1.581 . . . . 0.0 110.256 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.17 -30.84 19.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.954 1.769 . . . . 0.0 116.262 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.44 -6.59 16.1 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 124.052 0.941 . . . . 0.0 113.328 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.65 134.16 94.26 Favored Pre-proline 0 C--N 1.352 0.7 0 O-C-N 119.287 -2.133 . . . . 0.0 112.367 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.61 141.38 43.23 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 124.967 3.778 . . . . 0.0 117.685 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.7 mt -119.46 135.71 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.68 123.96 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 168.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.8 tp -89.02 124.02 33.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.87 120.68 65.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 121.977 0.894 . . . . 0.0 109.417 -174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.13 113.5 4.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.4 p -98.49 162.54 13.1 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.95 -1.324 . . . . 0.0 111.344 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.73 42.99 4.34 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.985 1.314 . . . . 0.0 112.865 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.4 -32.21 69.96 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.12 -30.23 69.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.764 2.025 . . . . 0.0 111.574 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.84 -5.37 56.93 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.77 -35.12 80.07 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.625 -1.297 . . . . 0.0 113.882 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.16 -1.36 48.6 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 111.386 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 118.03 12.08 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 119.877 -1.765 . . . . 0.0 111.326 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -44.99 93.32 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.6 -50.63 70.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.42 0.688 . . . . 0.0 111.244 175.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -55.54 -44.39 76.71 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.331 -1.481 . . . . 0.0 113.536 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.53 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.458 1.103 . . . . 0.0 112.715 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.4 -46.5 89.76 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.783 -1.198 . . . . 0.0 112.314 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.98 -37.27 79.14 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.71 -1.244 . . . . 0.0 114.111 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.05 -46.1 82.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.381 -1.45 . . . . 0.0 112.97 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.55 -34.76 73.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.76 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.737 1.215 . . . . 0.0 113.542 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.43 9.36 40.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.902 -1.124 . . . . 0.0 111.729 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.79 38.24 3.88 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 125.45 1.5 . . . . 0.0 114.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 161.33 24.6 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 125.933 1.693 . . . . 0.0 107.152 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.4 p -138.87 159.01 68.88 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.18 156.64 61.86 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.688 2.259 . . . . 0.0 114.213 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.99 117.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 122.729 1.252 . . . . 0.0 109.846 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 55.1 p -76.29 165.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.898 -1.126 . . . . 0.0 111.321 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -57.47 -46.2 99.81 Favored Pre-proline 0 C--N 1.354 0.769 0 O-C-N 120.531 -1.356 . . . . 0.0 112.671 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.37 -38.51 94.32 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 124.228 2.546 . . . . 0.0 116.051 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.47 -43.15 91.17 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.074 1.306 . . . . 0.0 112.744 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.33 -38.51 81.21 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 120.646 -1.284 . . . . 0.0 115.363 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.57 87.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.534 1.133 . . . . 0.0 113.518 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.1 90.66 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.334 1.054 . . . . 0.0 112.485 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.77 -41.17 97.35 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.46 85.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.059 0.943 . . . . 0.0 112.832 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.08 -43.46 95.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -62.22 -33.65 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.668 . . . . 0.0 113.928 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.417 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.66 2.9 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.634 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.81 41.17 50.75 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.265 -1.522 . . . . 0.0 116.32 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.28 148.05 52.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.224 1.012 . . . . 0.0 112.522 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.32 -34.28 65.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 O-C-N 121.006 -1.059 . . . . 0.0 110.582 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.4 150.72 30.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.815 -1.178 . . . . 0.0 109.679 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -115.63 128.74 56.15 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 169.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.9 mt -138.76 146.25 41.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.705 0.802 . . . . 0.0 109.552 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.53 137.94 54.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.77 30.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 123.532 1.634 . . . . 0.0 112.511 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.2 t -127.77 126.32 41.55 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.315 -0.866 . . . . 0.0 112.828 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 73.8 m -83.84 -41.21 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.556 -171.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.0 p -98.94 -13.74 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.302 93.7 mt-30 75.7 8.88 3.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.217 2.207 . . . . 0.0 113.481 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.81 115.91 5.27 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.3 -1.5 . . . . 0.0 113.08 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.01 -0.14 67.67 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.985 0.802 . . . . 0.0 114.274 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.16 -46.15 78.44 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -38.61 87.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.094 0.957 . . . . 0.0 112.316 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.76 -37.27 68.3 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.529 1.932 . . . . 0.0 112.216 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.403 ' HA ' HD13 ' A' ' 155' ' ' LEU . 94.0 t -57.64 -46.62 86.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.575 1.15 . . . . 0.0 112.535 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.15 -32.09 50.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 0.0 112.733 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.15 -44.22 97.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.405 1.082 . . . . 0.0 111.717 172.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.67 -34.06 76.17 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.013 -1.679 . . . . 0.0 114.415 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.26 88.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.617 -1.302 . . . . 0.0 112.118 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.99 -45.84 89.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 124.129 0.972 . . . . 0.0 113.449 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -61.48 -31.43 71.41 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.202 -1.562 . . . . 0.0 114.344 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.84 69.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.4 -39.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.351 0.657 0 C-N-CA 125.04 1.336 . . . . 0.0 112.04 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.54 -19.96 40.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.049 -1.657 . . . . 0.0 114.775 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.34 67.67 76.56 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.7 -176.41 2.47 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.688 1.592 . . . . 0.0 109.0 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -112.11 122.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.567 2.172 0 O-C-N 125.256 2.187 . . . . 0.0 116.132 157.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.048 3.166 . . . . 0.0 116.138 167.016 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.711 ' O ' HG22 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.51 68.32 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.866 ' O ' HG23 ' A' ' 24' ' ' THR . 11.9 t . . . . . 0 C--N 1.33 -0.27 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.737 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.903 HG12 ' H ' ' A' ' 47' ' ' ASP . 2.0 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.903 ' H ' HG12 ' A' ' 46' ' ' VAL . 98.6 m-20 -75.76 68.09 2.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.103 0.954 . . . . 0.0 111.054 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.51 89.78 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.298 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . 0.684 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.5 OUTLIER -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.684 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.27 72.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 21' ' ' ILE . 99.3 m . . . . . 0 N--CA 1.466 0.349 0 O-C-N 120.743 -1.223 . . . . 0.0 112.134 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 110.823 -0.066 . . . . 0.0 110.823 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.413 ' H ' HG12 ' A' ' 46' ' ' VAL . 66.5 t0 -82.82 67.94 9.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.145 0.974 . . . . 0.0 111.783 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 2.51 89.27 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 113.502 -1.681 . . . . 0.0 115.298 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.8 37.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.582 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 14.6 m 73.19 30.43 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 175.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 72.4 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.63 67.96 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.0 m . . . . . 0 C--N 1.343 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.664 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.467 0.414 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.31 24.99 5.48 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.322 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.39 2.51 84.31 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.9 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 99.1 m -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.68 67.78 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 20' ' ' LEU . 15.3 t . . . . . 0 CA--C 1.532 0.258 0 O-C-N 119.803 -1.811 . . . . 0.0 113.346 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' A' ' 49' ' ' LYS . 26.3 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -80.32 67.64 6.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.359 0.599 . . . . 0.0 112.343 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.51 90.58 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.042 -0.981 . . . . 0.0 115.298 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.579 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.52 70.64 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.2 m -62.5 -36.17 81.69 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.037 -1.039 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.14 19.85 11.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.034 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 60.4 m 73.21 30.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.29 125.46 36.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.23 59.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.4 m -84.52 -40.45 17.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -171.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.4 -13.78 19.42 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.599 ' HD3' ' SG ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.516 ' O ' ' O ' ' A' ' 24' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.0 69.87 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' ILE . 94.4 m . . . . . 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.21 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 47' ' ' ASP . 11.9 p . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 46' ' ' VAL . 97.0 m-20 56.23 17.19 2.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.021 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.88 2.51 82.04 Favored Glycine 0 C--N 1.318 -0.421 0 CA-C-N 115.137 -0.938 . . . . 0.0 115.298 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.74 70.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.88 -36.86 82.5 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.024 -1.048 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -95.67 19.85 10.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.034 -175.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.569 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 129.3 31.12 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.65 ' SG ' ' O ' ' A' ' 74' ' ' CYS . 0.5 OUTLIER 77.18 26.32 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.371 173.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -89.76 125.46 35.3 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.59 59.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.82 -41.02 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.665 -171.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.96 -13.78 19.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -51.29 56.95 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.233 0.195 0 O-C-N 124.635 1.209 . . . . 0.0 113.117 -177.154 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 N-CA-C 111.463 0.171 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' H ' ' HB ' ' A' ' 46' ' ' VAL . 54.5 p-10 -60.53 63.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.467 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.53 2.51 89.7 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HB2' HG23 ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 HE21 ' H ' ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 5.0 m 73.19 30.41 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.571 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 76.1 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.595 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.814 HD13 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.39 68.69 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.1 p -81.24 -52.64 7.12 Favored 'General case' 0 C--N 1.342 0.254 0 O-C-N 119.916 -1.74 . . . . 0.0 112.73 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.583 ' O ' ' O ' ' A' ' 21' ' ' ILE . 87.7 m -132.35 132.44 42.91 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.387 -0.525 . . . . 0.0 112.317 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.666 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 66.2 t30 -93.89 146.69 23.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.292 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.666 ' CB ' ' O ' ' A' ' 26' ' ' ASN . . . 107.48 145.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.781 0.676 . . . . 0.0 110.672 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.646 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 78.3 m-85 -57.3 -45.82 99.87 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.022 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 38.1 Cg_endo -66.59 -17.33 52.83 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.433 2.089 . . . . 0.0 113.24 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 31' ' ' CYS . . . -60.38 -35.11 87.73 Favored Glycine 0 N--CA 1.453 -0.208 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.814 ' HA ' HD13 ' A' ' 21' ' ' ILE . 22.6 p -23.73 93.37 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 30' ' ' GLY . 7.6 m-85 -98.85 161.84 13.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.48 1.134 . . . . 0.0 113.052 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.039 HG22 ' HD2' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -122.64 162.49 38.16 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 112.733 -2.031 . . . . 0.0 108.614 175.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 1.039 ' HD2' HG22 ' A' ' 33' ' ' ILE . 36.4 Cg_endo -65.89 -15.95 50.92 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.009 1.806 . . . . 0.0 112.007 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.1 p -70.62 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.248 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.699 HG12 ' H ' ' A' ' 38' ' ' ASP . 58.0 t -64.26 130.03 28.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -75.68 -12.31 60.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.699 ' H ' HG12 ' A' ' 36' ' ' VAL . 98.9 m-20 -61.28 -41.9 97.73 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.349 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' CG ' ' O ' ' A' ' 38' ' ' ASP . 21.0 m-20 152.88 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.202 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.585 ' CE2' ' O ' ' A' ' 55' ' ' LEU . 14.0 t80 -118.59 -37.68 3.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.788 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.4 p -72.89 163.82 27.57 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.704 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.06 141.33 48.27 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.852 0.358 . . . . 0.0 110.734 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -86.59 100.05 12.14 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.779 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.722 HG13 ' HB ' ' A' ' 51' ' ' VAL . 6.2 p -123.37 136.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.116 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.621 ' SD ' ' C ' ' A' ' 44' ' ' VAL . 4.6 mmt -129.66 121.03 26.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.3 t -127.94 128.82 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.199 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.4 t0 44.64 45.49 8.0 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.788 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.03 2.51 90.59 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.722 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.585 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.8 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.595 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.22 30.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.505 175.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.4 125.46 37.07 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.6 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.593 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 29' ' ' PRO . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.12 66.43 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -59.79 -45.05 93.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 29' ' ' PRO . 14.2 t -106.87 141.25 38.4 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.991 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.56 ' O ' ' O ' ' A' ' 25' ' ' THR . 62.0 t30 -52.43 -140.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.054 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' H ' ' CG ' ' A' ' 26' ' ' ASN . . . -63.18 142.01 58.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.1 t80 62.98 104.47 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.386 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.641 ' HA ' HG21 ' A' ' 25' ' ' THR . 39.0 Cg_exo -57.56 142.63 95.57 Favored 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 122.981 2.454 . . . . 0.0 113.176 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.612 ' H ' HG21 ' A' ' 25' ' ' THR . . . -106.51 115.05 4.6 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' C ' ' O ' ' A' ' 30' ' ' GLY . 55.8 m 23.01 -110.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.675 0.274 . . . . 0.0 110.629 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CD2' HG12 ' A' ' 33' ' ' ILE . 3.3 t80 -148.12 -91.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.62 HG12 ' CD2' ' A' ' 32' ' ' TYR . 47.8 mm -84.7 120.9 74.51 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -71.21 157.72 56.53 Favored 'Trans proline' 0 C--N 1.301 -1.972 0 C-N-CA 122.575 2.183 . . . . 0.0 112.128 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.4 p -64.81 -21.08 66.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.099 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 36' ' ' VAL . 8.3 p -120.93 126.45 75.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.439 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 23.1 p90 -108.95 58.2 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.871 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -91.14 111.16 22.52 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.625 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.44 ' C ' ' H ' ' A' ' 41' ' ' SER . 64.8 t30 58.86 46.56 13.73 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -68.61 1.42 3.18 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 121.866 0.841 . . . . 0.0 109.166 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.6 ' O ' ' O ' ' A' ' 53' ' ' LEU . 95.6 p -93.63 -3.02 53.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.802 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 50.55 116.36 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.092 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.76 ' O ' ' HE2' ' A' ' 45' ' ' MET . 48.5 p-10 -87.7 45.44 1.28 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 173' ' ' ILE . 9.7 p -36.33 137.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.442 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.76 ' HE2' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -116.65 115.41 25.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.808 -179.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.0 m -138.12 137.57 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.213 0.53 . . . . 0.0 112.252 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 54.5 t0 48.67 36.31 7.57 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.234 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 2.51 90.51 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.628 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 43' ' ' ASN . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.6 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.641 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.782 HD13 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.741 ' HE2' ' HB1' ' A' ' 42' ' ' ALA . 58.7 t80 -66.96 -49.87 64.08 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p -79.94 -21.3 44.0 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.719 HG22 ' O ' ' A' ' 21' ' ' ILE . 13.7 t -148.11 162.4 39.49 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.876 -0.73 . . . . 0.0 111.735 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.46 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 29.2 t-20 -121.94 39.26 3.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.31 149.28 42.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.339 . . . . 0.0 110.921 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.53 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.0 OUTLIER -59.61 -58.28 20.64 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.41 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.53 ' HD3' ' CB ' ' A' ' 28' ' ' PHE . 54.3 Cg_exo -49.18 -161.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.981 2.454 . . . . 0.0 112.798 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 40.36 53.97 3.35 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.782 ' HA ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.89 50.18 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.714 -179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.544 ' HB3' ' O ' ' A' ' 31' ' ' CYS . 79.9 t80 71.63 -5.19 1.7 Allowed 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 31' ' ' CYS . 1.8 mp -53.63 -48.09 94.33 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.334 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 24.5 Cg_exo -62.96 142.81 89.58 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.019 1.813 . . . . 0.0 110.022 177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -134.62 150.07 50.64 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 39' ' ' ASN . 48.2 t -147.48 90.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.294 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -65.46 -37.73 87.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.654 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.84 -42.46 97.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.514 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.683 ' H ' HG12 ' A' ' 36' ' ' VAL . 25.4 t-20 -154.96 94.45 1.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.947 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 84.3 t80 -143.11 107.13 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 92.7 p -158.73 159.98 35.85 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.247 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.066 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . . . -68.86 145.86 53.35 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.116 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 110.12 21.4 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.861 HG21 ' CD1' ' A' ' 173' ' ' ILE . 33.2 m -128.04 153.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.273 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 44' ' ' VAL . 11.5 mmt -141.89 144.46 33.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.485 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 48' ' ' GLY . 80.4 t -134.4 158.74 42.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.447 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 53.6 p30 -30.52 73.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.679 0.612 . . . . 0.0 112.604 -178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.09 2.51 88.94 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.645 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.611 ' HB ' HG23 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.066 ' CD1' ' HB2' ' A' ' 42' ' ' ALA . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 91.7 m -62.54 -36.09 81.51 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 110.982 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.034 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.61 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.861 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.676 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 72.6 mt -60.18 -48.37 88.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.837 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.455 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.32 71.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.614 ' O ' ' CB ' ' A' ' 25' ' ' THR . 43.2 m -53.97 131.34 40.18 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 120.492 -1.38 . . . . 0.0 111.203 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.614 ' CB ' ' O ' ' A' ' 24' ' ' THR . 2.3 m 95.28 -13.67 0.1 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.255 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' OD1' ' O ' ' A' ' 25' ' ' THR . 17.2 p30 32.07 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -153.77 140.24 18.75 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' O ' ' O ' ' A' ' 27' ' ' ALA . 2.6 p90 44.78 175.46 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' HD2' ' HB2' ' A' ' 28' ' ' PHE . 15.4 Cg_endo -57.2 148.93 67.01 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.556 1.504 . . . . 0.0 112.682 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 21' ' ' ILE . . . -61.3 140.72 47.75 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HG ' ' HZ ' ' A' ' 28' ' ' PHE . 1.8 m -76.79 -107.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.515 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.676 ' CE1' ' CD1' ' A' ' 21' ' ' ILE . 0.1 OUTLIER 167.78 155.95 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.668 HG22 HG22 ' A' ' 36' ' ' VAL . 26.2 pt -138.59 57.48 11.88 Favored Pre-proline 0 C--O 1.232 0.179 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.014 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 33' ' ' ILE . 63.8 Cg_exo -54.81 -43.38 59.84 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.676 2.25 . . . . 0.0 112.479 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 81.9 p -131.88 -8.13 3.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.862 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 33' ' ' ILE . 1.5 m -84.48 157.56 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.373 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' O ' ' C ' ' A' ' 38' ' ' ASP . 97.0 m-85 -77.04 -75.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.626 ' HB3' HG21 ' A' ' 33' ' ' ILE . 53.1 t0 39.97 49.18 2.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.25 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.556 ' O ' ' O ' ' A' ' 40' ' ' TYR . 32.8 m120 -100.95 16.57 24.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.498 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.556 ' O ' ' O ' ' A' ' 39' ' ' ASN . 50.1 m-85 -54.3 -143.08 0.0 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.482 0.658 . . . . 0.0 110.874 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 99.1 p -137.31 160.88 37.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.947 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 143.6 56.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.06 0.457 . . . . 0.0 110.593 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.708 ' OD1' ' HE3' ' A' ' 45' ' ' MET . 43.6 t30 -88.11 88.64 7.7 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.748 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.621 ' C ' ' SD ' ' A' ' 45' ' ' MET . 33.3 m -116.37 142.11 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.278 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.708 ' HE3' ' OD1' ' A' ' 43' ' ' ASN . 2.2 mpt? -157.36 85.76 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.647 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.63 161.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.873 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 t0 55.66 18.16 2.69 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.078 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.63 2.51 89.87 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.9 45.5 Favored Pre-proline 0 N--CA 1.45 -0.467 0 CA-C-N 118.471 1.136 . . . . 0.0 112.423 -174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.558 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.54 77.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 m -60.76 -26.68 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 120.294 -1.504 . . . . 0.0 114.367 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.54 19.81 18.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.304 -0.873 . . . . 0.0 112.041 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.0 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.53 15.2 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.38 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.687 1.13 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.09 -30.24 69.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.744 2.018 . . . . 0.0 111.574 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.85 -5.34 56.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.15 -1.37 48.61 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.25 1.42 . . . . 0.0 111.365 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.94 -1.725 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.61 -50.67 70.32 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.226 175.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.8 126.35 41.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 169.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.22 -29.19 60.2 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 121.294 -0.879 . . . . 0.0 112.851 168.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.602 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 88.6 m -70.23 -45.1 67.2 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.71 21.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 121.723 -0.611 . . . . 0.0 112.29 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.66 8.9 3.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.228 2.211 . . . . 0.0 113.489 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.82 115.9 5.26 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 120.256 -1.528 . . . . 0.0 113.076 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.98 -0.11 67.62 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.952 0.787 . . . . 0.0 114.274 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.7 tp -66.2 -46.09 78.51 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.24 -38.65 87.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.124 0.97 . . . . 0.0 112.28 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.5 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.17 167.026 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.602 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.583 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.574 ' O ' ' CB ' ' A' ' 25' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -50.02 63.61 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.3 p -89.18 -2.43 58.5 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.598 -0.689 . . . . 0.0 112.592 -177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 1.147 HG21 ' N ' ' A' ' 30' ' ' GLY . 94.2 m -109.16 130.44 55.48 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.935 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.534 ' O ' ' C ' ' A' ' 27' ' ' ALA . 33.6 m120 -47.37 135.07 11.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.31 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' C ' ' O ' ' A' ' 26' ' ' ASN . . . 27.97 -103.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.397 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 54.7 t80 -62.45 136.19 95.73 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.426 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.548 ' C ' HG21 ' A' ' 25' ' ' THR . 32.2 Cg_exo -59.59 144.86 99.32 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 123.001 2.468 . . . . 0.0 112.554 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 1.147 ' N ' HG21 ' A' ' 25' ' ' THR . . . -166.97 -177.71 38.9 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 30' ' ' GLY . 41.5 t 49.19 98.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.207 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -57.33 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.971 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.002 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.2 pp -129.58 155.04 80.89 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . 55.7 Cg_endo -69.25 142.61 50.66 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 122.311 2.007 . . . . 0.0 112.239 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.1 p -122.13 10.6 10.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.735 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.543 HG13 ' OH ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -117.16 131.28 70.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.735 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.638 ' O ' ' O ' ' A' ' 38' ' ' ASP . 97.0 m-85 -63.53 -40.84 98.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.333 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.638 ' O ' ' O ' ' A' ' 37' ' ' PHE . 45.5 t0 -6.34 -118.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.664 0.603 . . . . 0.0 111.946 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.505 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 88.3 m-20 -149.44 133.52 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.548 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 34' ' ' PRO . 43.2 m-85 -122.84 77.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.129 0.49 . . . . 0.0 110.969 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.725 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 48.7 m -121.37 -11.85 8.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.992 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . 85.52 160.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 45' ' ' MET . 50.6 p30 -100.08 35.65 2.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.816 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.784 HG11 ' CD1' ' A' ' 173' ' ' ILE . 2.0 p -68.68 113.81 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-O 121.478 0.656 . . . . 0.0 111.6 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.654 ' SD ' ' O ' ' A' ' 44' ' ' VAL . 6.9 mmt -136.86 106.15 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.3 t -125.95 135.49 63.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 59.87 37.28 21.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.759 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.6 2.51 90.55 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.776 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.588 ' C ' ' HB3' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.45 70.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.9 m -62.7 -35.92 81.29 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.012 -1.055 . . . . 0.0 110.949 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.29 19.85 11.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.034 -175.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.76 37.46 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.583 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.27 30.37 1.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.553 175.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.31 125.46 36.98 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.976 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 84.4 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.784 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.976 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.837 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.497 ' CG2' ' HA3' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.98 69.93 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.837 HG23 ' O ' ' A' ' 20' ' ' LEU . 71.2 p -51.86 169.21 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.65 -1.281 . . . . 0.0 112.751 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.558 ' O ' ' O ' ' A' ' 24' ' ' THR . 27.9 p -19.53 140.59 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.607 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -90.32 76.3 6.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.372 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.592 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -159.96 151.89 20.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.467 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.745 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 52.7 t80 54.97 151.43 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.745 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 83.5 Cg_exo -43.77 -24.42 0.76 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.414 2.076 . . . . 0.0 113.22 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . 146.77 114.17 0.82 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.984 -1.103 . . . . 0.0 112.043 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.549 ' HB3' ' OH ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -66.45 152.91 44.17 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' O ' ' O ' ' A' ' 33' ' ' ILE . 34.5 t80 -123.1 -112.14 0.32 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.248 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.575 ' O ' ' O ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER 51.6 115.19 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -178.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.38 -21.93 53.26 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.136 1.891 . . . . 0.0 111.83 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.618 ' OG1' ' CE1' ' A' ' 37' ' ' PHE . 78.3 p -82.4 168.79 17.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.667 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.121 HG22 ' HB3' ' A' ' 40' ' ' TYR . 1.1 t -116.59 122.14 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.38 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.618 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 87.3 m-85 -127.0 148.11 50.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.338 0.589 . . . . 0.0 111.242 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 52.4 t0 49.97 56.55 7.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.668 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 41' ' ' SER . 65.4 t30 57.98 50.39 10.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.704 -0.399 . . . . 0.0 112.001 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 1.121 ' HB3' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -69.27 68.84 0.21 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.898 0.856 . . . . 0.0 109.729 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 91.7 p -155.44 158.93 39.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.45 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.672 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -72.64 140.4 47.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.0 0.428 . . . . 0.0 111.207 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' A' ' 45' ' ' MET . 98.6 m-20 -101.0 10.65 40.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.841 HG23 ' HB ' ' A' ' 51' ' ' VAL . 16.7 m -10.92 133.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.779 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -135.36 95.56 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.561 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -141.34 143.07 28.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.107 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 62.27 23.85 14.15 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.57 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.46 2.51 90.62 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.841 ' HB ' HG23 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.672 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.55 15.2 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.727 1.149 . . . . 0.0 112.502 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.581 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 97.8 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.768 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.581 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.636 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.9 70.2 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -94.64 -5.2 46.22 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.569 -1.332 . . . . 0.0 113.88 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.636 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 7.2 p -137.17 177.48 7.83 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.947 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.542 ' O ' ' O ' ' A' ' 27' ' ' ALA . 53.7 p30 -92.48 -136.24 0.16 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.778 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 26' ' ' ASN . . . -45.4 -176.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.567 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 32.7 m-85 -48.7 -46.65 72.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 28' ' ' PHE . 28.0 Cg_exo -60.93 143.26 99.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 C-N-CA 122.318 2.012 . . . . 0.0 112.695 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.82 -29.11 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.684 ' C ' ' CG ' ' A' ' 32' ' ' TYR . 1.1 m 60.65 24.8 14.57 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.884 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER 52.68 -91.52 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.884 HD12 ' C ' ' A' ' 32' ' ' TYR . 3.2 mp -131.48 70.03 81.68 Favored Pre-proline 0 C--O 1.233 0.217 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.093 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.83 ' O ' HG23 ' A' ' 35' ' ' THR . 34.8 Cg_endo -65.36 -19.05 61.61 Favored 'Trans proline' 0 C--N 1.299 -2.041 0 C-N-CA 123.257 2.638 . . . . 0.0 112.486 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 34' ' ' PRO . 77.9 p 116.45 63.1 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 O-C-N 124.225 0.953 . . . . 0.0 110.041 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.93 HG12 ' CE1' ' A' ' 37' ' ' PHE . 98.7 t -64.84 -61.49 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.93 ' CE1' HG12 ' A' ' 36' ' ' VAL . 0.1 OUTLIER 167.88 -95.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.94 177.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.717 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 96.3 m-20 -92.13 11.59 24.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.748 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -76.32 119.43 20.2 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.717 ' CZ ' ' O ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -142.55 -46.37 0.33 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.429 178.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.634 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 89.7 p -162.7 162.08 26.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.138 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.78 157.45 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.758 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.665 ' O ' ' SD ' ' A' ' 45' ' ' MET . 98.6 m-20 -99.67 21.74 11.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.596 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' C ' ' O ' ' A' ' 43' ' ' ASN . 5.2 p -7.55 123.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 121.699 0.761 . . . . 0.0 110.926 -178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.665 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -120.26 85.5 2.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.127 -178.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.22 153.82 39.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 111.777 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 50.56 20.15 0.67 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.644 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.54 2.51 90.54 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.634 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 92.8 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.73 37.33 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.4 30.23 1.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.518 175.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.25 125.46 36.93 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.7 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.571 ' CG2' ' N ' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.04 66.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.5 p -84.81 -23.98 28.86 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 120.084 -1.635 . . . . 0.0 114.072 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.605 ' O ' ' HB3' ' A' ' 26' ' ' ASN . 26.3 m -96.74 -38.02 10.06 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.979 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.605 ' HB3' ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER 81.33 173.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.609 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.593 ' N ' ' CG ' ' A' ' 26' ' ' ASN . . . 24.3 -124.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.75 120.93 72.73 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HB2' HG21 ' A' ' 21' ' ' ILE . 44.4 Cg_endo -66.95 140.31 54.4 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 122.506 2.137 . . . . 0.0 114.367 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.571 ' N ' ' CG2' ' A' ' 21' ' ' ILE . . . 178.34 59.45 0.07 OUTLIER Glycine 0 CA--C 1.518 0.254 0 C-N-CA 119.422 -1.371 . . . . 0.0 112.174 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.594 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 1.1 t -177.82 48.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.435 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.954 ' CE1' HG22 ' A' ' 33' ' ' ILE . 1.8 t80 -41.24 -77.49 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.954 HG22 ' CE1' ' A' ' 32' ' ' TYR . 19.1 tt -151.51 46.84 0.39 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.67 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.594 ' HG3' ' HA ' ' A' ' 31' ' ' CYS . 91.3 Cg_endo -75.75 160.18 37.91 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.617 2.878 . . . . 0.0 112.286 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.6 m -61.4 129.51 41.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.036 0.446 . . . . 0.0 110.358 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.937 HG12 ' H ' ' A' ' 37' ' ' PHE . 21.8 t -137.14 -172.23 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.937 ' H ' HG12 ' A' ' 36' ' ' VAL . 96.6 m-85 -59.5 -45.35 91.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.761 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 37' ' ' PHE . 64.9 t0 163.46 106.66 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.129 0.268 . . . . 0.0 110.964 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.612 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 99.2 m-20 -145.98 -80.8 0.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.799 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' A' ' 39' ' ' ASN . 37.9 m-85 87.83 -32.39 0.03 OUTLIER 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.11 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 53' ' ' LEU . 88.0 p -159.03 158.86 33.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.69 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.74 152.2 31.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.915 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.569 ' HB3' ' CE ' ' A' ' 45' ' ' MET . 97.8 m-20 -87.36 119.04 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 51' ' ' VAL . 6.3 p -122.51 134.79 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.43 0.633 . . . . 0.0 111.379 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.569 ' CE ' ' HB3' ' A' ' 43' ' ' ASN . 0.5 OUTLIER -138.38 95.15 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.537 179.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 85.8 t -125.82 132.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 60.31 28.73 18.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.991 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.58 2.51 90.0 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.687 ' O ' HG12 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' HB2' ' HE2' ' A' ' 32' ' ' TYR . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 66.2 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.942 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 80.3 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.942 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.834 HG21 ' CG1' ' A' ' 33' ' ' ILE . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.622 ' CG2' ' HA3' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.72 64.56 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.4 p -66.17 -31.08 71.71 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.488 HG21 ' CA ' ' A' ' 30' ' ' GLY . 76.9 p -98.62 3.81 47.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.552 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.584 ' C ' HE22 ' A' ' 162' ' ' GLN . 98.0 m-20 55.37 33.13 20.18 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.728 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.652 ' O ' ' HA ' ' A' ' 22' ' ' SER . . . -173.89 144.5 1.04 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.749 ' CD1' ' O ' ' A' ' 160' ' ' CYS . 0.0 OUTLIER -40.46 -54.29 5.0 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.627 -179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.663 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 92.2 Cg_endo -75.51 159.18 39.77 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.209 1.939 . . . . 0.0 110.945 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.622 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . -157.94 -135.14 1.85 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.051 -1.219 . . . . 0.0 110.051 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.84 -77.3 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.775 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.872 ' H ' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -172.11 169.36 5.56 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.435 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.913 ' H ' HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -70.1 -62.21 2.41 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.582 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.768 ' HD3' ' HB ' ' A' ' 33' ' ' ILE . 83.9 Cg_endo -77.74 156.52 31.46 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.446 2.097 . . . . 0.0 111.637 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.52 28.05 5.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.872 HG21 ' H ' ' A' ' 32' ' ' TYR . 21.0 t -123.42 -41.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.859 0.361 . . . . 0.0 110.883 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.669 ' CZ ' ' HB2' ' A' ' 40' ' ' TYR . 12.3 t80 -91.81 46.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.351 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -62.43 -45.97 90.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.283 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -148.28 62.96 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.441 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.669 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.6 m-85 -88.28 68.48 8.97 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.182 0.515 . . . . 0.0 109.956 179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.59 ' OG ' ' ND2' ' A' ' 52' ' ' ASN . 39.3 t -62.25 -43.57 98.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.158 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 52' ' ' ASN . . . 69.55 126.33 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.382 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.626 ' O ' ' SD ' ' A' ' 45' ' ' MET . 50.5 p30 -118.21 36.73 4.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.944 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.926 HG12 ' O ' ' A' ' 51' ' ' VAL . 11.8 p -26.75 154.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 115.547 -0.752 . . . . 0.0 112.127 -178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.626 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 2.5 mmt -118.69 134.22 55.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.321 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.676 ' CG2' ' O ' ' A' ' 49' ' ' LYS . 7.2 m -142.87 -165.17 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.9 p-10 -64.18 62.01 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.845 0.831 . . . . 0.0 111.489 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.62 2.51 89.84 Favored Glycine 0 C--N 1.319 -0.394 0 CA-C-N 114.089 -1.414 . . . . 0.0 115.298 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.676 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.926 ' O ' HG12 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.59 ' ND2' ' OG ' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.6 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.255 -0.903 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.8 OUTLIER 72.54 15.19 5.09 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -179.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.37 125.46 32.33 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.736 1.153 . . . . 0.0 112.502 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.11 60.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.749 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 87.0 m -69.97 -45.44 67.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.46 -13.78 21.55 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.723 -0.611 . . . . 0.0 112.288 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.584 HE22 ' C ' ' A' ' 26' ' ' ASN 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.633 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.738 HD13 ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 26' ' ' ASN . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -49.18 66.26 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 25' ' ' THR . 0.7 OUTLIER -73.41 -37.83 65.8 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.449 -1.407 . . . . 0.0 113.814 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 28' ' ' PHE . 81.7 p -88.62 12.99 13.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.309 0.576 . . . . 0.0 110.613 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.602 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 98.9 m-20 64.32 -128.48 0.41 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.57 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -84.32 -8.22 59.08 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.583 ' O ' ' HB ' ' A' ' 25' ' ' THR . 95.9 m-85 -121.27 142.87 36.08 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 120.446 -0.502 . . . . 0.0 110.056 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.62 159.59 45.62 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 C-N-CA 123.423 2.749 . . . . 0.0 113.62 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.565 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -133.33 -36.76 0.26 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.738 ' HA ' HD13 ' A' ' 21' ' ' ILE . 3.8 m 83.25 99.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' H ' HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -59.06 104.95 0.28 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.872 ' C ' HD12 ' A' ' 33' ' ' ILE . 1.7 pp -90.12 159.25 42.77 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.706 ' O ' HG23 ' A' ' 35' ' ' THR . 33.5 Cg_exo -58.49 137.79 82.26 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.986 1.791 . . . . 0.0 112.086 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 46.53 127.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.409 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 38' ' ' ASP . 3.7 p -138.17 156.38 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -60.04 -44.3 94.76 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.709 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.62 ' O ' HG13 ' A' ' 36' ' ' VAL . 98.6 m-20 -83.96 153.03 24.14 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.561 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 40' ' ' TYR . 53.5 p30 -102.16 26.68 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.286 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 91.7 m-85 71.1 46.5 0.45 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.838 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.585 ' HB2' ' ND2' ' A' ' 52' ' ' ASN . 82.2 p -61.08 -38.08 84.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.462 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' VAL . . . 43.42 74.66 0.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.144 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.545 ' O ' ' OD1' ' A' ' 43' ' ' ASN . 54.5 p30 -65.85 69.66 0.05 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.201 0.525 . . . . 0.0 109.681 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.783 HG11 ' CD1' ' A' ' 173' ' ' ILE . 12.6 p -67.55 137.55 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.521 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.484 ' CE ' ' O ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -106.4 142.15 36.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.549 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 47' ' ' ASP . 1.4 t -142.33 -144.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.789 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 46' ' ' VAL . 66.3 t0 -81.3 67.61 7.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.668 0.747 . . . . 0.0 111.14 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.28 2.51 89.26 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.334 -1.303 . . . . 0.0 115.298 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.585 ' ND2' ' HB2' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 95.5 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 61.1 m 73.24 30.36 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.918 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 74.2 m -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.602 ' NE2' ' O ' ' A' ' 26' ' ' ASN 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.783 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.918 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.763 HG21 ' CB ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.8 70.5 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.5 p -89.83 -1.64 58.04 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.332 -1.48 . . . . 0.0 113.902 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.622 ' CG2' ' O ' ' A' ' 27' ' ' ALA . 30.4 m -113.78 128.35 56.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.453 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.4 p30 -78.13 -16.82 57.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.239 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.622 ' O ' ' CG2' ' A' ' 25' ' ' THR . . . -132.56 138.18 47.37 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.481 178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 16.8 m-85 -49.95 -46.68 81.44 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 31' ' ' CYS . 71.1 Cg_exo -53.99 -38.81 86.78 Favored 'Trans proline' 0 N--CA 1.505 2.194 0 C-N-CA 122.906 2.404 . . . . 0.0 115.107 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -58.46 -0.72 0.6 Allowed Glycine 0 N--CA 1.466 0.679 0 O-C-N 123.867 0.729 . . . . 0.0 112.026 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.763 ' CB ' HG21 ' A' ' 21' ' ' ILE . 28.0 p -68.12 81.81 0.22 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.651 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.621 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 16.5 t80 179.14 155.79 0.49 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 118.424 2.75 . . . . 0.0 118.424 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.925 HG23 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER 37.51 54.43 3.48 Favored Pre-proline 0 C--N 1.318 -0.776 1 CA-C-N 108.093 -4.14 . . . . 0.0 108.19 170.427 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 33' ' ' ILE . 32.0 Cg_exo -58.9 127.9 26.01 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 121.318 1.345 . . . . 0.0 111.366 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.607 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 77.6 p -130.19 2.03 4.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.093 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.757 ' O ' HG12 ' A' ' 36' ' ' VAL . 2.9 t 71.86 71.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -62.07 -43.85 97.95 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.542 -178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -171.61 108.14 0.25 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.792 0.329 . . . . 0.0 111.261 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' SER . 64.8 t30 53.55 56.6 7.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.557 ' HB2' HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -67.98 10.09 0.24 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.203 0.525 . . . . 0.0 110.085 178.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 42' ' ' ALA . 74.3 m -87.03 -5.54 59.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.942 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 48.73 128.61 0.0 OUTLIER 'General case' 0 C--O 1.227 -0.08 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.092 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.628 ' O ' ' SD ' ' A' ' 45' ' ' MET . 53.3 p-10 -92.8 50.56 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.959 HG13 ' HB ' ' A' ' 51' ' ' VAL . 2.1 p -29.39 144.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.72 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.628 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 5.0 mmt -106.8 139.17 41.64 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.72 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -143.52 -168.1 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -60.58 68.95 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.618 0.723 . . . . 0.0 112.579 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.0 2.51 88.78 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.705 -1.134 . . . . 0.0 115.298 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.959 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.587 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.7 m -62.47 -36.1 81.4 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.858 -1.151 . . . . 0.0 111.225 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.25 19.85 11.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.034 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 130.81 37.68 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER 73.15 30.49 1.58 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 175.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.42 125.46 37.08 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' CG ' ' SG ' ' A' ' 160' ' ' CYS . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.428 ' OG ' ' SG ' ' A' ' 160' ' ' CYS . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.43 59.36 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.892 ' SG ' ' N1 ' ' A' ' 201' ' ' GDP . 0.6 OUTLIER -83.94 -41.08 17.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.601 -171.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.892 ' CD1' HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.892 ' N1 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.6 71.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.6 p -84.04 -67.22 0.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.64 -1.288 . . . . 0.0 113.445 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.55 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 14.3 t -146.67 160.11 42.62 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.786 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.61 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 50.9 t30 -100.2 106.14 17.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.406 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 26' ' ' ASN . . . 166.61 115.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.641 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 44.9 m-85 -54.4 -48.09 95.75 Favored Pre-proline 0 CA--C 1.519 -0.215 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.952 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 36.3 Cg_endo -65.06 -24.72 59.37 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 C-N-CA 121.795 1.664 . . . . 0.0 112.072 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.594 ' O ' ' O ' ' A' ' 31' ' ' CYS . . . -93.5 -3.73 64.55 Favored Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.78 ' O ' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -28.12 145.1 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.78 ' C ' ' O ' ' A' ' 31' ' ' CYS . 37.9 t80 -20.17 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' N ' ' O ' ' A' ' 31' ' ' CYS . 16.8 tt -142.55 126.25 9.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.085 176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.99 -20.5 57.46 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.756 2.304 . . . . 0.0 112.792 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.445 ' C ' HG23 ' A' ' 36' ' ' VAL . 52.3 p -90.39 98.99 12.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.175 0.512 . . . . 0.0 111.543 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 36' ' ' VAL . 84.5 t -153.86 46.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.046 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 96.5 m-85 66.48 2.21 2.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.417 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -169.89 173.14 6.24 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.614 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -77.33 158.08 30.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 33' ' ' ILE . 1.5 m-85 -107.35 72.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.254 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.9 m -123.95 128.96 50.18 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . . . -68.89 135.35 50.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.35 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' O ' ' HG3' ' A' ' 45' ' ' MET . 65.6 t30 -98.5 16.91 20.32 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG11 HD13 ' A' ' 173' ' ' ILE . 6.1 p -26.67 126.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.243 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.572 ' HG3' ' O ' ' A' ' 43' ' ' ASN . 0.5 OUTLIER -120.98 88.09 2.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.091 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG23 HG22 ' A' ' 44' ' ' VAL . 65.5 t -127.22 132.43 69.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.466 0.651 . . . . 0.0 112.301 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 54.3 t0 64.12 24.6 13.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.171 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.42 2.51 90.18 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.55 77.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 73.3 m -60.79 -26.62 67.41 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.255 -1.528 . . . . 0.0 114.307 176.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.62 19.85 18.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 121.236 -0.915 . . . . 0.0 112.034 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.66 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m 72.54 15.21 5.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.34 125.46 32.31 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.786 1.175 . . . . 0.0 112.502 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.23 60.38 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.6 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 91.3 m -70.25 -45.07 67.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.38 -13.78 21.64 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.647 -0.658 . . . . 0.0 112.288 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.536 HD13 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.6 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.655 ' CG2' ' CD2' ' A' ' 32' ' ' TYR . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.693 HD11 ' CD2' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.535 ' O ' ' C ' ' A' ' 24' ' ' THR . 58.7 t80 -66.96 -49.09 66.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 20' ' ' LEU . 30.8 p -34.87 -39.16 0.09 Allowed 'General case' 0 C--N 1.332 -0.152 0 O-C-N 121.336 -0.853 . . . . 0.0 110.736 -178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.522 ' CB ' ' HZ ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -163.42 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.361 0.601 . . . . 0.0 111.062 179.396 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.664 ' O ' ' O ' ' A' ' 27' ' ' ALA . 4.9 p-10 -158.25 -179.19 7.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.448 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.69 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -28.18 -114.88 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 36.24 171.39 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.544 ' CD ' ' HB2' ' A' ' 28' ' ' PHE . 62.8 Cg_endo -96.69 -103.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.576 2.851 . . . . 0.0 113.479 -177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.34 -91.65 1.15 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.558 ' HB3' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 178.49 -159.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 1.017 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -108.57 -60.96 1.67 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.67 -178.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.017 HD12 ' C ' ' A' ' 32' ' ' TYR . 2.9 mp -135.41 49.34 3.48 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 73.6 Cg_endo -72.68 158.41 50.62 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.488 2.792 . . . . 0.0 111.803 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 76.4 m -77.98 106.17 9.67 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.017 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 38' ' ' ASP . 61.4 t -126.56 130.55 71.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -55.51 -22.55 21.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.858 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.637 ' H ' HG12 ' A' ' 36' ' ' VAL . 80.1 m-20 -62.02 -42.15 98.85 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.353 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.585 ' CG ' ' O ' ' A' ' 38' ' ' ASP . 14.5 m-20 166.6 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 40' ' ' TYR . 1.4 t80 -136.08 -11.78 1.95 Allowed 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.92 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.5 t -139.79 137.88 35.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.952 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.27 153.42 43.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.877 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.609 ' O ' ' O ' ' A' ' 44' ' ' VAL . 33.1 m120 -99.11 29.71 3.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.551 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.855 HG11 HD11 ' A' ' 173' ' ' ILE . 0.1 OUTLIER -6.87 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.585 -178.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.548 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 6.1 mmt -99.17 120.6 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.766 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 48' ' ' GLY . 5.6 m -133.42 168.88 23.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.17 -178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -47.09 66.74 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 82.54 2.51 90.63 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 114.68 -1.146 . . . . 0.0 115.298 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.601 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.827 ' HB ' HG23 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 126.65 21.31 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 87.55 12.02 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.512 171.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -80.16 125.46 29.86 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.917 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.7 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.855 HD11 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.917 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mmm . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.58 139.54 31.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 119.121 0.873 . . . . 0.0 111.498 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.21 128.0 53.81 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mt -126.42 126.18 68.68 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.611 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.63 124.83 45.22 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.713 -1.242 . . . . 0.0 111.752 174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 t -119.48 131.36 55.58 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.096 -1.003 . . . . 0.0 111.472 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.5 t -116.98 132.66 66.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.39 124.37 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.342 1.057 . . . . 0.0 109.463 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.08 166.45 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.538 -1.976 . . . . 0.0 109.914 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.07 165.85 10.44 Favored Glycine 0 CA--C 1.494 -1.231 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.64 151.46 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.275 1.83 . . . . 0.0 113.93 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.11 146.71 35.78 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 118.816 -2.427 . . . . 0.0 111.833 165.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.71 0.62 3.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.44 -16.64 15.03 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 O-C-N 119.206 -2.184 . . . . 0.0 113.989 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.69 17.28 9.26 Favored Glycine 0 C--N 1.345 1.076 0 O-C-N 120.365 -1.46 . . . . 0.0 115.454 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.64 -49.6 75.93 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.116 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 32' ' ' TYR . 14.8 m -61.54 -47.59 84.88 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.386 1.088 . . . . 0.0 113.004 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.1 m -63.12 -36.84 84.95 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.11 91.01 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 124.923 1.289 . . . . 0.0 112.31 172.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.7 mt -68.79 -47.13 66.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 175.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 32' ' ' TYR . 72.8 mt -60.15 -48.4 88.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.127 0.876 . . . . 0.0 110.805 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.6 t -60.49 -41.36 94.1 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.94 -48.78 67.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 O-C-N 121.261 -0.899 . . . . 0.0 113.401 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.2 p -93.11 -10.08 37.24 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 120.53 -1.356 . . . . 0.0 114.52 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.627 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 14.7 p -137.76 -173.38 3.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.571 -0.852 . . . . 0.0 112.21 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -70.08 159.05 34.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.746 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.19 86.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.118 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.665 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 98.2 m-85 -64.49 178.1 0.5 Allowed Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 28' ' ' PHE . 52.5 Cg_exo -51.4 118.98 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 120.867 1.044 . . . . 0.0 111.218 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . -90.85 -127.63 3.72 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.409 -178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.31 69.49 1.0 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.21 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.696 ' HB3' HD11 ' A' ' 21' ' ' ILE . 46.8 p90 -70.15 -16.64 63.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.881 HG23 HG23 ' A' ' 35' ' ' THR . 19.1 tt -56.57 139.55 75.33 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.5 ' HD2' HG13 ' A' ' 33' ' ' ILE . 17.7 Cg_endo -58.69 71.63 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.744 1.629 . . . . 0.0 111.517 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.881 HG23 HG23 ' A' ' 33' ' ' ILE . 81.5 p -129.88 150.43 51.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.509 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 t -131.14 130.45 63.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.114 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p90 -135.44 -7.36 2.24 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.977 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 37' ' ' PHE . 98.1 m-20 -136.22 -105.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.694 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 41' ' ' SER . 61.3 t-20 -146.79 117.17 7.43 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.757 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -61.62 3.02 0.15 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.945 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.705 ' OG ' ' ND2' ' A' ' 52' ' ' ASN . 12.3 t -59.8 -43.53 94.4 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 124.254 0.971 . . . . 0.0 110.973 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . 78.3 131.17 0.05 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.582 ' HA ' ' HE3' ' A' ' 45' ' ' MET . 65.0 t30 -79.98 79.09 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.892 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.633 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -126.36 110.49 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.949 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.715 ' O ' HG13 ' A' ' 46' ' ' VAL . 1.1 mpt? -147.21 131.66 17.64 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.651 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 45' ' ' MET . 1.5 m -161.59 154.63 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.227 0.537 . . . . 0.0 111.882 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 57.14 28.09 14.47 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.885 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.49 90.49 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.98 123.88 45.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 118.494 1.147 . . . . 0.0 112.413 -174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.88 110.4 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.403 0 CA-C-N 121.77 1.668 . . . . 0.0 110.613 -178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 44' ' ' VAL . 70.7 t -117.73 129.66 73.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.015 0.926 . . . . 0.0 109.413 -172.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.705 ' ND2' ' OG ' ' A' ' 41' ' ' SER . 3.2 m120 -103.01 106.11 16.56 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 171.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.8 tp -98.53 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.096 -176.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.28 127.41 7.98 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 120.974 -1.078 . . . . 0.0 111.308 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.76 133.03 54.26 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.934 0.894 . . . . 0.0 110.63 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.33 123.15 31.06 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 123.979 0.912 . . . . 0.0 108.629 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.01 11.45 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.037 1.335 . . . . 0.0 109.682 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.92 33.86 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 124.085 1.897 . . . . 0.0 113.439 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.58 108.26 11.85 Favored 'General case' 0 N--CA 1.438 -1.06 0 O-C-N 120.288 -1.508 . . . . 0.0 109.906 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.95 -5.58 88.85 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 120.408 -1.432 . . . . 0.0 115.938 -171.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -62.05 145.77 52.21 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.325 1.85 . . . . 0.0 112.159 -177.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.35 -30.59 70.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.861 2.064 . . . . 0.0 112.081 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.6 m -62.35 -36.21 81.51 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 120.874 -1.142 . . . . 0.0 111.235 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -96.15 19.83 11.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.028 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -56.3 -27.18 54.63 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 113.63 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.62 -29.53 25.68 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 175.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.9 tp -96.07 -36.97 10.81 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.978 1.311 . . . . 0.0 112.485 -173.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.0 ttp-105 -58.21 -39.68 77.42 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 119.869 -1.769 . . . . 0.0 115.181 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -65.2 -7.11 14.64 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 CA-C-N 124.739 2.728 . . . . 0.0 115.587 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.29 -16.96 62.49 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 111.832 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.6 p -92.03 -8.15 46.79 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 120.607 -1.308 . . . . 0.0 112.445 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.7 m-30 -68.47 -35.28 6.71 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 117.77 2.507 . . . . 0.0 117.77 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 97.4 Cg_exo -52.39 130.92 38.09 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.505 2.804 . . . . 0.0 115.316 173.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.611 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 2.8 m 72.94 30.76 1.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.388 175.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.1 m -92.54 125.4 37.16 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 170.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.24 -30.87 22.01 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.151 0.98 . . . . 0.0 112.33 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.3 143.51 18.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.812 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.95 43.01 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.522 -1.361 . . . . 0.0 110.526 174.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.88 114.06 27.82 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.35 115.95 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.7 m -109.05 142.62 39.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 122.655 1.217 . . . . 0.0 112.418 -172.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -139.82 152.16 46.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 171.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -85.81 132.32 34.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.995 -1.066 . . . . 0.0 110.126 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.24 -12.79 61.58 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 125.239 1.416 . . . . 0.0 113.561 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -110.8 18.27 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.686 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.5 t -132.19 103.75 13.92 Favored Pre-proline 0 C--N 1.352 0.716 0 O-C-N 119.71 -1.869 . . . . 0.0 109.94 173.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -66.43 -27.12 47.22 Favored 'Trans proline' 0 C--N 1.33 -0.419 0 C-N-CA 123.17 2.58 . . . . 0.0 114.099 174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.974 0.91 . . . . 0.0 112.597 175.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.35 -35.66 80.91 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.095 -1.003 . . . . 0.0 112.418 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.5 t80 -60.22 -49.26 78.34 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.747 1.219 . . . . 0.0 112.783 173.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.22 -23.07 60.32 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 120.451 -1.406 . . . . 0.0 113.175 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -66.45 -25.11 66.57 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 119.94 -1.725 . . . . 0.0 113.171 168.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.3 t -63.18 -43.29 98.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 O-C-N 119.674 -1.891 . . . . 0.0 111.763 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -64.81 -48.61 73.79 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.204 1.402 . . . . 0.0 114.161 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.98 25.57 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.84 -62.82 0.8 Allowed 'General case' 0 C--N 1.356 0.86 0 O-C-N 120.405 -1.435 . . . . 0.0 113.016 -172.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -67.78 -44.56 77.14 Favored 'General case' 0 C--N 1.349 0.566 0 N-CA-C 117.303 2.335 . . . . 0.0 117.303 -169.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.417 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.75 -48.37 79.79 Favored Pre-proline 0 C--N 1.353 0.751 0 CA-C-O 116.667 -1.635 . . . . 0.0 113.034 171.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -56.25 -42.91 61.18 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.117 2.545 . . . . 0.0 114.603 172.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.12 -51.38 66.74 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 119.074 0.852 . . . . 0.0 112.726 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.21 -42.27 92.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 120.028 -1.67 . . . . 0.0 111.529 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -66.64 -38.44 86.9 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.98 -44.44 97.36 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.429 1.013 . . . . 0.0 112.824 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -82.49 -31.31 29.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.72 -1.237 . . . . 0.0 113.228 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.64 90.06 14.96 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 120.17 -1.581 . . . . 0.0 110.256 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.17 -30.84 19.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 121.954 1.769 . . . . 0.0 116.262 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.44 -6.59 16.1 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 124.052 0.941 . . . . 0.0 113.328 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.65 134.16 94.26 Favored Pre-proline 0 C--N 1.352 0.7 0 O-C-N 119.287 -2.133 . . . . 0.0 112.367 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -51.61 141.38 43.23 Favored 'Trans proline' 0 C--N 1.328 -0.514 0 C-N-CA 124.967 3.778 . . . . 0.0 117.685 167.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.7 mt -119.46 135.71 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.68 123.96 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 168.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.8 tp -89.02 124.02 33.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.87 120.68 65.37 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 121.977 0.894 . . . . 0.0 109.417 -174.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.13 113.5 4.14 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.4 p -98.49 162.54 13.1 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 120.95 -1.324 . . . . 0.0 111.344 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.73 42.99 4.34 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.985 1.314 . . . . 0.0 112.865 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.4 -32.21 69.96 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.12 -30.23 69.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.764 2.025 . . . . 0.0 111.574 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 67.1 mt -89.84 -5.37 56.93 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.77 -35.12 80.07 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.625 -1.297 . . . . 0.0 113.882 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.16 -1.36 48.6 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 125.25 1.42 . . . . 0.0 111.386 178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.73 118.03 12.08 Favored 'General case' 0 C--N 1.354 0.804 0 O-C-N 119.877 -1.765 . . . . 0.0 111.326 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.64 -44.99 93.32 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -174.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.6 -50.63 70.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.42 0.688 . . . . 0.0 111.244 175.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 65.3 m -55.54 -44.39 76.71 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.331 -1.481 . . . . 0.0 113.536 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.53 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 C-N-CA 124.458 1.103 . . . . 0.0 112.715 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.4 -46.5 89.76 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 120.783 -1.198 . . . . 0.0 112.314 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.98 -37.27 79.14 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.71 -1.244 . . . . 0.0 114.111 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.2 mt -65.05 -46.1 82.63 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.381 -1.45 . . . . 0.0 112.97 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -59.55 -34.76 73.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.76 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.737 1.215 . . . . 0.0 113.542 172.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.43 9.36 40.29 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.902 -1.124 . . . . 0.0 111.729 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.79 38.24 3.88 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 125.45 1.5 . . . . 0.0 114.315 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 161.33 24.6 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 125.933 1.693 . . . . 0.0 107.152 -177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.4 p -138.87 159.01 68.88 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.18 156.64 61.86 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.688 2.259 . . . . 0.0 114.213 171.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.99 117.72 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-O 122.729 1.252 . . . . 0.0 109.846 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 55.1 p -76.29 165.3 25.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.898 -1.126 . . . . 0.0 111.321 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -57.47 -46.2 99.81 Favored Pre-proline 0 C--N 1.354 0.769 0 O-C-N 120.531 -1.356 . . . . 0.0 112.671 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.37 -38.51 94.32 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 CA-C-N 124.228 2.546 . . . . 0.0 116.051 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.47 -43.15 91.17 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.074 1.306 . . . . 0.0 112.744 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.33 -38.51 81.21 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 120.646 -1.284 . . . . 0.0 115.363 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.57 87.81 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.534 1.133 . . . . 0.0 113.518 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.1 90.66 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.334 1.054 . . . . 0.0 112.485 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.77 -41.17 97.35 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 176.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.46 85.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.059 0.943 . . . . 0.0 112.832 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.08 -43.46 95.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -62.22 -33.65 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 125.869 1.668 . . . . 0.0 113.928 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.417 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.66 2.9 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.634 177.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.81 41.17 50.75 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.265 -1.522 . . . . 0.0 116.32 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.28 148.05 52.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.224 1.012 . . . . 0.0 112.522 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.32 -34.28 65.17 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 O-C-N 121.006 -1.059 . . . . 0.0 110.582 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.4 150.72 30.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.815 -1.178 . . . . 0.0 109.679 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -115.63 128.74 56.15 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 169.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.9 mt -138.76 146.25 41.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.705 0.802 . . . . 0.0 109.552 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.53 137.94 54.11 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.77 30.1 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 123.532 1.634 . . . . 0.0 112.511 -173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.2 t -127.77 126.32 41.55 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.17 -20.46 59.33 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.315 -0.866 . . . . 0.0 112.828 168.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.91 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 73.8 m -83.84 -41.21 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.556 -171.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.0 p -98.94 -13.74 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.248 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.302 93.7 mt-30 75.7 8.88 3.63 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.217 2.207 . . . . 0.0 113.481 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.81 115.91 5.27 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.3 -1.5 . . . . 0.0 113.08 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.01 -0.14 67.67 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.985 0.802 . . . . 0.0 114.274 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.16 -46.15 78.44 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -38.61 87.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.094 0.957 . . . . 0.0 112.316 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.76 -37.27 68.3 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 126.529 1.932 . . . . 0.0 112.216 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.403 ' HA ' HD13 ' A' ' 155' ' ' LEU . 94.0 t -57.64 -46.62 86.5 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 124.575 1.15 . . . . 0.0 112.535 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.15 -32.09 50.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 121.054 -1.028 . . . . 0.0 112.733 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.15 -44.22 97.09 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.405 1.082 . . . . 0.0 111.717 172.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -67.67 -34.06 76.17 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.013 -1.679 . . . . 0.0 114.415 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.5 -43.26 88.98 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 120.617 -1.302 . . . . 0.0 112.118 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.99 -45.84 89.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 C-N-CA 124.129 0.972 . . . . 0.0 113.449 172.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.3 mtm-85 -61.48 -31.43 71.41 Favored 'General case' 0 C--N 1.351 0.649 0 O-C-N 120.202 -1.562 . . . . 0.0 114.344 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.06 -29.84 69.97 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.4 -39.59 11.44 Favored 'Isoleucine or valine' 0 C--N 1.351 0.657 0 C-N-CA 125.04 1.336 . . . . 0.0 112.04 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.54 -19.96 40.99 Favored 'General case' 0 CA--C 1.505 -0.776 0 O-C-N 120.049 -1.657 . . . . 0.0 114.775 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.34 67.67 76.56 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.7 -176.41 2.47 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 121.688 1.592 . . . . 0.0 109.0 -175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -112.11 122.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.567 2.172 0 O-C-N 125.256 2.187 . . . . 0.0 116.132 157.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.048 3.166 . . . . 0.0 116.138 167.016 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.91 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.711 ' O ' HG22 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.659 HG22 ' CA ' ' A' ' 30' ' ' GLY . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.51 68.32 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.866 ' O ' HG23 ' A' ' 24' ' ' THR . 11.9 t -99.81 84.76 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.737 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.887 HG21 ' HA2' ' A' ' 30' ' ' GLY . 4.9 t 174.78 -179.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.197 0.522 . . . . 0.0 111.067 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 56.9 p30 -146.22 172.87 12.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.512 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 26' ' ' ASN . . . 64.37 -114.98 0.38 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.64 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 29.4 t80 -52.28 147.45 13.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.64 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 9.7 Cg_endo -52.51 13.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.385 2.057 . . . . 0.0 113.757 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.887 ' HA2' HG21 ' A' ' 25' ' ' THR . . . 121.92 97.37 1.45 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.88 67.11 1.28 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' C ' ' HD2' ' A' ' 34' ' ' PRO . 74.1 m-85 -149.33 108.35 3.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.938 0.399 . . . . 0.0 110.872 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.836 ' O ' HG22 ' A' ' 33' ' ' ILE . 29.1 mm -113.18 19.97 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.328 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.769 ' CD ' ' N ' ' A' ' 33' ' ' ILE . 90.2 Cg_endo -79.27 177.27 8.78 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 122.468 2.112 . . . . 0.0 111.52 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.667 ' O ' ' C ' ' A' ' 36' ' ' VAL . 70.4 p -68.23 -16.68 64.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.048 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.761 HG22 ' HG2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 0.96 88.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.692 ' O ' ' N ' ' A' ' 39' ' ' ASN . 94.8 m-85 -61.75 -51.9 66.46 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.856 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 38.95 11.68 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.727 0.299 . . . . 0.0 111.705 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.692 ' N ' ' O ' ' A' ' 37' ' ' PHE . 87.2 m-20 54.44 18.86 2.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.183 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' C ' ' O ' ' A' ' 39' ' ' ASN . 98.2 m-85 33.97 27.55 0.0 OUTLIER 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.912 0.387 . . . . 0.0 109.968 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.653 ' N ' ' O ' ' A' ' 39' ' ' ASN . 75.5 m -62.07 -41.9 98.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.775 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 59.53 90.01 0.06 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.637 ' O ' ' CE ' ' A' ' 45' ' ' MET . 67.2 t30 -71.83 61.6 0.4 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.827 HG12 ' O ' ' A' ' 51' ' ' VAL . 14.0 p -64.13 146.38 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.63 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.637 ' CE ' ' O ' ' A' ' 43' ' ' ASN . 1.0 OUTLIER -114.69 136.79 52.67 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.582 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.903 HG12 ' H ' ' A' ' 47' ' ' ASP . 2.0 t -140.69 -165.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.903 ' H ' HG12 ' A' ' 46' ' ' VAL . 98.6 m-20 -75.76 68.09 2.28 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.103 0.954 . . . . 0.0 111.054 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.59 2.51 89.78 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 113.633 -1.621 . . . . 0.0 115.298 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.827 ' O ' HG12 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.57 ' ND2' ' HB3' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.7 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.684 ' SG ' HG23 ' A' ' 161' ' ' THR . 0.5 OUTLIER -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.684 HG23 ' SG ' ' A' ' 160' ' ' CYS . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.534 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.744 ' CD1' ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -47.27 72.1 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.592 ' CG2' ' CE2' ' A' ' 40' ' ' TYR . 99.3 m -101.83 131.02 48.4 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.743 -1.223 . . . . 0.0 112.134 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 24' ' ' THR . 16.3 m 73.65 129.96 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.977 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 62.1 t30 -89.28 102.93 15.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.088 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 26' ' ' ASN . . . 158.46 133.18 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.031 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.529 ' O ' ' O ' ' A' ' 29' ' ' PRO . 1.7 m-85 -51.23 -49.4 81.84 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.449 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 28' ' ' PHE . 51.2 Cg_exo -50.77 -149.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 123.467 2.778 . . . . 0.0 112.279 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 32' ' ' TYR . . . 59.57 48.8 84.24 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.744 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . 3.6 t -57.33 62.41 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.676 ' N ' HD11 ' A' ' 21' ' ' ILE . 76.0 t80 34.1 32.16 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.638 ' N ' ' O ' ' A' ' 31' ' ' CYS . 44.6 mm -64.32 136.75 96.88 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.15 22.59 0.56 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 C-N-CA 121.607 1.538 . . . . 0.0 111.88 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 33' ' ' ILE . 98.6 m -61.49 -44.55 96.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.163 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.768 ' O ' HG23 ' A' ' 36' ' ' VAL . 3.3 m -61.3 101.52 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.71 -42.08 99.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.605 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 39' ' ' ASN . 68.0 t0 -90.41 115.89 27.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 110.83 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.585 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 51.1 p30 -36.0 142.55 0.08 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.279 0.561 . . . . 0.0 111.319 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.592 ' CE2' ' CG2' ' A' ' 24' ' ' THR . 68.5 t80 -95.18 121.09 36.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.871 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.5 m -141.18 91.96 2.44 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.673 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.39 142.7 58.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.635 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.696 ' O ' ' SD ' ' A' ' 45' ' ' MET . 56.3 p30 -81.82 62.09 5.46 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.592 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 12.9 p -36.91 147.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.968 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.696 ' SD ' ' O ' ' A' ' 43' ' ' ASN . 1.7 mmt -105.15 122.96 47.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.694 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 47' ' ' ASP . 0.5 OUTLIER -129.77 -151.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.823 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.413 ' H ' HG12 ' A' ' 46' ' ' VAL . 66.5 t0 -82.82 67.94 9.09 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.145 0.974 . . . . 0.0 111.783 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.29 2.51 89.27 Favored Glycine 0 C--N 1.318 -0.463 0 CA-C-N 113.502 -1.681 . . . . 0.0 115.298 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.592 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.507 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.54 -36.06 81.42 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.019 -1.051 . . . . 0.0 111.005 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.23 19.85 11.24 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.034 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.8 37.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.582 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 14.6 m 73.19 30.43 1.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 175.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.898 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 72.4 m -83.83 -41.21 17.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.597 -171.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.93 -13.78 19.83 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.474 HD13 HG11 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.898 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.66 HG21 ' O ' ' A' ' 29' ' ' PRO . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.63 67.96 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 1.04 HG22 HG23 ' A' ' 25' ' ' THR . 76.0 m -38.43 -77.54 0.02 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 1.04 HG23 HG22 ' A' ' 24' ' ' THR . 53.2 p -133.72 157.06 46.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.573 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.714 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 27.4 t-20 -101.26 98.7 9.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.422 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.714 ' HB2' ' O ' ' A' ' 26' ' ' ASN . . . 143.31 144.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.496 0.497 . . . . 0.0 110.102 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CD2' ' HD2' ' A' ' 29' ' ' PRO . 2.1 t80 56.97 147.25 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.66 ' O ' HG21 ' A' ' 21' ' ' ILE . 19.9 Cg_endo -60.14 -27.94 85.94 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 C-N-CA 121.824 1.683 . . . . 0.0 112.343 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . 84.08 -100.98 2.37 Favored Glycine 0 N--CA 1.453 -0.212 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.619 ' O ' ' O ' ' A' ' 32' ' ' TYR . 7.0 t 72.22 81.79 0.14 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.619 ' O ' ' O ' ' A' ' 31' ' ' CYS . 51.9 m-85 -31.74 152.51 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.964 HG22 HG23 ' A' ' 35' ' ' THR . 0.2 OUTLIER 162.88 163.44 0.05 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.742 ' HD2' HG23 ' A' ' 33' ' ' ILE . 12.2 Cg_endo -55.7 14.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.923 2.415 . . . . 0.0 113.744 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.964 HG23 HG22 ' A' ' 33' ' ' ILE . 70.5 p -86.71 -18.49 31.08 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.051 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -99.46 -40.04 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 120.937 0.398 . . . . 0.0 110.239 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' O ' ' O ' ' A' ' 36' ' ' VAL . 1.4 m-30 53.03 142.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.663 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 97.0 m-20 56.31 43.37 26.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.025 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.424 ' C ' ' OD1' ' A' ' 39' ' ' ASN . 54.5 p30 -83.0 174.7 10.65 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.689 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -172.87 -101.64 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.916 -179.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.642 ' OG ' ' O ' ' A' ' 53' ' ' LEU . 30.5 t -154.55 141.58 19.3 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.206 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.83 146.21 53.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.595 ' O ' ' CE ' ' A' ' 45' ' ' MET . 98.5 m-20 -79.56 64.6 4.48 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.396 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.616 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 7.4 p -41.14 129.42 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 119.909 -0.717 . . . . 0.0 109.912 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.659 ' N ' ' SD ' ' A' ' 45' ' ' MET . 0.5 OUTLIER -118.72 99.05 6.53 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.768 -178.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.1 145.2 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.31 24.99 5.48 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.322 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.39 2.51 84.31 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.616 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.642 ' O ' ' OG ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -35.63 78.14 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 71.9 m -61.19 -26.36 67.67 Favored 'General case' 0 CA--C 1.553 1.068 0 O-C-N 120.933 -1.105 . . . . 0.0 113.679 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -102.59 19.85 18.27 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.034 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -52.4 137.65 56.62 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 t 72.79 15.21 4.82 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -84.41 125.46 32.35 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 119.078 0.854 . . . . 0.0 112.502 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -29.19 60.37 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.572 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 99.1 m -70.58 -44.85 66.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -97.34 -13.78 21.68 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.572 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.592 ' O ' HG22 ' A' ' 24' ' ' THR . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 31' ' ' CYS . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.68 67.78 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 20' ' ' LEU . 15.3 t -87.87 -42.17 12.71 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 119.803 -1.811 . . . . 0.0 113.346 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.572 ' O ' ' O ' ' A' ' 21' ' ' ILE . 13.1 t -146.16 -158.48 0.91 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.552 ' CG ' ' HG2' ' A' ' 29' ' ' PRO . 44.4 t-20 -98.28 142.59 29.74 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.402 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' N ' ' OD1' ' A' ' 26' ' ' ASN . . . -42.63 -108.54 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 30.6 m-85 -39.8 -45.7 4.4 Favored Pre-proline 0 N--CA 1.468 0.46 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.552 ' HG2' ' CG ' ' A' ' 26' ' ' ASN . 74.9 Cg_exo -52.87 -40.16 76.08 Favored 'Trans proline' 0 C--N 1.295 -2.246 0 C-N-CA 122.253 1.968 . . . . 0.0 113.223 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 31' ' ' CYS . . . -100.02 -111.22 3.26 Favored Glycine 0 CA--C 1.52 0.344 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.68 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 49.8 t 120.54 40.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.659 ' CD1' HD13 ' A' ' 33' ' ' ILE . 80.1 t80 61.52 133.03 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.837 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.8 OUTLIER 47.96 63.8 9.66 Favored Pre-proline 0 CA--C 1.522 -0.132 0 C-N-CA 116.655 -2.018 . . . . 0.0 109.182 -176.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.656 ' O ' ' CB ' ' A' ' 35' ' ' THR . 72.9 Cg_exo -51.74 -38.49 66.87 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 123.294 2.663 . . . . 0.0 112.172 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.762 ' O ' HG22 ' A' ' 35' ' ' THR . 96.1 m 111.14 44.19 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 O-C-N 124.161 0.913 . . . . 0.0 110.326 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.73 ' O ' HG12 ' A' ' 36' ' ' VAL . 58.6 t -93.12 19.86 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.652 ' CD1' ' O ' ' A' ' 36' ' ' VAL . 16.1 m-85 121.72 -58.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.399 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -159.76 173.36 16.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.115 0.484 . . . . 0.0 111.447 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.71 144.49 56.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.749 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -116.36 152.29 34.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.874 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.672 ' O ' ' O ' ' A' ' 53' ' ' LEU . 96.4 p -89.56 11.42 19.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.889 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 60.93 137.9 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.637 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -90.28 120.83 31.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.574 ' CG1' ' HB ' ' A' ' 51' ' ' VAL . 9.7 p -126.22 135.74 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.343 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -113.73 132.61 55.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.339 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.579 ' CG2' ' HB2' ' A' ' 49' ' ' LYS . 26.3 m -135.76 -153.07 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.211 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -80.32 67.64 6.22 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.359 0.599 . . . . 0.0 112.343 -178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.02 2.51 90.58 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.042 -0.981 . . . . 0.0 115.298 177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.579 ' HB2' ' CG2' ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' HB ' ' CG1' ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.422 ' ND2' ' OG ' ' A' ' 41' ' ' SER . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.672 ' O ' ' O ' ' A' ' 41' ' ' SER . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.52 70.64 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 96.2 m -62.5 -36.17 81.69 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.037 -1.039 . . . . 0.0 110.934 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.14 19.85 11.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.034 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 60.4 m 73.21 30.35 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.535 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.29 125.46 36.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.23 59.46 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.924 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.4 m -84.52 -40.45 17.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 -171.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.4 -13.78 19.42 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.407 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.924 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.599 ' HD3' ' SG ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.673 HD11 ' HB3' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -48.0 69.87 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.76 HG22 HG23 ' A' ' 25' ' ' THR . 94.4 m -103.36 129.28 50.39 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.041 -0.412 . . . . 0.0 111.21 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.76 HG23 HG22 ' A' ' 24' ' ' THR . 67.9 p 62.15 102.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.245 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.488 HD22 ' HG2' ' A' ' 29' ' ' PRO . 99.1 m-20 37.81 -157.92 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.542 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 22' ' ' SER . . . -122.9 -71.62 0.72 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.671 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.593 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 49.5 m-85 -60.63 -42.22 86.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.433 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 34.5 Cg_exo -59.88 144.95 99.39 Favored 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 123.251 2.634 . . . . 0.0 113.438 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.626 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -65.35 174.91 16.14 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.831 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.626 ' SG ' ' O ' ' A' ' 30' ' ' GLY . 1.3 m 156.54 28.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.373 -0.913 . . . . 0.0 108.784 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.673 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -85.03 70.06 10.88 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.328 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.682 HD12 ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -106.18 113.32 63.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ILE . 14.9 Cg_endo -56.04 -38.26 95.03 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.923 1.749 . . . . 0.0 111.541 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.5 p -138.7 146.56 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.748 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.046 HG11 ' HB2' ' A' ' 39' ' ' ASN . 86.3 t -133.36 133.8 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.135 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -60.54 -48.3 82.38 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.966 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 68.2 t0 -144.94 73.89 1.39 Allowed 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.49 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 1.046 ' HB2' HG11 ' A' ' 36' ' ' VAL . 22.4 m120 -166.04 -30.43 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.159 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.7 42.93 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 39' ' ' ASN . 63.1 m -118.68 151.53 37.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.814 ' HB3' ' H ' ' A' ' 53' ' ' LEU . . . -122.69 149.56 43.9 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.691 ' O ' ' HE2' ' A' ' 45' ' ' MET . 67.3 t30 -110.99 14.1 22.02 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.097 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -23.06 129.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.131 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.691 ' HE2' ' O ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -127.72 110.32 12.52 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.583 179.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 47' ' ' ASP . 11.9 p -168.6 154.58 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' N ' HG22 ' A' ' 46' ' ' VAL . 97.0 m-20 56.23 17.19 2.67 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.021 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.88 2.51 82.04 Favored Glycine 0 C--N 1.318 -0.421 0 CA-C-N 115.137 -0.938 . . . . 0.0 115.298 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 42' ' ' ALA . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.814 ' H ' ' HB3' ' A' ' 42' ' ' ALA . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.74 70.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.1 m -61.88 -36.86 82.5 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.024 -1.048 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -95.67 19.85 10.59 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.034 -175.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.569 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 129.3 31.12 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.65 ' O ' ' SG ' ' A' ' 74' ' ' CYS . 0.5 OUTLIER 77.18 26.32 0.73 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.371 173.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -89.76 125.46 35.3 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.59 59.28 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.911 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 75.1 m -83.82 -41.02 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.665 -171.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -98.96 -13.78 19.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.911 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -95.55 139.53 31.68 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 119.156 0.889 . . . . 0.0 111.509 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.18 127.93 53.77 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -176.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.5 mt -126.38 126.18 68.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 74' ' ' CYS . 82.6 tttt -99.59 124.84 45.17 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 120.758 -1.214 . . . . 0.0 111.768 174.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.1 t -119.48 131.31 55.57 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.128 -0.983 . . . . 0.0 111.49 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.9 132.66 65.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 C-N-CA 124.616 1.166 . . . . 0.0 109.149 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.39 124.37 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.344 1.057 . . . . 0.0 109.47 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.07 166.48 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 O-C-N 119.588 -1.945 . . . . 0.0 109.918 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.04 165.84 10.43 Favored Glycine 0 CA--C 1.494 -1.227 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -48.68 151.52 1.15 Allowed 'General case' 0 C--N 1.347 0.499 0 C-N-CA 126.239 1.815 . . . . 0.0 113.927 -177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.17 146.72 35.97 Favored Glycine 0 C--N 1.346 1.137 0 O-C-N 118.856 -2.403 . . . . 0.0 111.836 165.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.69 0.62 3.69 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 116.658 2.096 . . . . 0.0 116.658 178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.39 -16.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 O-C-N 119.224 -2.172 . . . . 0.0 114.01 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.7 17.28 9.26 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 120.352 -1.467 . . . . 0.0 115.454 176.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -57.55 -49.61 75.8 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 119.325 1.562 . . . . 0.0 114.183 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 m -61.57 -47.5 85.2 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-O 122.364 1.078 . . . . 0.0 113.019 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 93.8 m -63.21 -36.8 84.84 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.3 -46.13 90.95 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.894 1.278 . . . . 0.0 112.325 172.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.76 -47.14 66.98 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 175.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.84 HD13 ' HA ' ' A' ' 32' ' ' TYR . 72.6 mt -60.17 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 CA-C-N 119.111 0.869 . . . . 0.0 110.813 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -60.46 -41.32 93.89 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.96 -51.29 56.95 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 121.257 -0.902 . . . . 0.0 113.357 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.438 HG21 ' HE2' ' A' ' 40' ' ' TYR . 99.3 m -63.52 -45.38 90.86 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 124.635 1.209 . . . . 0.0 113.117 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.813 HG21 ' HB3' ' A' ' 31' ' ' CYS . 60.8 p -95.13 156.04 16.48 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.799 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -133.11 61.7 1.67 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.216 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 28' ' ' PHE . . . -158.75 -157.41 0.61 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.218 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.665 ' CG ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -48.34 -165.58 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.298 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.665 ' HD3' ' CG ' ' A' ' 28' ' ' PHE . 89.8 Cg_endo -90.54 -36.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.687 2.258 . . . . 0.0 113.169 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 32' ' ' TYR . . . -62.01 18.03 0.06 OUTLIER Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.223 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.813 ' HB3' HG21 ' A' ' 25' ' ' THR . 77.9 m -76.89 20.98 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.684 0.742 . . . . 0.0 110.65 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.84 ' HA ' HD13 ' A' ' 21' ' ' ILE . 76.9 m-85 -69.46 150.62 47.01 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.897 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.639 ' O ' ' O ' ' A' ' 32' ' ' TYR . 97.6 mt 52.95 119.84 0.0 OUTLIER Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.92 138.06 76.97 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.901 1.734 . . . . 0.0 111.936 -177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 99.4 m -62.22 -45.24 94.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.435 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.755 HG22 ' N ' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -97.41 -60.96 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.878 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.755 ' N ' HG22 ' A' ' 36' ' ' VAL . 5.3 m-30 133.34 160.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.04 0.837 . . . . 0.0 109.814 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 25.6 m-20 155.05 171.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 40' ' ' TYR . 98.7 m-20 -98.86 11.99 37.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.861 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 87.9 m-85 75.88 74.86 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.215 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.635 ' O ' ' O ' ' A' ' 42' ' ' ALA . 75.1 m -60.11 -42.86 95.63 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.904 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.635 ' O ' ' O ' ' A' ' 41' ' ' SER . . . 47.65 129.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.624 0.726 . . . . 0.0 111.643 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.596 ' O ' ' C ' ' A' ' 44' ' ' VAL . 98.6 m-20 -101.69 19.86 17.33 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.802 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.901 HG13 ' HB ' ' A' ' 51' ' ' VAL . 11.5 p -19.25 121.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.872 0.844 . . . . 0.0 110.662 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.645 ' N ' ' SD ' ' A' ' 45' ' ' MET . 0.5 OUTLIER -110.94 135.34 51.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.005 -178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -134.36 -157.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.463 -178.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' H ' ' HB ' ' A' ' 46' ' ' VAL . 54.5 p-10 -60.53 63.85 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.09 0.472 . . . . 0.0 111.467 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 46' ' ' VAL . . . 80.53 2.51 89.7 Favored Glycine 0 C--O 1.227 -0.329 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HB2' HG23 ' A' ' 46' ' ' VAL . 99.3 mttt -100.01 123.87 45.61 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 118.471 1.136 . . . . 0.0 112.4 -174.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -89.85 110.41 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.407 0 CA-C-N 121.766 1.666 . . . . 0.0 110.637 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.901 ' HB ' HG13 ' A' ' 44' ' ' VAL . 71.0 t -117.74 129.65 73.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 C-N-CA 124.008 0.923 . . . . 0.0 109.416 -172.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -102.99 106.12 16.59 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.7 tp -98.57 104.17 16.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 124.24 1.016 . . . . 0.0 111.057 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.29 127.4 7.97 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 120.921 -1.112 . . . . 0.0 111.335 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.9 mt -111.74 133.02 54.25 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.963 0.905 . . . . 0.0 110.663 -174.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -129.4 123.13 30.9 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.993 0.917 . . . . 0.0 108.593 -176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -88.06 170.0 11.46 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.003 1.321 . . . . 0.0 109.686 171.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . 0.259 36.0 p -141.32 141.93 33.86 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 124.076 1.893 . . . . 0.0 113.434 -175.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.6 108.31 11.91 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 120.346 -1.471 . . . . 0.0 109.929 168.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.98 -5.61 88.9 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 120.435 -1.415 . . . . 0.0 115.887 -171.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' H ' HE21 ' A' ' 61' ' ' GLN . 0.5 OUTLIER -61.99 145.79 52.01 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 126.347 1.859 . . . . 0.0 112.185 -178.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.45 -30.49 70.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.829 2.052 . . . . 0.0 112.043 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 97.6 m -62.58 -36.04 81.45 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.019 -1.051 . . . . 0.0 110.965 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -96.2 19.85 11.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.034 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -56.35 -27.12 54.96 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 124.776 1.23 . . . . 0.0 113.637 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.69 -29.51 25.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 175.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 66.1 tp -96.01 -37.03 10.82 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.035 1.334 . . . . 0.0 112.492 -173.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -58.2 -39.65 77.22 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 119.884 -1.76 . . . . 0.0 115.165 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -65.28 -7.09 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 CA-C-N 124.742 2.729 . . . . 0.0 115.529 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.1 mt -71.28 -16.98 62.49 Favored 'General case' 0 C--N 1.355 0.826 0 CA-C-N 120.706 1.594 . . . . 0.0 111.812 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.5 p -92.02 -8.15 46.82 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.574 -1.329 . . . . 0.0 112.426 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -68.51 -35.23 6.58 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 117.758 2.503 . . . . 0.0 117.758 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 74' ' ' CYS . 96.5 Cg_exo -52.4 130.81 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.558 2.839 . . . . 0.0 115.291 173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.591 ' O ' ' HD3' ' A' ' 5' ' ' LYS . 5.0 m 73.19 30.41 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.571 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.0 m -92.36 125.46 37.03 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -86.25 -30.95 21.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.154 0.982 . . . . 0.0 112.311 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.26 143.53 18.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 O-C-N 120.962 -1.086 . . . . 0.0 110.839 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -108.88 139.91 43.07 Favored 'General case' 0 C--N 1.348 0.522 0 O-C-N 120.517 -1.365 . . . . 0.0 110.526 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.85 114.06 27.81 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 164.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -100.3 115.97 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 175.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.8 m -109.08 142.65 39.5 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 122.689 1.233 . . . . 0.0 112.426 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -139.83 152.1 46.24 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 171.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.1 t -85.79 132.3 34.15 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.985 -1.072 . . . . 0.0 110.156 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.1 mt -68.17 -12.83 61.61 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 125.253 1.421 . . . . 0.0 113.566 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.8 18.32 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 O-C-N 121.022 -1.049 . . . . 0.0 110.708 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.4 t -132.2 103.79 13.91 Favored Pre-proline 0 C--N 1.353 0.741 0 O-C-N 119.655 -1.903 . . . . 0.0 109.955 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -66.53 -27.03 46.53 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.132 2.555 . . . . 0.0 114.118 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.45 -42.28 96.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.98 0.912 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -66.38 -35.68 80.95 Favored 'General case' 0 C--N 1.356 0.878 0 O-C-N 121.084 -1.01 . . . . 0.0 112.429 176.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 145' ' ' MET . 31.4 t80 -60.15 -49.3 78.2 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.732 1.213 . . . . 0.0 112.774 173.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -73.27 -22.99 60.26 Favored 'General case' 0 C--N 1.347 0.495 0 O-C-N 120.445 -1.41 . . . . 0.0 113.157 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -66.53 -25.04 66.47 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 119.946 -1.721 . . . . 0.0 113.132 168.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -63.18 -43.32 98.76 Favored 'Isoleucine or valine' 0 C--N 1.345 0.411 0 O-C-N 119.628 -1.92 . . . . 0.0 111.747 168.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttm-85 -64.81 -48.65 73.63 Favored 'General case' 0 CA--C 1.506 -0.722 0 C-N-CA 125.259 1.423 . . . . 0.0 114.136 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.18 -21.96 25.59 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -132.81 -62.88 0.8 Allowed 'General case' 0 C--N 1.355 0.822 0 O-C-N 120.431 -1.418 . . . . 0.0 112.993 -172.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -67.74 -44.55 77.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 -169.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 149' ' ' ILE . 92.0 t80 -63.77 -48.34 79.75 Favored Pre-proline 0 C--N 1.354 0.778 0 CA-C-O 116.659 -1.639 . . . . 0.0 113.025 171.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -56.3 -42.89 61.23 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.09 2.527 . . . . 0.0 114.608 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -63.11 -51.38 66.76 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-N 119.07 0.85 . . . . 0.0 112.717 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.0 t -61.14 -42.32 92.85 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 120.068 -1.645 . . . . 0.0 111.558 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 mmt-85 -66.64 -38.49 87.01 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -60.9 -44.5 97.06 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.424 1.011 . . . . 0.0 112.832 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -82.42 -31.35 29.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 120.704 -1.247 . . . . 0.0 113.256 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.1 m -137.62 90.05 15.02 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.167 -1.583 . . . . 0.0 110.287 -176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -70.23 -30.78 19.58 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 121.949 1.766 . . . . 0.0 116.256 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -108.46 -6.62 16.07 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.11 0.964 . . . . 0.0 113.346 -172.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.8 t -66.67 134.16 94.24 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 119.287 -2.133 . . . . 0.0 112.337 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.55 141.33 42.84 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 124.971 3.781 . . . . 0.0 117.716 167.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 82.0 mt -119.4 135.77 58.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.4 mm -112.74 123.91 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 168.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.7 tp -89.0 124.02 33.88 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.367 -0.833 . . . . 0.0 108.757 176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 t -117.88 120.63 65.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-O 121.947 0.879 . . . . 0.0 109.415 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -89.09 113.46 4.12 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 169.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 p -98.42 162.56 13.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.98 -1.306 . . . . 0.0 111.369 -175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 89.2 mttt 64.65 43.04 4.45 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 125.03 1.332 . . . . 0.0 112.878 178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.45 -32.19 70.0 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.06 -30.23 69.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.751 2.02 . . . . 0.0 111.601 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.7 mt -89.87 -5.34 56.92 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -64.81 -35.1 80.01 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.663 -1.273 . . . . 0.0 113.865 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -96.13 -1.35 48.72 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.236 1.414 . . . . 0.0 111.4 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.74 118.04 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 119.916 -1.74 . . . . 0.0 111.335 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -59.68 -44.95 93.41 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.4 OUTLIER -62.62 -50.68 70.27 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 123.417 0.687 . . . . 0.0 111.189 175.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 64.8 m -55.48 -44.43 76.49 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 120.342 -1.474 . . . . 0.0 113.526 176.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 95.9 mt -61.54 -45.57 98.37 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 C-N-CA 124.483 1.113 . . . . 0.0 112.68 174.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.757 -1.215 . . . . 0.0 112.335 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 124' ' ' ASP . 12.7 mptt -59.99 -37.31 79.29 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.764 -1.21 . . . . 0.0 114.091 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 92.3 mt -65.04 -46.04 82.91 Favored 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 120.357 -1.464 . . . . 0.0 113.0 169.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -59.55 -34.81 73.14 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.666 1.186 . . . . 0.0 113.487 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.95 -35.99 69.75 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.769 1.228 . . . . 0.0 113.533 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -95.47 9.39 40.22 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 120.87 -1.144 . . . . 0.0 111.709 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.5 mttt 66.76 38.29 3.91 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 125.429 1.492 . . . . 0.0 114.304 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.17 161.35 24.65 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 125.916 1.686 . . . . 0.0 107.123 -177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 36.3 p -138.88 159.0 68.87 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -65.19 156.64 61.88 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.708 2.272 . . . . 0.0 114.2 171.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.4 mm -73.98 117.73 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-O 122.742 1.258 . . . . 0.0 109.85 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 54.5 p -76.31 165.32 25.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 120.871 -1.143 . . . . 0.0 111.277 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.52 -46.18 99.8 Favored Pre-proline 0 C--N 1.354 0.796 0 O-C-N 120.507 -1.371 . . . . 0.0 112.66 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -57.38 -38.5 94.31 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 CA-C-N 124.275 2.563 . . . . 0.0 116.054 170.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -65.43 -43.2 91.24 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.133 1.333 . . . . 0.0 112.765 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.34 -38.45 81.1 Favored Glycine 0 C--N 1.347 1.147 0 O-C-N 120.652 -1.28 . . . . 0.0 115.363 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.61 -37.59 87.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 124.53 1.132 . . . . 0.0 113.511 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.03 90.89 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.343 1.057 . . . . 0.0 112.509 173.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 90' ' ' PHE . 13.5 tpt -61.86 -41.15 97.5 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.46 85.11 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 124.081 0.952 . . . . 0.0 112.814 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -64.11 -43.38 95.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 172.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.26 -33.66 75.05 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.814 1.646 . . . . 0.0 113.941 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 98' ' ' TYR . 32.3 pt -95.57 2.79 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 121.257 -0.902 . . . . 0.0 112.638 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.13 51.35 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 120.26 -1.525 . . . . 0.0 116.304 -175.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.22 148.04 52.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.186 0.993 . . . . 0.0 112.522 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.2 t -68.33 -34.33 65.41 Favored 'Isoleucine or valine' 0 C--N 1.345 0.386 0 O-C-N 121.003 -1.061 . . . . 0.0 110.57 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 30.1 tptt -151.42 150.7 30.75 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 120.765 -1.209 . . . . 0.0 109.727 -178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -115.65 128.73 56.14 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 168' ' ' VAL . 39.7 mt -138.73 146.28 41.29 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 123.704 0.802 . . . . 0.0 109.549 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -120.55 137.93 54.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 31.4 p -148.39 165.79 30.03 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 123.482 1.611 . . . . 0.0 112.532 -173.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 t -127.78 126.31 41.51 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 169.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.16 -20.47 59.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.274 -0.891 . . . . 0.0 112.867 168.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.922 ' SG ' ' C6 ' ' A' ' 201' ' ' GDP . 76.1 m -83.88 -41.07 17.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.633 -171.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.7 p -99.02 -13.78 19.73 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . 0.301 93.7 mt-30 75.71 8.88 3.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.213 2.205 . . . . 0.0 113.489 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -63.8 115.9 5.25 Favored 'General case' 0 C--N 1.353 0.751 0 O-C-N 120.313 -1.492 . . . . 0.0 113.076 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.0 -0.1 67.77 Favored Glycine 0 C--N 1.354 1.573 0 C-N-CA 123.971 0.796 . . . . 0.0 114.228 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.6 tp -66.2 -46.12 78.41 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -170.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -61.23 -38.63 87.34 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.103 0.961 . . . . 0.0 112.302 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 33.4 m -55.72 -37.33 68.27 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.54 1.936 . . . . 0.0 112.243 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.404 ' HA ' HD13 ' A' ' 155' ' ' LEU . 93.9 t -57.65 -46.54 86.52 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 C-N-CA 124.53 1.132 . . . . 0.0 112.567 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.16 -32.17 50.1 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.081 -1.012 . . . . 0.0 112.722 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -62.09 -44.24 97.09 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.373 1.069 . . . . 0.0 111.728 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -67.62 -34.11 76.33 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 120.073 -1.642 . . . . 0.0 114.424 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.3 88.85 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.631 -1.293 . . . . 0.0 112.095 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.861 ' CD1' HG21 ' A' ' 44' ' ' VAL . 96.8 mt -65.98 -45.86 89.76 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 C-N-CA 124.104 0.962 . . . . 0.0 113.472 172.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.5 mtm-85 -61.37 -31.53 71.42 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.169 -1.582 . . . . 0.0 114.349 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.98 -29.88 69.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 172.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -92.42 -39.53 11.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 C-N-CA 125.001 1.32 . . . . 0.0 112.04 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.1 mt -81.56 -19.95 40.96 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 120.079 -1.638 . . . . 0.0 114.807 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 65.9 m -133.35 67.71 76.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -84.71 -176.43 2.47 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.678 1.585 . . . . 0.0 108.986 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -112.08 122.64 0.02 OUTLIER 'Trans proline' 0 CA--C 1.568 2.175 0 O-C-N 125.314 2.218 . . . . 0.0 116.151 157.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo . . . . . 0 C--O 1.259 1.573 0 C-N-CA 124.044 3.163 . . . . 0.0 116.134 167.026 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GDP . . . . . 0.922 ' C6 ' ' SG ' ' A' ' 160' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_